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Summary 
The first part of this thesis aims to develop new tools to explore mitochondrial Ca2+ dynamic in vivo by the 
improvement of a mitochondria targeting Cameleon probes and by creating a mitochondria targeted 
Channelrhodopsin.  
Genetically encoded calcium indicators (GECIs) allow quantitative Ca2+ measurements in different 
experimental models. Organelle-specific targeting signals are fused with the GECI’s sequence, achieving 
selective targeting to a specific organelle or cytoplasmic domain. Moreover, GECI’s coding sequences can 
be placed under the control of tissue specific or inducible promoters, allowing spatial and temporal control of 
their expression. Different types of GECIs have been created: in our laboratory we use a class of FRET-
based Ca2+ sensors, called Cameleons. FRET (Förster resonance energy transfer) microscopy detects the 
direct transfer of energy from a donor to an acceptor fluorescence protein (FP) in a living cell. Cameleon 
structure consists of two Ca2+-responsive elements that alter the efficiency of FRET between two FPs: a cyan 
fluorescent protein (CFP), the donor, and a yellow fluorescent protein (cpV), the acceptor. The two Ca2+-
responsive elements are Calmodulin (CaM) and the CaM-binding domain of myosin light chain kinase.   
As reported in the beginning, the aim of this study is to develop novel molecular sensors and new 
methodologies to express the probes in vivo in intact tissues as well as in organisms in order to explore 
organelle Ca2+ dynamics in vivo (in particularly in brain and heart).  
One of the limitations of Cameleon probes, especially critical for in vivo applications, is the low fluorescence 
of CFP, reducing the maximal obtainable signal-to-noise ratio, and a multi-exponential lifetime, indicating 
the presence of multiple excited-state decay pathways. Recently, a brighter and more stable FP, compared to 
CFP, has been developed: mCerulean3. It has high fluorescence quantum yield and high photostability, 
making this protein a good donor candidate in Cameleon probes. For this reason, CFP has been replaced with 
mCerulean3 in two different Cameleons: the cytosolic D3cpv and the mitochondria-targeted probe named 
4mtD3cpv. The new probes have been tested in different cell types: HeLa, neonatal rat cardiomyocytes and 
neonatal mouse neurons. The brightness, the photostability, the pH-sensitivity and the dissociation constant 
(Kd) of the new probes have also been measured in situ and the data show a clear improvement in brightness 
and in photostability, compared to the original Cameleons, in both cytosolic and mitochondrial probes. The 
only drawback of the new probes is a reduced amplitude (about 20-30%) in the maximum change in the 
fluorescence emission ratio due to Ca2+ binding (dynamic range). In order to extend the dynamic range 
different approaches have been used. The addition of 16 glycines between the two Ca2+ responsive elements 
allowed us to generate a new cytosolic probe (D3mCerulean3+16) with an increased dynamic range (+ 20%). 
Similarly, we have modified the mitochondrial probe, starting from the targeting sequence, each N-terminal 
sequence of COX-VIII (subunit VIII of human cytochrome C oxidase) was elongated of 5 aminoacids. 
Indeed, 24 h after transfection a significant mis-localization in the cytosol was observed with the original 
probe, while the mis-targeting of the modified targeting sequence containing probe was decreased. 
Moreover, the reduction in the dynamic range due to the mCerulean3 presence was almost fully recovered 
adding the 16 glycines linker. We than analysed the effect of pH, observing a general stability of all the 
probe variants in the pH range tested. Finally, we evaluated the Ca2+ affinity of all the mitochondrial variants 
generated so far, obtaining a Kd of 0.06 µM and one of 10.84 µM in 4mtD3cpV, a Kd of 6,5 µM  in 
4mtD3mCerulean3 and a Kd of 0.03 µM and one of 10.7 µM in 4mtD3mCerulean3+16. To better 
characterize the new cytosolic and mitochondrial Cameleon probes, we purified the proteins expressed in 
E.Coli in order to measure also in vitro all the parameters described above. Up to now only preliminary data 
have been obtained, however a comparison of in situ and in vitro data suggests that the DR calculated for 
cytosolic probes is about 3, while that for a mitochondria like environment is about 2.5. Concerning the Ca2+ 
affinity, just few [Ca2+] concentrations have been tested so far, therefore all the mitochondrial and cytosolic 
probes display a single Kd. However, further experiments are required to confirm the in vitro calculated Kd.  
In parallel, we are also assessing another method to measure Ca2+ with FRET-GECIs, as an alternative of the 
classical intensity-based method. We are indeed employing FLIM technique that measures the lifetime of 
FPs (the time the molecule spend in the exited state), which is totally independent from phenomena such as 
probe photobleaching, expression level, image shading. Preliminary results in cells expressing all the 
Camelon probes described so far, suggest the presence of homo-FRET phenomena and mCerulean3-based 
Ca2+ sensors seem to be less affected by them.  
Finally, to express the new probes in vivo we are testing three strategies: i) adeno-associated virus (serotype 
9) with cardiac tropism viral vectors; ii) adeno-associated virus (serotype 9) with neuron-specific promoters 
(synapsin promoter) for intracranial injection; iii) transgenic mice. These strategies will allow us to perform 
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in vivo Ca2+ measurements in different tissues and subcellular compartments. We have just generated the 
AAV9 for the expression of the D3mCerulean3 and 4mD3mCerulean3 under the control of CMV promoter. 
A good expression levels in heart was obtained through intraperiotneal injection of neonatal mice. 
In conclusion, the results obtained so far make the mCerulean3-based Cameleons an attractive choice for in 
vivo experiments.  
To study the role of mitochondria in situ and in vivo, we also took advantage of an optogenetic tool: Channel 
Rhodopsins (ChRs). ChRs represent the only type of ion channels directly gated by light. When excited by 
light, ChRs open and depolarize the plasma membrane. For activation, opsins require binding of retinal, a 
vitamin A–related organic cofactor. In collaboration with Prof. Sekler’s group (Ben-Gurion University-
Israel), we have developed a new mitochondria-targeted ChR, called mitochondrial Stabilized Step Function 
Opsin (4mt-SSFO). This ChR variant was modified to stabilize the conducting state of the channel: SSFO 
deactivation occurs in 30 minutes after a brief pulse of activating blue light (460-480 nm). It has also been 
reported the possibility to terminate the photocurrents with red light. To create a non-functional control, a 
truncated form Chr2(TR) lacking retinal binding site was generated. The targeting of proteins to the inner 
mitochondrial membrane (IMM) was obtained fusing four signal sequences, derived from human 
cytochrome C oxidase subunit VIII sequence, to the N-terminus of ChR. To verify the correct topology of 
the probe, confocal microscopy, elecrtophisiological recordings and fluorescence quenching experiments 
were carried out. When 4mtSSFO-YFP is properly inserted in the IMM, its C-terminal YFP tag should face 
the mitochondrial matrix. Indeed, the application of proteinase K to Digitonin permeabilized cells did not 
cause a significant reduction of 4mtChR2B-YFP signal, while that of N33D3cpv (a probe in which the YFP 
is located on the cytoplasmic surface of the OMM) is completely abolished. Trypan blue addition, that is 
permeable across the OMM, but not the IMM, did not affect the fluorescence of 4mtSSFO-YFP or that of the 
matrix located Cameleon 4mtD3cpv. The 4mtD3cpv fluorescence however was totally lost after alamethicin 
application that permeabilizes both mitochondrial membranes and releases all matrix proteins into the 
medium, while the fluorescence of 4mtSSFO-YFP was not affected by the latter treatment, as expected for a 
membrane bound protein. Taken together these data are consistent with a proper IMM localization.  
The new mitochondrial 4mtSSFO-YFP constructs were then tested in situ for their ability to change the 
mitochondrial membrane potential in response to light, resulting in a significant organelle depolarization in 
cells expressing 4mtSSFO-YFP, while no effect was induced by blue light in control cells. We then analysed 
in more details the effects of mitochondrial depolarization on mitochondrial Ca2+ uptake using two 
genetically encoded probes, 4mtD3cpv and mt-aequorin. Both approaches demonstrate that the 
depolarization of mitochondria triggered by photo-activation of the channel causes, as predicted, a significant 
reduction in the amplitude of the mitochondrial Ca2+ rise observed upon stimulation of HeLa cells with an 
IP3-generating agonist. Thus, we generated a tool able to modulate diverse mitochondria activities in a 
temporary-controlled, reversible (at least in principle) and cell-specific manner, offering an approach to 
quantitatively investigate mitochondrial role in a large variety of critical cellular processes.  
 
In the second part of the thesis, the investigation was focused on the role of Presenilins in 
Ca2+dyshomeostasis associated to Alzheimer's Disease (AD) using a single cell analysis approach and 
focusing on the role of AD Presenilin 1 and Presenilin 2 mutations in the modulation of Capacitative 
Calcium Entry (CCE).  
AD is the most frequent form of dementia. A small percentage of cases is inherited (Familial AD, FAD) and 
is due to dominant mutations on three genes, coding for Amyloid Precursor Protein (APP), Presenilin-1 
(PS1) and Presenilin-2 (PS2). Mutations in these genes cause alterations in the cleavage of APP by a PS1- or 
PS2- containing enzyme, named -secretase complex, thus leading to an increase in the ratio between A42 
and A40, the two main peptides eventually derived from APP maturation. This event, in turn, leads to an 
increased deposition of amyloid plaques, one of the main histopathological feature of AD. To date, the 
generation of A42 peptides, its oligomers and amyloid plaques is the core of the most widely accepted 
pathogenic hypothesis for AD, the “Amyloid Cascade Hypothesis”. PS1 and PS2 are ubiquitous 9 
transmembrane domains homologous proteins localized mainly in intracellular membranes (Endoplasmic 
Reticulum, ER, Golgi apparatus, and endosomes) and plasma membrane. Despite being the catalytic core of 
-secretase complex, PSs display also some specialized, -secretase independent activities. On this line, 
numerous studies reported a role for FAD-linked PS mutations in cellular Ca2+ alterations. Ca2+ is a key 
second messenger in living cells and it regulates a multitude of cell functions; thus, alterations in its 
signalling cascade can be detrimental for cell fate. Ca2+ mishandling has been proposed as a causative 
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mechanism for different neurodegenerative diseases and in particular for AD. Although supported by several 
groups for many years, the Ca2+ hypothesis for AD pathogenesis has never been undisputedly accepted, since 
some data were clearly conflicting, especially those considering FAD-PS2 mutations. One of the Ca2+ 
pathway reported to be modulated by different FAD-PSs mutation is the so called CCE or Store Operated 
Calcium Entry (SOCE). CCE is the mechanism responsible for Ca2+ entry in response to ER Ca2+ depletion. 
The key molecules responsible for this Ca2+ entry have been identified only recently: STIM and Orai. 
Basically, Orai forms the channels located in the PM, while STIM is the protein that can “sense” the [Ca2+] 
in the ER lumen. Upon store depletion, STIM1 changes its distribution from diffuse to clusterized “puncta” 
and interacts with plasma membrane-located Orai1. Employing a cytosolic Cameleon probe (D3cpV), the 
CCE variation in SH-SY5Y cells overexpressing PSs or in human FAD and control fibroblasts was 
investigated. In particular, measuring the effect of PS1-A246, PS2-T122R (in overexpression) and PS1-A246 
and PS2N141I (in fibroblasts) FAD-linked mutations, a decrease in both peak and rate of CCE was observed. 
This phenomenon could be explained by a decrease in STIM1 protein levels, while Orai1 level was not 
analysed because no antibody sufficiently specific is available. In the over-expression system of SH-SY5Y 
cells also wild type forms of PS1 and PS2 cause a decrease in CCE and this could be due to the accumulation 
of the full-length form of the proteins that is thought to be the mediator of the effect. 
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Riassunto  
La prima parte di questa tesi si propone di sviluppare nuovi strumenti per esplorare l'omeostasi del calcio 
(Ca2+) mitocondriale in vivo, migliorando la sonda Cameleon indirizzata ai mitocondri, già presente in 
laboratorio, e creando un canale regolato dalla luce (Channelrhodopsin) indirizzato a sua volta ai mitocondri. 
Gli indicatori per il Ca2+ geneticamente codificati (Genetically encoded calcium indicators, GECIs), 
consentono di eseguire misure quantitative di Ca2+ in diversi modelli sperimentali. Segnali di indirizzamento 
a specifici organelli possono essere fusi con la sequenza codificante i GECIs, consentendo di misurare 
variazioni della concentrazione di Ca2+ in diversi compartimenti subcellulari. Inoltre, le sequenze codificanti 
i GECIs possono essere poste sotto il controllo di promotori tessuto-specifici o inducibili, consentendo così il 
controllo spaziale e temporale della loro espressione. Diversi tipi di GECIs sono stati creati: nel nostro 
laboratorio usiamo una classe di sensori Ca2+ basati su FRET, chiamati Cameleon. La microscopia FRET 
(trasferimento di energia di risonanza Förster) si basa sul trasferimento diretto di energia da una proteina 
fluorescente (FP), detta donatore, a un'altra FP, detta accettore, in una cellula vivente. Strutturalmente, la 
sonda Cameleon, è composta da due elementi responsivi per il Ca2+, che modificano l'efficienza di FRET tra 
le due FPs. All'interno di questa sonda sono infatti presenti due FPs: una proteina fluorescente di colore 
ciano (CFP), il donatore, e una proteina fluorescente gialla (cpV), l'accettore. I due elementi che rispondono 
a variazioni di Ca2+ sono la Calmodulina (CaM) e il dominio di legame della calmodulina (M13) della 
chinasi della catena leggera della miosina. 
Come anticipato, lo scopo del mio studio è lo sviluppo di sensori molecolari e di nuove metodologie per 
esprimere le sonde in vivo al fine di esplorare le dinamiche di Ca2+ di particolari organelli in vivo (in 
particolare nel cervello e nel cuore). 
Un limite delle sonde Cameleon, particolarmente critico per le applicazioni in vivo, è il basso grado di 
fluorescenza della CFP, che causa un basso rapporto segnale-rumore ed è caratterizzato da un tempo di vita 
multi-esponenziale, che indica la presenza di percorsi multipli di decadimento dallo stato eccitato. 
Recentemente è stata sviluppata una FP più luminosa e più stabile, rispetto alla CFP: mCerulean3. 
Quest'ultima ha elevata resa quantica di fluorescenza e alta fotostabilità, rendendo questa proteina un buon 
candidato alla sostituzione del donatore originale nelle sonde Cameleon. Per questo motivo, la CFP è stata 
sostituita con mCerulean3 in due differenti sonde Cameleon: la sonda citosolica D3cpv e la sonda 
mitocondriale 4mtD3cpv. Le nuove sonde sono state testate in diversi tipi cellulari: HeLa, cardiomiociti di 
ratto neonato e neuroni da topi neonati. Sono quindi stati misurati in situ vari parametri indicativi della 
qualità delle nuove sonde create, quali la luminosità, la fotostabilità, la sensibilità al pH e la costante di 
dissociazione (Kd), mostrando un netto miglioramento della luminosità e fotostabilità, rispetto alle sonde 
Cameleon originali. L'unico inconveniente delle nuove sonde è una riduzione del range dinamico, di circa il 
20-30%, un parametro molto importante che rende conto della massima variazione del rapporto di 
fluorescenza emessa alle due lunghezze d'onda in seguito a variazioni di Ca2+. Al fine di sopperire a tale 
svantaggio, sono stati utilizzati diversi approcci, tra cui l'aggiunta di una sequenza di 16 glicine tra i due 
elementi responsivi al Ca2+ che ha consentito di recuperare il range dinamico della sonda mitocondriale e di 
aumentare del 20% quello della sonda citosolica, senza modificare i miglioramenti prima descritti, ottenuti 
con la semplice sostituzione del donatore. Parallelamente, poiché era stata osservata una scarsa 
localizzazione mitocondriale a 24 ore dalla trasfezione del 4mtD3cpV, anche la sequenza di indirizzamento è 
stata modificata (allungando ciascuna delle sequenze originali di 5 minoacidi), diminuendo notevolmente la 
quantità di sonda espressa erroneamente nel citosol. Come anticipato, l'effetto del pH è stato valutato, 
evidenziando una stabilità generale delle varie delle sonde tra pH 7 e pH 9. Infine, sono state calcolate le 
costanti di affinità delle varie sonde mitocondriali. Una doppia affinità per il Ca2+ è stata rilevata: la sonda 
4mtD3cpV ha una Kd di 0.06 µM e una di 10.84 µM, mentre la sonda 4mtD3mCerulean3+16 ha una Kd di 
0.03 µM e una di 10.7 µM. Per caratterizzare meglio le nuove sonde Cameleon, citosolica e mitocondriale, 
esse sono state prodotte in E.Coli e purificate per misurare anche in vitro tutti i parametri sopra descritti.  
Ad oggi sono stati ottenui solo dati preliminari che evidenziano una riduzione del range dinamico passando 
dall’ambiente citosolico (DR=3) a quello mitocodnriale (DR=2.5). Per quanto riguarda l’affinità per il Ca2+, 
solo poche concentrazioni di questo ione sono state testate, dando come risultato una Kd singola sia per la 
sonda mitocondriale che per quella citosolica. Tale dato dovrà essere confermato da ulteriori esperimenti. 
Tipicamente, le variazioni di Ca2+ rilevate da sonde basate su FRET vengono effettuate utilizzando metodi 
basati sull'intensità delle due proteine fluorescenti, tuttavia tecniche alternative basate sul tempo di vita della 
proteina sembrano dare risultati più accurati e robusti. Stiamo perciò iniziando a valutare biofisicamente le 
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sonde Cameleon utilizzando la tecnica FLIM, tecnica che misura quanto tempo una molecola fluorescente 
resta nello stato eccitato. Il FLIM presenta diversi vantaggi in quanto è totalmente indipendente da fenomeni 
come il photobleaching, i diversi livelli di espressione, i cambi di fuoco. I dati prelimianri raccolti 
eveidenziano la presenza di fenomeni di homo-FRET nelle sonde testate, fenomeni che sembrano tuttavia 
essere meno evidenti nelle sonde in cui la CFP è stata sostituita da mCerulean3. 
Infine, per esprimere questi due nuove sonde in vivo stiamo applicando tre strategie: i) la creazione di un 
virus adeno-associato (sierotipo 9) con tropismo cardiaco; ii) la generazione di un altro virus adeno-associato 
(sierotipo 9) dotato di un promotore neurone specifico (sinapsina) per l'iniezione intracranica; iii) la 
creazione di topi transgenici. Queste strategie ci permetteranno di effettuare misurazioni in vivo di Ca2+ in 
diversi tessuti e compartimenti subcellulari. Recentemente, la generazione di un AAV9 per l'espressione del 
D3mCerulean3 e 4mD3mCerulean3 sotto il controllo di un promotore ubiquitario (CMV) ci ha consentito di 
osservare un buon livello di espressione nel cuore, iniettando il virus per via intraperitoneale in topi neonati. 
In conclusione, i risultati finora ottenuti rendono le nuove sonde Cameleon, basate su mCerulean3, una scelta 
interessante per gli esperimenti in vivo. 
Come anticipato, al fine di studiare il ruolo dei mitocondri in situ e in vivo, abbiamo anche approfittato di 
uno strumento optogenetico, le Channelrhodopsine (ChRs), canali appartenente alla famiglia delle opsine. I 
ChRs sono l'unico tipo di canali ionici, direttamente controllati dalla luce, in grado di indurre 
depolarizzazione della membrana plasmatica, se opportunamente illuminati. Per l'attivazione, le opsine 
richiedono il legame con un cofattore organico della vitamina A, chiamato retinale. In collaborazione con il 
gruppo del Prof. Sekler (Ben-Gurion University-Israel), abbiamo fuso una variante del classico ChR2, detta 
SSFO (Step stabilized function Opsin), con una sequenza di localizzazione mitocondriale, al fine di creare 
una canale controllato dalla luce in grado di depolarizzare i mitocondri in modo reversibile (4mt-SSFO). 
Infatti, le SSFOs sono varianti di ChR in grado di aprirsi, se eccitate con luce blu, e di chiudersi, dopo circa 
30 minuti dall'attivazione. É possibile tuttavia accelerare la chiusura del canale utilizzando della luce rossa. 
Per creare un controllo non funzionante di questo 4mt-SSFO, è stata creata una forma tronca di ChR2(TR) 
mancante del sito legante il retinale. La localizzazione di SSFO alla membrana mitocondriale interna (IMM) 
è stato ottenuta fondendo al N-terminale del ChR quattro sequenze di indirizzamento mitocondriale derivate 
da quella presente nella subunità VIII della citocromo C ossidasi umana. Per verificare la corretta topologia 
della sonda, sono stati effettuati esperimenti in microscopia confocale, di elettrofisiologia e di fluorescenza 
sfruttando la variante del 4mtSSFO fusa ad una YFP. Utilizzando vari “quenchers” di fluorescenza e diverse 
proteasi (Trypan Blue, Proteinase K, Alamethicin) abbiamo dimostrato che il nuovo canale localizza 
correttamente in IMM con il C-terminale protetto nella matrice mitocondriale. Il secondo passo è stata la 
verifica della funzionalità dei nuovi costrutti 4mtSSFO-YFP in situ, verificando la loro capacità di 
modificare il potenziale di membrana mitocondriale in risposta alla luce. Confermata la funzionalità, 
abbiamo poi analizzato più in dettaglio l'effetto della depolarizzazione mitocondriale sulla capacità del 
mitocondrio di regolare l'ingresso di Ca2+, utilizzando due sonde geneticamente codificate, il 4mtD3cpv e 
l'aequorina indirizzata ai mitocondri. Entrambi gli approcci dimostrano che la depolarizzazione dei 
mitocondri, innescata dalla fotoattivazione del canale, induce, come atteso, una significativa riduzione 
dell’entrata del Ca2+ all'interno del mitocondrio. L'ingresso di Ca2+ in questo organello è stato indotto 
stimolando cellule HeLa con un agonista producente IP3. Concludendo, i dati ottenuti sino ad ora 
confermano la generazione di uno strumento molecolare in grado di modulare l'attività dei mitocondri con 
precisione temporale e in modo reversibile (almeno in linea di principio) e specifico, offrendo così un nuovo 
approccio per determinare quantitativamente il ruolo mitocondriale in una grande varietà di processi cellulari 
critici. 
 
Nella seconda parte della mia tesi, mi sono concentrata sullo studio del ruolo delle Preseniline 
nell'alterazione dell'omeostasi del Ca2+ nella malattia di Alzheimer (AD), utilizzando un approccio a singola 
cellula e concentrandomi sul ruolo delle mutazioni presenti in Presenilina 1 e Presenilina 2 correlate ad AD 
nella regolazione dell'ingresso capacitativo di calcio (CCE). 
AD è la forma più frequente di demenza. Una piccola percentuale di casi è ereditaria (Familial AD, FAD) ed 
è dovuta a mutazioni dominanti in tre geni, che codificano per la proteina precursore dell'amiloide (APP), 
Presenilina-1 (PS1) e presenilina-2 (PS2). Mutazioni in questi geni provocano alterazioni nel taglio di APP 
mediato da un enzima, detto complesso -secretasico, che annovera tra i suoi componenti PS1 e PS2, e che è 
in grado di causare un aumento del rapporto tra A42 e A40, i due peptidi derivati dalla maturazione di 
APP. La generazione di tali peptidi, a sua volta, aumenterebbe la deposizione di placche amiloidi, una delle 
caratteristiche istopatologiche principali dell'AD. Ad oggi, la generazione dei peptidi A42, dei suoi 
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oligomeri e delle placche amiloidi, costituisce il cuore dell’ipotesi patogenetica più accreditata per AD, 
“l'ipotesi della cascata amiloide". PS1 e PS2 sono proteine omologhe e ubiquitarie formate da 9 domini 
trans-membrana. Esse sono localizzate prevalentemente nelle membrane interne di reticolo endoplasmatico 
(ER), apparato di Golgi, endosomi e nella membrana plasmatica (PM). Pur essendo il nucleo catalizzatore 
della -secretasi, le PSs svolgono anche ruoli indipendenti dall'attività di questo enzima, tra cui la 
regolazione dell'omeostasi del Ca2+. Quest'ultimo fenomeno infatti risulta variamente alterato in presenza di 
mutazioni FAD nelle PSs. Il Ca2+ è un secondo messaggero intracellulare chiave nelle cellule viventi e regola 
una moltitudine di funzioni cellulari, pertanto alterazioni nelle sue vie di segnale possono essere dannose per 
il destino della cellula. Alterazioni nell'omeostasi del Ca2+ sono state proposte come meccanismo causale per 
diverse malattie neurodegenerative e in particolare per l'AD. Sebbene supportata da diversi lavori, l'ipotesi 
del Ca2+ per la patogenesi dell'AD è stata a lungo messa in discussione, a causa dello scarso consenso della 
comunità scientifica sull'effetto di mutazioni in PSs nella regolazione di questo ione. Uno dei meccanismi 
che sembra essere modulato da diverse mutazioni FAD associate a PSs, è il cosiddetto CCE, o Store 
Operated Calcium Entry (SOCE). Il CCE è il meccanismo responsabile dell'influsso di Ca2+ all'interno della 
cellula in risposta allo svuotamento dell'ER. Le molecole chiave responsabili del CCE sono state identificate 
solo di recente: STIM e Orai. Brevemente, Orai1 forma i canali situati in PM, mentre STIM1 è la proteina 
che "sente" la [Ca2+] nel lume dell'ER. Quando l'ER si svuota, STIM1 cambia la sua distribuzione diffusa, 
oligomerizza in punte (puncta) discrete che, a questo punto, sono in grado di interagire con Orai1 a livello 
della PM. Utilizzando una sonda citosolica Cameleon (D3cpV), ho valutato le variazione di CCE in cellule 
SH-SY5Y sovra-esprimenti PSs e in fibroblasti derivati da pazienti FAD o da controlli sani. In particolare, le 
mutazioni FAD, PS1-A246 e PS2-T122R (in sovra-espressione) e PS1-A246 e PS2-N141I (in fibroblasti) 
causano una diminuzione del CCE, sia della sua entità che della sua velocità di attivazione. Questo fenomeno 
può essere spiegato da un diminuito livello di STIM1 nei campioni FAD rispetto ai controlli, mentre non è 
stato possibile valutare i livelli proteici di Orai, poiché non è disponibile un anticorpo abbastanza specifico. 
Negli esperimenti di sovra-espressione, anche la forma wild type di PS1 e PS2 causa una diminuzione del 
CCE, fenomeno probabilmente dovuto all'accumulo della forma lunga (non tagliata) delle PSs, forma che 
sembra essere responsabile degli effetti mediati dalle PSs sull'omeostasi del Ca2+. 
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DEVELOPMENT OF NEW TOOLS TO EXPLORE 
ORGANELLE CALCIUM DYNAMICS IN VIVO: A NEW 
FRET-BASED CALCIUM SENSOR AND A 
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Introduction 
1. Ca2+ homeostasis 
The majority of extracellular signals, such as hormones, neurotransmitters and growth factors, cannot enter 
the cell freely and act by binding to plasma membrane receptors that in turn propagate such signals 
intracellularly. In order to adapt to changing environments, cells have developed a complex signal system 
based on messengers whose concentration changes in both time and space. The intracellular signalling 
depends either on the activation of a cascade of events initiated by the intrinsic enzymatic activity of the 
receptors (e.g., the tyrosine kinase activity of growth factor receptors) or through the generation of second 
messengers. In turn, the latter (e.g., cAMP, inositol 1,4,5 trisphosphate) can be synthesized by specific 
enzymes coupled to the receptors via G-proteins, or, in the case of calcium (Ca2+), they diffuse into the 
cytoplasm through selective ion channels. The number of second messengers is relatively small and they can 
be classified in: (I) hydrophobic molecules, such as diacylglycerol and phosphoinositides; (II) hydrophilic 
molecules, like cyclic adenosine monophosphate (cAMP), cyclic guanosine monophosphate (cGMP), 
inositol 1,4,5 trisphosphate (IP3), cyclic adenosine diphosphate - ribose (cADPR), nicotinic acid adenine 
dinucleotide phosphate (NAADP) and Ca2+; (III) gaseous molecules, such as nitric oxide, carbon monoxide, 
hydrogen sulphide. The latter share some properties with classical second messengers, but they are produced 
intracellularly and, unlike second messengers, diffuse at short distance through the membranes. Second 
messengers are able to trigger and modulate a wide range of cellular functions such as proliferation, 
differentiation, contraction, migration, survival, apoptosis and gene transcription. As far as Ca2+ is 
concerned, such a broad spectrum of functions is ensured by a fine spatial and temporal regulation of its 
concentration ([Ca2+]). Since Ca2+ is a small highly diffusible molecule, it cannot be chemically altered, thus 
cells develop mechanisms to store this ion in specific subcellular compartments and to release it into the 
cytosol upon specific stimuli. The complex toolkit that ensures the tight control of Ca2+ concentration 
comprises a variety of channels, antiporters, pumps and Ca2+-binding-proteins that are expressed 
differentially in the different cell compartments and are subjected to specific regulation of activity and 
expression level.  
Originally, cells began to exclude Ca2+ from cytoplasm, in order to prevent its ability to precipitate 
phosphate; later the energy spent by cells to exclude this ion was used to trigger signal transduction 
(Clapham 2007). In resting conditions, the cytosolic Ca2+ concentration ([Ca2+]c) is maintained at around 100 
nM (variability is observed in different cell type), compared to an extracellular millimolar concentration 
([Ca2+]e is around 1.8 mM). Upon different stimuli, [Ca2+]c can rapidly increase up to 1-3 micromolar, 
triggering different cellular events ranging from exocytosis to muscle contraction, fertilization and 
transcription activation. This increase in both excitable and non-excitable cells is due to the release of Ca2+ 
from the intracellular stores (mainly endo/sarcoplasmic reticulum, ER/SR, where [Ca2+] can reach 200-900 
M) and/or the entry of Ca2+ from the extracellular space. In the first case, the predominant mechanism in 
the majority of tissues (but not in muscle cells) is the activation of phospholipase C (PLC) that results in the 
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production of IP3 and diacylglycerol (DAG). IP3 interacts with Ca2+ releasing channels located in the ER and 
Golgi Apparatus (GA), causing their opening and the release of Ca2+ into the cytosol. The subsequent Ca2+ 
depletion into the stores often induces also a Ca2+ influx through PM channels, triggering a phenomenon 
called Capacitative Ca2+ Entry (CCE) (Figure1) (Wang et al., 2010; Lewis, 2007). cADPR and NAADP 
similarly cause the release of Ca2+ through RyRs (cADPR) or other, still poorly identified, channels 
(NAADP) possibly located in acidic Ca2+ stores. The mechanisms leading to the production, upon receptor 
activation, of these two messages remain still not completely understood and the target and localization of 
NAADP are still debated (Ogunbayo et al., 2011).  
 
 
FIGURE 1. The Ca2+ signalling toolkit. (Berridge, 2012) 
 
1.1 PLASMA MEMBRANE 
The plasma membrane (PM) is the barrier that isolates the intracellular from the extracellular environment, 
maintaining different features between these two compartments. The PM is able to rapidly transmit signals in 
the form of ionic movements from the extracellular space into the cell, thanks to a lot of different receptor 
and channels present on its surface (Rizzuto and Pozzan, 2006). The ionic movements are driven by 
electrochemical gradients (maintained by the PM itself) and are allowed by the opening of specific channels. 
Most ion channels are gated, i.e. capable of making transitions between conducting and non-conducting 
conformations. Gating of ion channels depends on different electrical or chemical stimuli (Piertrobon et al., 
1990; Fasolato et al., 1994). These channels could be distinguished on the basis of their ionic selectivity and 
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the mechanism for their activation/opening (Berridge et al., 2003). Basically we can distinguish: ligand-gated 
Ca2+ channels and voltage-operated Ca2+ channels (VOCCs). 
1.1.1 Ligand-operated Ca2+ entry.  
Ligand-gated Ca2+ channels are characterized by a lower selectivity for Ca2+ over other monovalent cations if 
compared to VOCCs (see below). This family of Ca2+ channels is usually divided into four subgroups:  
(1) Receptor-operated Ca2+ channels (ROCCs or ROCs). This first type of channel possesses a ligand-
binding site in the same polypeptide or in the same molecular complex forming the channel itself. The 
extracellular binding of the ligand, either hormone or neurotransmitter, may trigger channels opening 
and the further Ca2+ entry. Among them, NMDAr and AMPAr are activated by their physiological ligand 
glutamate and play a fundamental role in neurons, where, depending from their specific subcellular 
localization (i.e., in the soma or at synapses) and the amount of Ca2+ that they allow to enter, could 
generate different or even opposite signals, such as LTD (long term depression) or LTP (long term 
potentiation) (Wojda et al., 2008). 
(2) G-protein-Operated Ca2+ channels. The function of these channels, called G-protein-coupled receptors 
(GPCRs), is coupled with the action of G-proteins. These proteins exert a fundamental role in several 
intracellular transduction pathways that are activated by seven transmembrane receptors. G-proteins are 
heterotrimeric molecules composed of  and subunits. In the resting state, G-proteins carry 
guanosine diphosphate (GDP) bound in a pocket of their  subunit, but after stimulation of the receptor, 
the GDP is released and a guanosine triphosphate (GTP) molecule from the cytoplasm takes its place. 
The heterotrimeric G-protein then dissociates into two parts, a cytosolic G-GTP and a membrane-
bound G dimer. These subunits are the active forms of the G-protein and are capable of signalling to 
specific membrane associated effectors such enzymes and ion channels. Typically, GPCRs generate IP3 
through PLC activation, thus triggering Ca2+ release (Berridge, 2003).  
(3) Second-messenger Operated Ca2+ channels (SMOCs). Second-messenger Operated Ca2+ channels are 
activated by second messengers produced or released after activation of G-protein or enzyme-coupled 
receptors. The most common second messengers are: cAMP, cGMP, IP3, DAG, arachidonic acid and 
Ca2+ itself (Clapham, 2007).  
(4) Store-Operated Ca2+ channels (SOCCs or SOCs). These channels are responsible for a Ca2+ entry in 
response to ER (ER) Ca2+ depletion. The key molecules accountable for this Ca2+ entry have been 
identified only recently: STIM and Orai. Basically, Orai forms the channels located in the PM (Feske et 
al., 2006; Yeromin et al., 2006), while STIM is the protein that can “sense” the [Ca2+] into ER lumen. 
Upon store depletion, STIM1 changes its distribution from diffuse to cluster in “puncta” on ER 
membrane and interacts with Orai in PM, stimulating Ca2+ entry (Roos et al, 2005; Liou et al., 2005). For 
an extensive description of this mechanism see the PART II. 
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1.1.2 Voltage Operated Ca2+ Channels (VOCCs) 
In excitable tissues, such as nervous system and heart, an important role is played by VOCCs, whose 
opening is regulated by membrane depolarization, which transforms electrical signals into chemical signals. 
VOCCs are multi-subunit complexes made up of a pore-forming subunit, a voltage-sensing 1 subunit, and 
several auxiliary subunits, such as 2 and  subunits and, in some cases, also  subunits. They constitute a 
complex family of channels comprising a large number of different subtypes, which have in common a steep 
voltage dependence of the open probability and a very high selectivity for Ca2+ over Na+ and K+ ions in 
physiological condition (Catterall 2011). Based on their voltage and inhibitors sensitivity they have been 
classified in L-, N-, T-, P/Q-, and R- type. For example the N- and P/Q-subtypes are present in synapses and 
control the Ca2+ dependent release of neurotransmitters, while the L-type are present in dendrites and can 
mediate a Ca2+-dependent gene transcription (Berridge et al., 2003). L-type VOCCs are also reported to be 
present in skin fibroblast, but their function in these cells is still unknown (Baumgarten et al., 1992). In the 
nervous system they control a broad array of functions including neurotransmitter release, neurite outgrowth, 
synaptogenesis, neuronal excitability, differentiation, plasticity, etc... VOCCs are present also in other cell 
types, such as cardiac and smooth muscle cells, where their activation initiates contraction directly by 
increasing cytosolic [Ca2+] and indirectly by activating Ca2+ induced Ca2+ release (CICR) (Catterall, 2011). 
VOCCs are also present in endocrine cells, where they mediate Ca2+ entry that initiates secretion of 
hormones (Yang and Berggren, 2006).  
1.1.3 PM Ca2+ ATPases 
Ca2+ signals must be finely tuned and controlled both spatially and temporally, to ensure the specificity 
required to control cell function and to avoid excessive and dangerous stimulation. During a typical Ca2+ 
transient, the reactions that cause an increase in [Ca2+]i (“on” reactions) are counteracted by the reactions 
aimed at decreasing it (“off” reactions); the “off” reactions depend on various pumps and exchangers that 
remove Ca2+ from cytosol, assuring that [Ca2+]i at resting is maintained at ~100 nM and that internal stores 
are kept loaded. Two main mechanisms extrude Ca2+ from the cells through PM: the PM Ca2+ ATPases 
(PMCA) and the Na+/Ca2+ exchangers (NCX) (Berridge et al., 2003). 
The PMCA is a ubiquitous PM protein of about 125-140 KDa that catalyses the active transport of Ca2+ out 
of the cell. The energy required for this reaction is supplied by ATP hydrolysis. The Ca2+:ATP stoichiometry 
is 1:1. PMCA is classified as a type P pump since its mechanism of Ca2+ extrusion is mediated by the 
formation of a phosphorylated intermediate during the reaction cycle. PMCA has a lower transport rate 
compared to NCX, but a higher affinity, and thus it functions as a housekeeping protein that controls [Ca2+]c 
at resting state. Four different genes codifying for PMCA are present in higher eukaryotes; their different 
expression pattern, the existence of splice variants and the regulation of PMCA activity by various 
mechanisms, explain its flexibility in responding to different tissue or cell-specific Ca2+ homeostasis 
demands (Carafoli, 2005). The NCX is an electrogenic antiport located in the PM; it exchanges 3 moles of 
Na+ for 1 mole of Ca2+, either inward or outward, depending on the electrochemical gradient across the 
membrane. Thanks to its lower affinity for Ca2+, but higher transport rate compared to PMCA, it constitutes 
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the principal Ca2+ extrusion system in excitable cells (Rizzuto and Pozzan, 2006). A closely related family of 
exchangers, the Na+/Ca2+-K+ exchange (NCKX) gene family, has been discovered (Haug-Collet et al., 1999). 
This family of proteins comprises five members; NCKXs exchange 4 moles of Na+ for 1 mole of Ca2+ and 1 
mole of K+ (Schnetkamp, 2013).  
 
1.2 NUCLEUS 
The nucleus is the organelle that separates genomic material from the cytosol. It is formed by an Outer 
Nuclear Membrane (ONM), exposed to the cytosol, and an Inner Nuclear Membrane (INM), in continuity 
with the lumen of the ER that face the nucleoplasm and isolate the perinuclear space (PNS). It is organized in 
different subregions: nucleolus, “chromosome territories”, Cajal bodies, promyelocytic leukaemia nuclear 
bodies and SC35 domains (Rippe, 2007). 
The nuclear Ca2+ homeostasis is of great interest since Ca2+ signal mediates the regulation of nuclear 
functions, modulating the transcription of several genes (Hardingham et al., 1997). Indeed it has been 
reported that it is endowed with a Ca2+ toolkit similar to those present in ER membranes (i.e., 
Sarco/Endoplasmatic Reticulum Calcium ATPase or simply SERCA pumps; IP3Receptors called IP3Rs; 
Ryanodine Receptor or RyRs, as well as NAADP receptors), in particular in the area occupied by the intra-
nuclear branching of the envelope, called nucleoplasmic reticulum (Echevarria et al., 2003). Anyway, large 
protein pores in the nuclear membrane allow the permeability of molecules smaller than 20 kDa. 
Consequently, it is well accepted that, in mammalian cells, Ca2+ very rapidly diffuses across the nucleus 
(with a short delay of about 100-200 ms), mirroring cytosolic Ca2+ changes (Zampese and Pizzo, 2012).  
 
1.3 CYTOSOL: Ca2+ BINDING-PROTEINS 
Two are the main mechanisms to terminate a Ca2+ signal: extrusion from the cytosol into the extracellular 
space or re-accumulation into intracellular Ca2+ stores (Clapham, 2007). However, in the generation and 
propagation of cytosolic Ca2+ signals, it must be considered also the buffering capacity not only of specific 
organelles within the cytosol (such as mitochondria and other see below), but also of the cytosol itself. 
Indeed, the cytosol is endowed with Ca2+ binding-proteins involved in chelating Ca2+ ions, characterized by a 
broad spectrum of affinities for Ca2+ (that can vary from nM to mM) and also by different Ca2+ binding rate. 
Many Ca2+ binding-proteins exist, such as Parvalbumin, S100, Calbindin and Calretinin (Schwaller, 2009). 
These proteins are characterized by the presence of conserved EF-hands domains specialized in Ca2+ binding, 
containing a “helix-turn-helix peptide, where several negatively charged oxygen atoms can coordinate Ca2+ 
in a 12 amino acids group (turn) between two orthogonal α-helices. One of the best-known proteins able to 
shape and transduce Ca2+ signal is Calmodulin (CaM), a ubiquitous Ca2+ sensor. CaM has been highly 
conserved during evolution, indicating its essential function in all eukaryotes. It is made up of a central α-
helix with two EF hand domains at each end of the protein. Upon Ca2+ binding, a conformational change 
causes the exposure of the hydrophobic surface that in turn allows CaM to interact with the amphipatic 
regions of target proteins, thus modifying their activities (Hoeflich and Ikura, 2002). However, other Ca2+ 
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binding domain exist, such as C2 domain, where the binding of two or three Ca2+ ions cause protein’s 
association with a specific region of cellular membranes. This domain is often associated with enzymatic 
domains and is typical of phosphatases (Donato, 1999).  
 
1.4 INTRACELLULAR CALCIUM STORES 
Several subcellular compartments exert a role in Ca2+ homeostasis by accumulating or releasing this ion and 
also by shaping its transients: mitochondria, Golgi apparatus, exocytic vesicles and nucleus. However, the 
main intracellular Ca2+ store is the ER or SR, its muscle equivalent (Pozzan et al., 1994; Rizzuto and Pozzan 
2006). Another important Ca2+ store is the Golgi Apparatus (GA). 
1.4.1 Endoplasmic Reticulum 
The ER is a complex and continuous membrane network that extends in the whole cytoplasm, with its 
luminal space occupying up to 10% of the whole cell volume. It is subdivided into three major regions: the 
smooth ER, the rough ER (with bound ribosomes on its surface) and the nuclear envelope. A specialized 
version of ER is the SR, found in the striated muscle cells. 
In addition to its fundamental role in protein synthesis/folding/modifications/transport and lipid synthesis, 
the ER represents also the main intracellular Ca2+ store and plays a major role in cell Ca2+ homeostasis and 
signalling (Csala et al, 2006). Indeed this compartment houses several proteins that actively regulate the 
traffic of molecules from and towards the ER (proteins, ions, etc.). Being endowed with Ca2+ toolkit, it 
contains ATP driven pumps for Ca2+ uptake (SERCAs), Ca2+ binding-proteins for Ca2+ storage within the 
lumen, and channels for Ca2+ release (the IP3R and the RyR) (Figure 2). In many cell types increases in 
[Ca2+]c can be due, at least in part, to the release of Ca2+ from the ER. The ER contains a high intra-luminal 
[Ca2+] that has been measured with different methodologies in different cell types, ranging from 200 μM up 
to 1mM (Meldolesi and Pozzan 1998). 
 
FIGURE 2. The Endoplasmic Reticulum Ca2+ toolkit (adapted from Syntichaki et al., 2003) 
 
The ER Ca2+ accumulation depends on the activity of SERCAs, a family of transmembrane proteins that can 
pump actively two Ca2+ ions in the ER lumen employing the energy of one molecule of ATP (Wuytack et al., 
2002). SERCA has the same membrane topology and mechanism of action of PMCA pump. In mammals 
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three genes (ATP2A1, ATP2A2, and ATP2A3) are present encoding three SERCA proteins that have also 
different splicing variants. The different tissue-specific expression pattern of the SERCA variants can also 
change during development. The SERCA2b, considered the housekeeping isoform, is almost ubiquitous 
(Brini and Carafoli, 2009). Several drugs are able to inhibit the SERCAs, such as the irreversible inhibitor 
thapsigargin (Tg) (Thastrup et al, 1990) and the reversible inhibitors: cyclopiazonic acid (CPA) (Seidler et al, 
1989) and 2,5-di-(ter-butyl)-1,4-benzohydroquinone (t-BHQ) (Oldershaw and Taylor, 1990). 
In the ER lumen different proteins bind Ca2+, acting as Ca2+ buffers or chaperones, such as: 
(1) calreticulin (CRT), responsible for the binding of almost half of the Ca2+ present in the ER (Michalak 
et al., 2009); 
(2) calnexin (CNX), the main Ca2+ buffering-protein in the SR, similar to CRT but membrane bound; 
(3) calsequestrin (CSQ), located in SR; 
(4) glucose-related protein 78 (GRP78 or Bip) and glucose-related protein 94 (GRP94), two ER 
chaperons also active as buffers (Zampese and Pizzo, 2012). 
All these proteins have multiple Ca2+ binding sites with low Ca2+ affinity (Kd around 1mM). These latter 
features provide a double advantage: they are able to buffer a large amount of Ca2+ and they can free it 
rapidly within the organelle, allowing its prompt release upon opening of Ca2+ releasing channels (Zampese 
and Pizzo, 2012).  
Upon release into the cytosol and consequent store depletion, the SERCA activity and the activation of CCE 
ensure a rapid reuptake of Ca2+ into the ER, reestablishing a new equilibrium. 
The ER Ca2+ release is tightly controlled by several factors, including Ca2+ itself and an expanding group of 
messengers, such as IP3, cADP-R, NAADP and sphingosine-1-phosphate that either stimulate or modulate 
ER Ca2+ release channels.  
Two distinct channels are responsible for Ca2+ release: the IP3R and the RyRs, found primarily, but not 
exclusively, in excitable cells.  
Three IP3Rs isoforms are encoded by three different genes. These three isoforms are differently expressed 
depending on the cell type, but they have also an overlapping expression pattern, since they are thought to 
mediate different types of signalling. The IP3R is a ligand-gated ion channel of 310 kDa, with 6 
transmembrane (TM) domains. It is controlled by the second messenger IP3, generated by enzymes of the 
PLC family that include distinct isoforms differing in their activation mechanism (Foskett et al., 2007). An 
IP3R molecule contains:  
(1) a large cytoplasmic N-terminal domain (~85% of the protein), that includes the IP3 binding region 
(Mignery et al., 1990) and a regulatory/coupling domain containing phosphorylation sites and binding sites 
for nucleotides and proteins;  
(2) a central hydrophobic region that forms six membrane-spanning helices that contribute to the ion-
conducting pore of the channel;  
(3) a relatively short cytoplasmic C-terminus that contains a suppressor domain that can inactivate the 
channel (Foskett et al, 2007).  
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The complete IP3R channel is a homo- or hetero-tetramer of four IP3R molecules (Joseph et al., 1997; Patel 
et al., 1999), in which the 5th and 6th helices of the TM region and the cytosolic C-terminus are critical for 
creating the basic pore structure (Michikawa et al., 1999; Ramos-Franco et al., 1999). When IP3 binds the N-
terminus of the channel, it induces conformational changes that activate the gate, enabling ions to flow 
through the channel (Foskett et al., 2007). 
Different proteins have been reported to interact with and modulate IP3Rs activity, although one of the most 
important regulators of its activity is Ca2+ itself (Zampese and Pizzo, 2012). Indeed several molecules such 
as homer, protein phosphatases (PP1, PP2A), RACK1, chromogranin, Na+/K+-ATPase, carbonic anhydrase-
related protein (CARP) and IRBIT interact with the IP3R and modulate its activity, suggesting that the 
receptor can form multi-molecular complexes and function as a centre for signalling cascades (Mikoshiba, 
2007). Anyway, Ca2+ itself is the most important modulator of the IP3R, following a biphasic operation: at 
low cytosolic [Ca2+] (250-300 nM) the channel is activated, potentiating the IP3 response, while at a higher 
concentration (>10 μM), occurring in close proximity of a receptor upon Ca2+ release, the channel is blocked 
(Foskett et al, 2007). This contributes to the so called Ca2+-induced Ca2+ release (CICR), a phenomenon 
capable of coordinating the opening of a single or few channels transforming them into more complex 
events, such as the propagation of a Ca2+ wave, by recruiting neighbouring channels.  
The other major Ca2+-releasing channel located on ER membranes is the RyR. RyRs owe their name to the 
plant alkaloid Ryanodine, a high specific antagonist of the channel. RyRs are large conductance channels of 
550 kDa, capable of creating rapid transient increases of [Ca2+]c. Four receptor molecules assemble into a 
homo-tetramer forming the 2 MDa ion channel (Zampese and Pizzo, 2012). Most of the RyR protein, 
similarly to the IP3R, forms a large cytoplasmic assembly that is connected to the TM region. Indeed the 
RyR and the IP3R share an overall 17% sequence identity and the identity increases up to 35% within the 
predicted TM region, forming the ion-conducting pore of the two proteins (Ponting, 2000). Moreover, the 
two receptors show also similarities in their function and regulation: indeed both permeate Ca2+ and are 
regulated by it in a biphasic manner (Roderick et al., 2003);  
The cytoplasmic region has distinctive structural domains and intervening cavities that permit interaction 
with modulators. The clamp-shaped regions, located at the corners of the cytoplasmic assembly, contain 
domains for the interdigitation of neighbouring RyRs and for the interaction with some modulators 
(Hamilton and Serysheva, 2008). The crystallization of RyR proved to be hard to obtain and many open 
questions about the structure remained. Recently, thanks to advances in crio- electron microscopy, Marks 
group shed new light on the rabbit RyR1 structure (for details see Zalk et al., 2015). 
In mammals three different genes encode for RyR1 (predominantly expressed in skeletal muscle), RyR2 
(expressed mainly in the heart, but also in Purkinje cells and in cortical neurons) and RyR3 (ubiquitously 
expressed at low levels). RyR is responsible for the release of Ca2+ from the SR into the cytosol, which sets 
off a cascade of events resulting in muscle contraction (Lamb, 2000). Indeed, Excitation-Contraction (E-C) 
coupling refers to the close interaction between dihydropyridine receptors (DHPRs) L-type Ca2+ channels 
and RyRs: in skeletal muscle, depolarization of the PM activates DHPRs and is coupled to opening of RyR1 
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on SR membrane (Beam and Bannister, 2010). While in skeletal muscle RyR1 opening is primarily (or 
exclusively) due to the E-C coupling with DHPRs, the major gating mechanism of RyR2 and RyR3, 
fundamental in cardiac muscle cells, is CICR. In this latter case, the opening of RyRs is stimulated by the 
local Ca2+ increase, occurring in the proximity of PM L-type Ca2+ channels (Fill and Copello 2002). 
Finally, a basal Ca2+ leak from the ER contribute to determine the steady state of [Ca2+]ER. However, despite 
its physiological relevance, the mechanism of ER Ca2+ leak remains elusive. Several players have been 
proposed to take part to this process, including the ribosomal-translocon complex; channels of the transient 
receptor potential (TRP) family-like, such as polycystin-2 (TRPP2); Presenilins (PSs); members of anti-
apoptotic Bcl-2 families; hemichannel-forming-proteins such as pannexins (Zampese and Pizzo, 2012). Also 
RyRs and IP3Rs are known to undergo spontaneous activity, maybe contributing to the basal ER Ca2+ leak. 
1.4.2 Golgi apparatus 
The GA is the main sorting and processing site along the secretory pathway, ensuring that lipids and proteins 
synthesized in the ER are properly modified (e.g., glycosylated, phosphorylated, processed and packaged 
into carrier vesicles) and eventually directed to their final destination within or outside the cell. Thus, it 
contains numerous enzymes such as glycosyltransferases, glycosidases, sulphatases, kinases and pro-protein 
convertases (such as furin) that cleave protein precursors into their mature forms (Schaefer et al., 1995). 
Morphologically, GA is a highly dynamic structure that consists of multiple membranous cisternae arranged 
in close apposition forming multiple polarized stacks. GA is composed by three regions: a cis-side associated 
with a tubular reticular network of membranes (cis-Golgi network, CGN), a medial area of disc-shaped 
flattened cisternae, and a trans-side associated with another tubular reticular membrane network (trans-Golgi 
network, TGN). The steady-state structure of Golgi stacks depends on the balance of anterograde and 
retrograde vesicle trafficking between the various GA cisternae, the ER and other cellular compartments 
(Pizzo et al., 2011). The polarized morphology of GA parallels specific functionalities: for example, 
glycosyltransferases act sequentially in consequent compartments and, in general, enzymes that need to act 
early in glycan biosynthetic pathways are located within cis- and medial- compartments of the GA, whereas 
enzymes that need to act later tend to reside within the TGN (Breton et al., 2001). 
As mentioned before, GA play a key role as intracellular Ca2+ store, containing up to 5% of whole cell Ca2+ 
(Chandra et al., 1991, Pezzati et al., 1991). It can be considered an acidic Ca2+ store, as its luminal pH ranged 
from 6.8 to 5.9. Activity of processing enzymes located in the GA show a strong Ca2+ dependency. 
Moreover, retrograde membrane traffic from the Golgi to the ER (Oda, 1992) and selective aggregation of 
regulated secretory proteins in the TGN is also critically dependant on GA Ca2+ content (Chanat and Huttner, 
1991). The Golgi complex contains all the essential components of a Ca2+-storage organelle, i.e. pumps for 
Ca2+ uptake, channels for Ca2+ release and Ca2+ binding-proteins for Ca2+ storage (Zampese and Pizzo, 2012). 
Thus, in the space of a few microns and despite the continuous inter-mixing dynamics, the GA Ca2+ toolkit 
has a precise distribution in different subregions, drawing areas with different Ca2+ features and different 
properties in Ca2+ handling.  
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The use of a specific Cameleon Ca2+ sensor targeted to the different GA compartments, allowed our group to 
directly demonstrate the functional GA heterogeneity in Ca2+ homeostasis: 
(1) CGN. The cis-side of GA closely resembles the Ca2+ homeostatic properties of the ER, being 
endowed with IP3R, RyR (as efflux Ca2+channels) and SERCA (as influx Ca2+ channel). The [Ca2+] 
in this compartment is around 250 µM (Pizzo et al., 2011; Cifuentes et al., 2001). 
(2) Medial-Golgi. This compartment accumulates Ca2+ through SERCA pump and through secretory 
pathway Ca2+-ATPase 1 (SPCA1, see below) and it releases Ca2+ through IP3Rs and RyRs. The 
steady state [Ca2+] is lower than that in the ER, but higher than that in then Trans-Golgi, being 
around 250-300 µM (Wong et al., 2013). 
(3) TGN. Trans-Golgi is IP3-insensitive and utilizes solely SPCA1 to uptake Ca2+, keeping [Ca2+] around 
130 µM (Lissandron et al., 2010) (Figure 3). 
 
 
FIGURE 3. Schematic representation of GA Ca2+ toolkit and concentrations (Pizzo et al., 2011). 
 
As mentioned before, in addition to SERCA the GA expresses also another ATP-dependent Ca2+ pump: the 
SPCA (Pizzo et al., 2011). In human cells, two different genes encoding for SPCA have been identified: 
ATP2C1 (expressed in 4 protein variants) and ATP2C2. SPCAs are single subunit integral membrane 
proteins composed by a large cytosolic head containing an actuator, a nucleotide-binding, and a 
phosphorylation domain, and a TM domain with 10 hydrophobic helices. Within the TM region, SPCAs 
contain one high-affinity binding site for Ca2+ and Mn2+, providing both cations to the GA. Indeed, Mn2+ 
supply is fundamental for the correct glycosylation of secretory proteins (Kaufman et al., 1994). 
The GA is also equipped with luminal Ca2+-binding-proteins: CALNUC is the most abundant and better 
characterized of the GA Ca2+ binding-proteins (Lin et al., 1998); Cab45, a luminal soluble protein important 
for vesicles sorting (Scherer et al, 1996); p45/NEFA, a luminal protein strongly associated to GA membranes 
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(Karabinos et al., 1996); Calumenin, a protein present also in the ER and in the secretory pathway, that 
interacts with SERCA and RyR2 modulating their activity (Jung et al. 2006; Sahoo et al, 2009).  
 
1.4.3 Acidic compartments 
Other intercellular Ca2+ stores, beside ER and GA, are acidic organelles such as endosomes, lysosomes and 
secretory granules. The Ca2+ content within these organelles is heterogeneous, ranging from 10-40 M in 
mast cell and chromaffin cell granules to 100–200 M in insulin granules, and from 1mM in formed 
endosomes to ten of mM in secretory granules of many cell types and in the related synaptic vesicles of 
neurons, underlying the existence of some not well-identified Ca2+ buffers. Other acidic compartment rich of 
Ca2+ (around 500 M) are lysosomes and lysosome-related organelles, such as melanosomes, lytic granules 
in lymphocyte etc. (Zampese and Pizzo, 2012). Finally, recent results indicate that also peroxisomes are 
capable of taking up and storing Ca2+ within their lumen at concentrations much higher than those found in 
the cytoplasm (Raychaudhury et al. 2006; Drago et al. 2008). The mechanism of Ca2+ uptake and release by 
acidic organelles is still poorly understood, but evidence suggest that those Ca2+ stores take up Ca2+ from the 
cytoplasm using both a SERCA-type Ca2+ ATPase and an SPCA-based system, present in dense core 
secretory vesicles of neuroendocrine cells (Mitchell et al., 2001). Other ATP-dependent Ca2+ uptake 
mechanism not yet identified could also participate to Ca2+ influx. However, the idea that the proton gradient 
is involved in Ca2+ homeostasis is well-accepted, since Ca2+/H+ exchanger are present (Patel et al., 2010), 
and also indirect pathways involving Na+/H+ and Na+/Ca2+ exchangers have been reported (Mahapatra et al., 
2004; Krieger-Brauer et al., 1983). Concerning Ca2+ release from acidic stores, different stimuli have been 
reported to act on these organelles: IP3, cADPR and also a RyR activator, caffeine (Zampese and Pizzo, 
2012). Recently, the NAADP has been shown to act as a second messenger, mobilizing intracellular Ca2+ 
stores by activation of two-pore channels (TPCs) in endosomal membranes (Calcraft et al. 2009).  
Up to now, many obstacles have been encountered in measuring Ca2+ in acidic compartments, since their 
internal environment is highly acid and rich in protease. Lysosomes and peroxisomes in particular are 
emerging as crucial organelles involved in cell life, development and human pathology, with some 
functionalities related to Ca2+ homeostasis. Future efforts are thus needed to develop and modify Ca2+ 
sensors able to properly measure Ca2+ in these compartments.  
 
1.5 Mitochondria 
Mitochondria are known as a factory for energy transduction in eukaryotic cells. They metabolize organic 
molecules to produce ATP through oxidative phosphorylation, thereby powering cellular activities in animals 
and other eukaryotes. Mitochondria not only form the cell metabolic hub, but also are crucial players in 
many cellular pathways, like regulation of Ca2+ homeostasis, oxidative stress response, apoptosis and innate 
immune response, putting the organelle in a central position in controlling cellular function and fate 
(Contreras et al., 2010; Nunnari and Suomalainen et al., 2012). Mitochondria are dynamic membrane-
enclosed cytoplasmic organelles that form an elaborate network in a constant state of change, due to 
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processes of fission and fusion. Mitochondrial network is organized together with the cytoskeleton and move 
along the microtubular network aided by the molecular motor proteins dynein and kinesin. Mitochondria are 
constituted by:  
(1) the outer mitochondrial membrane (OMM), characterized by the presence of porins that allow molecules 
<5 kDa to freely diffuse;  
(2) the intermembrane space (IMS), with a concentration of small molecules similar to the cytosol;  
(3) the inner membrane (IMM), a highly impermeable membrane in which oxidative phosphorylation takes 
place;  
(4) cristae, generated by infoldings of IMM that expand its surface area and enhance the ability of ATP 
production;  
(5) the mitochondrial matrix, delimited by the IMM, containing the major part of the mitochondrial proteins 
and involved in pyruvate and fatty acids oxidations and citric acid cycle (Henze et al., 2003).  
The endosymbiotic origin of mitochondria explains their unique features such as the presence of 
mitochondrial DNA, usually organized as a single, circular, double-stranded molecule which encodes for 13 
proteins involved in the respiratory chain, 22 tRNAs and 2 rRNAs. The remaining part of mitochondrial 
proteome is encoded by nuclear genes (Anderson et al., 1981). 
The regulation of gene expression and proteins signalling networks in mitochondria, seems to be controlled 
by Ca2+. Mitochondrial Ca2+ homeostasis strongly depends on energy process, in particular Ca2+ influx is 
driven by electrochemical gradient due to the electron transport chain (chemiosmotic hypothesis). Indeed, 
respiring mitochondria are characterized by a negative membrane potential (m), about -180mV, tightly 
coupled to a pH gradient (pPizzo et al., 2012. According with the Nernst equation, m and p 
regulate the three processes controlling Ca2+ handling:  
(1)  Ca2+ uptake, mediated by mitochondrial Ca2+ uniporter (MCU) (De Stefani et al., 2011);  
(2) Ca2+ buffering in mitochondrial matrix, mainly due to insoluble xCa2+–xPO4x–xOH complexes 
(Nicholls et al., 2005);  
(3) Ca2+ extrusion in the surrounding, mediated by xNa+/Ca2+ exchanger (mNCX) (Gunter et al., 1990) and 
Ca2+ /xH+ exchanger (mHCX) (Villa A. et al., 1998) (Figure 4). 
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FIGURE 4. Mitochondrial Ca2+ toolkit (Di Benedetto et al., 2014) 
 
1.5.1 Mitochondrial Ca2+ equipment 
Ca2+ uptake in mitochondrial matrix depends on the ion capability to cross the OMM and the IMM. Recently, 
it has become clear that the OMM function as the first Ca2+ barrier, indeed changes in membrane 
conductivity or manipulation of VDAC (Voltage-dependent anion channel) expression levels, can affect the 
mitochondrial Ca2+ concentration ([Ca2+]m) (Rapizzi et al., 2002; Bathori et al., 2006). VDAC is a porin ion 
channel with a molecular weight of 30 kDa, which forms a barrel that spans the OMM. In humans three 
VDAC genes have been identified. They are modulated by different cytosolic proteins and by mitochondrial 
lipids composition (Rostovtseva et al., 2008). VDACs show weak anion selectivity and become weak 
sensitive to cations at m>25mV (Tan et al., 2009). The three proteins display different distribution in 
OMM and specific interactions with apoptotic regulators (Roy et al., 2009a-b; Cheng et al., 2003). VDAC1 
and VDAC2 localized similarly in the OMM, but only VDAC1 is reported to be enriched in mitochondria-
associated ER membranes (MAMs) (Szabadkai et al., 2006), while VDAC3 is uniformly distributed over 
mitochondrial surface (Neumann et al., 2010).  
Mitochondria Ca2+ influx 
Different proteins have been reported to be involved in the mechanism of mitochondrial Ca2+ uptake, 
although several data are controversial and still to confirm. One of that is RyR1 found in IMM of heart 
mitochondria immune-electron-microscopy and suggested to work in reverse mode, mediating mitochondrial 
Ca2+ uptake (Beutner et al., 2001). Further investigations are needed to confirm this hypothesis. 
In another paper, it has been reported that the down-regulation or the overexpression of the uncoupling-
proteins 2 and 3 (UCP2/3) reduces or increases the accumulation of Ca2+ into mitochondria (Trenker et al., 
2007). The same group reported also that UCP2 and 3 are able to modulate the activity of the uniporter, and 
thus mitochondrial Ca2+ uptake, only when cytosolic Ca2+ rises, released from the ER (Waldeck-Weiermair 
et al., 2010). A direct role of UCP2/3 on mitochondrial Ca2+ uptake, however, has not been confirmed by 
others. In particular, mitochondria isolated from UCP2 KO and UCP3 KO mice take up Ca2+ normally 
(Brookes et al., 2008). Moreover, UCP3 has been reported to inhibit SERCA activity by decreasing the 
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ability of mitochondria to produce ATP (De Marchi et al., 2011). Thus, UCP2/3 effects on mitochondrial 
Ca2+ uptake, if any, could be explained by a general cellular metabolic alteration. 
In 2009, the previously believed component of the PM H+/K+ exchanger, Letm1, was proposed to be a 
mitochondrial H+/Ca2+ electrogenic antiport with high Ca2+ affinity, distinct from the low affinity MCU 
(Jiang et al., 2009). Purified Letm1 reconstituted into liposomes was able to mediate a Ruthenium Red 
sensitive mitochondrial Ca2+ uptake. Other groups, however, challenged this idea, showing compelling 
evidence that Letm1 is probably a H+/K+ antiporter, since in MEFs the Letm1 KO phenotype could be 
rescued by nigericin, a bona fide H+/K+ ionophore (for a review see Nowikovsky et al., 2012). For these 
reasons, the Letm1 role in mitochondria Ca2+ uptake is still matter of debate. Anyway, the recent RNA-
interference (RNAi) screening, that permitted the identification of MCUR1 (Mallilankaram et al., 2012b), 
confirmed a role for Letm1 in mitochondrial Ca2+ handling, since its silencing induces a decreased Ca2+ 
uptake into the organelles. Again, further investigations will be required to better clarify this issue. 
Another mechanisms has been proposed to be involved in mitochondrial Ca2+ influx, named rapid mode or 
RaM, but it still has a debated functional significance. The RaM mechanism has been reported to transfer 
Ca2+ quickly from cytosol to mitochondria during the rising phase of Ca2+ pulses (Buntinas et al., 2001).  
However, the most accepted mechanism of mitochondrial Ca2+ uptake across the IMM is the mitochondrial 
Ca2+ uniporter (MCU). Well before the molecular identification of the protein, its properties as a channel 
were well-known. The mitochondrial Ca2+ uniporter was defined as an highly selective channel, sensitive to 
Ruthenium Red (RuR) and lanthanide and with low affinity to Ca2+ (Bernardi et al., 1984; Mela et al., 1969 
and Bragadin et al., 1979). The Vmax of MCU is >1400 nmol Ca2+ per mg of protein per min (Bragatin et 
al., 1979), while its affinity for Ca2+ is around 20-30 µM. After many years spent in searching this channel, 
in 2011 two groups independently reported the identification of this channel. MCU is a 35 kDa protein 
located at the IMM with two highly conserved TM domains, with N- and C-terminus facing the matrix 
(Baughman et al., 2011; Martell et al., 2012) and endowed with two EF-hand Ca2+ binding domains. In 2 
years the general picture has become far more complex than anticipated from functional data: in addition to 
the MCU pore-forming subunits, other proteins have been described that are capable of modulating the 
activity, the Ca2+ affinity and (probably) the assembly of the channel in the mitochondrial membrane, 
forming the so called MCUC (Mitochondrial Ca2+ Uniporter Complex). The exact stoichiometry of the 
different subunits forming MCUC and their specific role is still debated but the present picture shows the 
MCU as one of the most sophisticated ion channel described thus far. Such complexity in subunit 
composition and regulation, maintained and increased during evolution, suggests an essential role of this 
mitochondrial function in cell physiology.  
Basically MCUC is a super complex with a molecular weight around 480 kDa (Baughman et al., 2011), 
composed by: 
(1) MCU, the pore forming subunit of the channel. Its down-regulation inhibits and overexpression 
increases Ca2+ uptake by mitochondria. Moreover, De Stefani et al. showed that when expressed 
recombinantly in E. coli or in a wheat germ extract cell-free system, purified MCU forms channels 
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permeable to Ca2+ and inhibited by Ruthenium Red. The nuclear MCU gene encodes a 40 kDa protein, 
while the mature form of MCU is a 35 kDa protein, generating by the cleavage of the N-terminal import 
domain. MCU is located in IMM and possesses two predicted TM helixes domains. The topology 
model predicts that both its N- and C-terminal domains face the mitochondrial matrix, with the two 
membrane-spanning domains connected in the IMS by a short loop containing the DIME motif (De 
Stefani et al., 2011; Baughman et al., 2011). The putative pore region of MCU is defined by eight helices 
and the negative electrostatic potential needed for cations permeability is due to a cluster of negatively 
charged aminoacids found in the DIME region, in proximity of the pore (Raffaello et al., 2013). About 
the functionality of MCU, the first model proposed that MCU is arranged in oligomers, possibly 
tetramers (Raffaello et al., 2013) that constitute the channel-forming subunits of MCUC.  
(2) MCUb. MCUb is a protein structurally similar to MCU, showing an inhibitory role on mitochondrial 
Ca2+ uptake. MCUb is a 35 kDa protein with two TM domains, encoded by a gene located on Homo 
sapiens chromosome 4. Its primary sequence is 50% homologous to that of MCU, but with key 
mutations in the predicted pore forming region. Its overexpression in intact cells reduces Ca2+ uptake of 
mitochondria in response to cytosolic Ca2+ increases, while in lipid bilayers the co-expression of MCU 
and MCUb dramatically inhibits the Ca2+ current due of MCU alone. MCUb expression is quite variable 
in mouse tissues, and in general lower than that of MCU: MCUb mRNA is abundant in heart and lung, 
while it is scarce in skeletal muscle (Raffaello et al., 2013). These data on tissue expression, from a 
functional point of view, relates on Ca2+ uptake efficacy, which is greater in skeletal muscle than in heart 
(Fieni et al., 2012). Structurally, the main differences between MCU and MCUb concern the DIME 
domain: an E256V substitution makes MCUb less electronegative, affecting the kinetics of Ca2+ 
permeability; aminoacid substitutions R251W and D256V in the putative pore-forming domain inhibit 
the Ca2+ channel activity of MCU. Finally, it has been reported that MCUb can be co-
immunoprecipitated with MCU (Sancak et al., 2013).  
(3)  MICU. Three different isoforms has been identified. The first one, MICU1, discovered about one 
year before MCU itself (Perocchi et al., 2010), was more recently followed by other two similar protein, 
MICU2 and MICU3 (Plovanich et al., 2013). They are located on the outer surface of the IMM where 
they appear to modulate the function of MCU. 
a. MICU 1. MICU1 is a 54 kDa membrane protein endowed with two classical EF-hand Ca2+ binding 
domain. The knockout (KO) of MICU1 abolished mitochondrial Ca2+ uptake, though overexpression did 
not result in a major effect on the rate and extent of Ca2+ uptake by the organelle (Perocchi et al., 2010). 
MCU and MICU1 physically interact and have a similar tissue expression pattern (Baughmann et al., 
2011). They are both highly conserved during evolution but, while there is general agreement on the fact 
that MCU represents the pore forming subunit of MCUC, the role of MICU1 is, on the contrary, less 
clear and contradictory data have been published by different groups. Some groups reported an activator 
action of MICU1 (Perocchi et al., 2010 and Abell et al., 2011); on the contrary, two other groups suggest 
a role for MICU1 in establishing a threshold that prevents Ca2+ uptake in basal conditions 
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(Mallilankaraman et al., 2012; Csordas et al., 2013; Hoffman et al., 2013). Very recently, Alvarez and 
co-workers showed that in HeLa cells silenced for MICU1, the mitochondrial Ca2+ uptake is increased at 
cytosolic Ca2+ concentration <2 µM, while it is decreased at cytosolic Ca2+ concentration > 4 µM (De La 
Fuente et al., 2013). No consensus has been reached yet also on the topology of MICU1. 
b. MICU2 and MICU3. Mootha’s group revealed the expression in most eukaryotic cells of two 
paralogs of MICU1, MICU2 and MICU3. The authors suggests that these other two genes arose by gene 
duplication of MICU1, but they exhibit a distinct pattern of tissue expression. MICU2 and 3 share about 
25% sequence identity with MICU1 and, similarly to it, possess two EF-hands Ca2+ binding sites. 
MICU2 is a 45 kDa protein ubiquitously expressed in mammalian tissues, exclusively localized in the 
IMM. MICU3 seems to be mostly expressed in the nervous system and up to now it has not been 
functionally characterized. On the contrary, an extensive characterization of the role of MICU2 has been 
done, showing an effect similar to MICU1 on MCU. They proposed a reciprocal regulation of MICU1 
and 2 activity that appears to be cell specific and related to reciprocal regulation of MCU, MICU1 and 
MICU2 proteins expression levels (Plovanich et al., 2013). Anyway, up to now, no general consensus 
has been obtained about the function of MICU2. Of note, Rizzuto and co-workers recently demonstrated 
that MICU1 and MICU2 heterodimerize through the formation of a disulphide bond and they interact 
with MCU through the short DIME loop of MCU. MICU2 seems to exert an inhibitory effect on MCU 
channel activity in planar lipid bilayers and in intact HeLa cells at low Ca2+ level, while MICU1 shows a 
stimulatory effect on MCU activity during cytosolic Ca2+ rise. However, the protein levels of MICU1 
and 2 (but not the mRNA) are strongly correlated: the decrease of MICU1 protein expression decreases 
also the level of MICU2 and results in the absence of gate-keeping on MCU (Patron et al., 2014).  
(4) MCUR1. MCUR1 (Mitochondrial Ca2+ Uniporter Regulator 1) is another recently discovered 
member of the complex, whose deletion results in abrogation of mitochondrial Ca2+ uptake. It is a 40 
kDa protein with two TM domains and one coiled-coil region (Mallilankaraman et al., 2012). The N- and 
C-terminus face the IMS, while the major part of the protein is exposed to the matrix (Rhee et al., 2013). 
The striking phenotype of cells deprived of MCUR1 is the lack of any energy dependent Ca2+ uptake, 
without effect on mitochondrial membrane potential. MCUR1 co-precipitates with MCU, but not with 
MICU1, and its overexpression results in an increase of mitochondrial Ca2+ uptake, but only when MCU 
is co-expressed. MCUR1 appears also to regulate the expression of MCU, as down-regulation of 
MCUR1 results in a significant increase of both the mRNA and the protein levels of MCU 
(Mallilankaraman et al., 2012). Although MCUR1 possesses two predicted TM domains, no evidence 
was obtained in support of its channel forming activity, suggesting that MCUR1 affects either the 
opening of MCU or the assembly of the complex or both. As for the binding partners of MCUR1, 
contrasting results have been reported, indicating in one case that MCUR1 did not co-immunoprecipitate 
with the other MCUC proteins (Sancak et al., 2013) and in another case that it co-immunoprecipitates 
with MCU (Mallilankaraman et al., 2012). 
(5) EMRE (Essential MCU Regulator). EMRE is the last identified member of MCU-associated 
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proteins. Its KO completely blocks Ca2+ uptake by mitochondria, which cannot be rescued by 
overexpressing MCU. EMRE is a 10 kDa single-pass membrane protein with a highly conserved C-
terminus enriched in aspartate. No EMRE homologous exist in plants, fungi or protozoa, suggesting that 
it most likely arose in the metazoan lineage. As far as EMRE mRNA expression is concerned, it has been 
found in all mouse tissues analysed and is predicted to be broadly expressed in mammalian tissues. 
MCUs and MICUs co-immunoprecipitate with EMRE, indicating that it possibly acts as a bridge 
between MCU and MICUs. Furthermore, EMRE seems to be necessary for the association of MCU with 
MICU1/2, since, in absence of EMRE MCU cannot co-precipitate with MICU1/2, although it still co-
precipitates with MCUb and MICU1 and 2 dimerize (Sancak et al., 2013). EMRE thus appears to be a 
necessary regulator (or a MCUC assembler), of the MCU transport, rather than a pore-forming unit 
(Figure 5).  
 
 
FIGURE 5. Schematic representation, based on our interpretation of published data, of the MCUC organization. IMM: inner 
mitochondrial membrane, IMS: inter membrane space (Pendin et al., 2014). 
 
Taken together, the data presented so far about MCUC indicate that mitochondria Ca2+ import involves an 
extremely complex molecular machinery, highly conserved in its basic features with regulatory mechanisms 
that have been probably added during evolution. Together with the enormous set of data indicating the 
involvement of mitochondrial Ca2+ uptake in many key aspect of cell physiology and pathology, it was 
almost obvious to anticipate that functional KO of MCU would result in an embryonic lethal phenotype. 
Indeed, a dramatic phenotype was obtained in a study carried out in zebrafish using morpholinos against 
MCU (Prudent et al., 2013). Anyway a recent paper by Finkel and co-workers show that MCU KO mice, 
obtained using the gene trap technique, are not only regularly born, but their phenotype is very mild: the 
animals are slightly smaller than their wild type littermates and they have modest defects in skeletal muscle 
strength and some alterations of metabolic functions (in particular in the control of pyruvate dehydrogenase). 
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Furthermore, the same group observed that mitochondria isolated from both skeletal and cardiac muscles of 
MCU KO mice are totally incapable of accumulating Ca2+ in an energy dependent way. In MEFs from the 
same transgenic mice, Ca2+ mobilization from intracellular stores results in no detectable increase in 
mitochondrial Ca2+ levels, but, surprisingly, only a partially reduction of mitochondrial Ca2+ content in 
resting condition was observed in MCU KO compared to that in wild type animals. Moreover, mitochondria 
from MCU KO mice lack evidence for Ca2+-induced permeability transition pore (PTP) opening, but 
unexpected this defect does not seem to protect MCU KO cells and tissues from cell death. Furthermore, 
whereas, as expected, the PTP inhibitor Cyclosporine A (CsA) provided significant protection against 
ischemia-reperfusion injury to WT hearts, this agent had no demonstrable effect on MCU KO hearts. Thus, 
in the absence of MCU, alternative PTP- or Ca2+-independent cell death mechanisms could emerge and 
become predominant. The authors themselves thus hypothesized the existence of alternative Ca2+ uptake 
pathways, capable of catalysing only a slow Ca2+ accumulation (Pan et al., 2013). The nature of this (these) 
pathway(s), if any, remains unknown. On the existence of alternative mitochondrial Ca2+ uptake pathways of 
interest are the recent observations by Graier and co-workers that up to 5 different Ca2+ currents can be 
identified in mitoplasts by electrophysiology (Jean-Quartier et al., 2012). In a more recent study, the same 
group observed that one of these currents (different from the one generated by MCU) is increased in 
mitoplast ablated of MCU (Bondarenko et al., 2013). They suggested the existence in mitochondria of at 
least two different Ca2+ channels, one MCU dependent and another, MCU-independent. As much as the 
existence of multiple mitochondrial Ca2+ influx pathways is fascinating (and could explain the mild 
phenotype of MCU KO mice), it needs stressing that, in MCU KO animals, either in isolated organelles or in 
living cells, Pan et al. did not found any evidence for energy dependent Ca2+ uptake.  
Mitochondria Ca2+ efflux 
The Ca2+ extrusion toolkit is composed by mNCX (or NCLX) in excitable cells, and mHCX exchangers in 
non-excitable cells. mNCX has been extensively studied in isolated mitochondria (Gunter et al., 1990; 
Bernardi et al., 1999), but only in 2010 Sekler’s group, identified this exchanger as a product of the mNCX 
gene (included in the super-family of NCX genes, comprising NCXs present on ER and PM), located on 
mitochondria and characterized by a low affinity Ca2+ exchange with Na+. The final discovery has originated 
from a fortuitous manifestation, i.e., the partial mistargeting of the overexpressed mNCX to PM. Indeed, they 
found that this mistargeted protein was able not only to exchange Na+/Ca2+, but is also to mediate an efficient 
Li+/Ca2+ exchange, a unique feature of the unidentified mitochondrial mNCX, not shared with members of 
the PM-NCX family. mNCX is also functionally distinct from the other two members of the family because: 
(i) its inhibition is specifically mediated by a pharmacological compound called CGP-37-157, (ii) its down-
regulation or overexpression affects mitochondrial Ca2+ release and (iii) fractionation experiments 
demonstrate that it is enriched in the mitochondrial fraction. mNCX channel is highly similar to the PM ones, 
thus, the scientific community agrees with the idea that 3 or 4 Na+ ions are changed per one Ca2+ ion (Patly et 
al., 2004-2010; Cai et al., 2004). mNCX Vmax ranges from 2.6 to 18 nmol Ca2+ per mg of protein per min in 
different cell types and its dependence on [Na+] has a sigmoidal trend with a Km around 8-10 mM (Cox et 
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al., 1993).  
Less is known about the role on mitochondrial Ca2+ efflux played by mHCX, which molecular identity is still 
debated; indeed no encoding genes have been isolated, but a 66 kDa protein that displays exchanger 
properties in liposomes has been purified. The ion stoichiometry is still debated also for this exchanger (2/3 
H+ per 1 Ca2+), but it’s clear that its functionality depends on membrane potential (Bernardi et al., 1983; 
Villa et al., 1998). mHCX has a Vmax around 1.2 nmol Ca2+ per mg of protein per min and its saturation 
point is around 25 nmol Ca2+ per mg of protein (Wingrove and Gunter, 1986). 
Finally, another system utilised by mitochondria to release Ca2+ is the permeability transition pore (PTP), a 
powerful mechanism of rapid and massive cations release associated with Ca2+ overload conditions (Bernardi 
et al., 1999). PTP is a large-size pore, that can undergo transient openings (flickerings), both in isolated 
mitochondria and in intact cells, thus permitting Ca2+ release from mitochondria when the [Ca2+] into the 
matrix is higher than in the external medium. This phenomenon contributes to organelle Ca2+ homeostasis, 
acting as a rapid, pro-survival Ca2+-induced Ca2+ release mechanism without causing catastrophic and 
irreversible PT (for a review see Rasola and Bernardi, 2011). The molecular nature of PTP is not completely 
clear. A recent paper, however, provided evidence that dimers of the F0F1-ATP synthase form a channel 
with features identical to those of the mitochondrial mega channel (MMC), the electrophysiological 
equivalent of the PTP (Giorgio et al., 2013). 
Mitochondrial buffering capacity 
Mitochondria have a Ca2+ buffering capacity due to the xCa2+–xPO4– xOHcomplex in the mitochondrial 
matrix, with a molecular stoichiometry similar to that of hydroxyapatite. These Pi function as a 
compensatory machine to prevent drops in membrane potential and increases in pH due to Ca2+ influx (Rossi 
et al., 1964; Zoccarato et al., 1982). This Ca2+ buffering mechanism to prevent Ca2+ overload is observed 
within mitochondria when extracellular [Ca2+] exceeds 400-500 nM or when mitochondrial membrane 
potential strongly favours Ca2+ influx in the organelles. The solubility of Pi strongly depends on matrix pH 
and, in particular, the formation of Ca2+- Pi precipitates is favoured at matrix alkaline pH (Chalmers et al., 
2003; Nicholls et al., 1978-2004). 
 
1.5.2 The functionality of mitochondrial Ca2+ homeostasis  
Researchers started to study the role of mitochondria in Ca2+ homeostasis since 1961. First Deluca, and then 
Vasington, demonstrated that energized mitochondria from rat kidney were able to accumulate Ca2+ (De 
Luca et al., 1961; Vasington et al., 1962). In 1977 the presence of an extrusion mechanism was demonstrated 
for the first time and also the existence of a balance between Ca2+ influx and efflux. Experimental evidence 
obtained in the 1980s tended to disprove a role of mitochondria as Ca2+ stores (Streb et al, 1983), discovering 
the ER as the central organelle for Ca2+ signaling. Despite biochemical works in the same years 
demonstrating the role of Ca2+ in the regulation of metabolic enzymes inside the mitochondria, their function 
in Ca2+ homeostasis was considered marginal. The demonstration of the existence of an active mechanism of 
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rapid Ca2+  uptake in intact cells stimulated with an IP3-generating agonist (Rizzuto at al., 1992-1993) 
reversed this assumptions, and proposed mitochondria as organelles promptly responding to [Ca2+]c rises.  
Mitochondrial Ca2+ homeostasis has effects at different levels, since it influences both mitochondrial and 
cellular functions. 
It was clear since 90s that Ca2+ was involved in mitochondrial functionality (McCormack et al., 1990). The 
first evidence that [Ca2+]c influenced the mitochondrial metabolism was provided by experiments in intact 
cell performed by Duchen et al., demonstrating that influx of Ca2+ from cytosol to mitochondria, could 
increase ATP production by activating three enzymes: pyruvate dehydrogenase, α-chetoglutarate 
dehydrogenase and isocitrate dehydrogenase (Duchen et al., 2000). The first one is regulated by a Ca2+ 
dependent phosphatase, while the latest two are regulated by direct binding of Ca2+. The activation of these 
three enzymes leads to an increase in NADH availability, which results in a flow of electrons down the 
respiratory chain, finally increasing ATP synthesis (Pralong et al., 1992; Hansford et al., 1994; Jouaville et 
al., 1999). The amplitude and the kinetics of the [Ca2+] increasing is also sensed by the Ca2+- binding site of 
the glycerol phosphate dehydrogenase, an enzyme involved in the electron supply of complex II in the 
respiratory chain. ATP production and metabolite transport is enhanced also by aralar1 and citrin, two 
aspartate/glutamate exchangers of the IMM, endowed with an EF-hand Ca2+ -binding domain exposed in the 
intermembrane space. Rises in [Ca2+]c leads to an activation of these two exchangers (Lasorsa et al., 2003; 
Contreras et al., 2007; Satrustegui et al., 2007).  
The tight connection between ATP production and mitochondrial Ca2+ uptake was demonstrated in different 
experiments: Wiederkehr and coworkers showed that the stimulated increase of ATP is inhibited by cytosolic 
Ca2+ chelators and by Ca2+ binding proteins targeted to mitochondrial matrix; it has been also observed an 
increase in NADPH production upon an augment of [Ca2+]m (Voronina et al.,2002); Foskett and colleagues 
demonstrated that mitochondrial ATP synthesis is maintained by Ca2+ shuttling from ER to mitochondria 
(Càrdenas et al., 2010). 
Ca2+ influenced also the shaping of this organelle by activating Drp1 through calcineurin-driven 
dephosphorylation that occurs after [Ca2+]c rise (Breckenridge et al., 2003; Cribbs and Strack., 2007). Two 
other proteins, Miro 1 and Miro 2, involved in mitochondrial fusion, are endowed of EF-hand Ca2+ binding 
domains (Frasson et al., 2006). 
Ca2+ signalling is also strictly correlated to mitochondrial biogenesis: a reduction in [Ca2+]m and an increase 
in mitochondrial volume befall by inducing biogenesis through employing PGC-1peroxisome 
proliferator-activated receptor-gamma (PPAR) co-activator-1) (Bianchi et al., 2005; Puigserver et al., 
2003). 
Mitochondrial Ca2+ modulates also many fundamental cellular functions. One of the functional consequences 
of mitochondrial ability to take up Ca2+ is the buffering of bulk [Ca2+]c, indeed [Ca2+]c waves can be localized 
at specific cell regions (such as synaptic regions, secretory pole of exocrine cells or immunological 
synapsis), can diffuse across the cells or they can also oscillate with different frequencies.  
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The buffering capacity varies in different cells types, depending on mitochondrial number, volume and Ca2+ 
buffering capacity.  
Depolarization of excitable cells induces an increase in [Ca2+]c that leads to an initial rapid recovery phase 
followed by a slower second phase, owing to [Ca2+]m redistribution mediated by mNCX (Thayer et al., 1990; 
David et al, 1998). 
Experiments performed in vivo in mature skeletal muscles, demonstrated that inhibition of mNCX augments 
Ca2+ buffering capacity of mitochondria, reducing the amplitude of [Ca2+]c peaks. Similar results are obtained 
from Maack and co-workers in cardiac myocytes, confirming the important role of mitochondria in 
modulation of [Ca2+]c peaks. The red skeletal muscle has high mitochondrial density located in close 
proximity to Ca2+ release sites. By inhibiting mitochondrial Ca2+ uptake, there is an alteration in the 
relaxation rate of skinned red fibers (Franzini-Armstrong et al., 2007; Gillis et al., 1997). 
In cardiac muscle, mitochondrial uptake and release of Ca2+ seems to follow a “beat-to-beat” model, but this 
hypothesis is still debated as well as the role of mitochondria. Local [Ca2+]c sparks are associated by the 
direct transfer of Ca2+ to mitochondria leading to transient increase in [Ca2+]m (Lukyaneco et al., 2000); 
Pacher et al., showed that in cardiac cells mitochondrial Ca2+ uptake decreases the frequency and the 
duration of [Ca2+]c sparks modulating RyR (Pacher et al., 2002). Moreover, mitochondrial Ca2+ buffering at 
the Z-line affects transverse propagation of Ca2+ waves (Subramanian et al., 2001). In neonatal cardiac 
myocytes, the downregulation of MCU increases the cytosolic Ca2+ peaks, while the overexpression of MCU 
decreases Ca2+ peak (Drago et al., 2012).  
In neurons, there is a powerful example of how mitochondria can shape [Ca2+]c dynamics by redistributing at 
Ca2+ release area. Indeed they are able to buffering an amount of [Ca2+]c up to > 10 mmol per kg and they 
influence neurotransmitter release by buffering [Ca2+]c at synapses. 
In sympathetic neurons (Colegrove et al., 2000) and in adrenal medulla cells (Montero et al., 2000; Montero 
et al., 2001), mitochondria buffer the massive Ca2+ increase due to K+-dependent depolarization or due to 
long trains of action potential. Indeed in pre-synaptic terminals, the enhanced synaptic response due to 
consecutive stimulations, is guaranteed by an elevated [Ca2+]c baseline due to the re-equilibration of [Ca2+]m 
after a cytosolic Ca2+ plateau. 
Rat astrocytes show a prolonged high [Ca2+]m, perhaps due to a slow activity of the mNCX modulating 
negatively the propagation of the [Ca2+]c waves (Boitier et al., 1999). 
In pancreatic acinar cells, mitochondrial Ca2+ buffering pledge the correct activation of the secretory granules 
by preventing the spread of [Ca2+]c from the apical pole to the basal pole. Moreover, the mitochondria at the 
basal pole seems to be more sensitive to CCE preventing high [Ca2+]c in this side of the pancreatic acinar 
cells (Petersen et la, 2006a; Petersen et la, 2006b; Petersen et al., 2012). 
T lymphocytes activation by antigens and chemokines seems to be due to a complex interaction between 
mitochondrial and SOCCs located at PM. Indeed mitochondria seems to regulate Ca2+ release-activated Ca2+ 
channel (CRAC) at the immunological synapses, buffering Ca2+ influx and modulating the rate of CCE (Hoth 
et al., 1997). 
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The mitochondrial ability of shaping [Ca2+]c waves both spatially end temporally is confirmed by different 
studies in endothelial and epithelial cells, demonstrating the importance of mitochondria located near the PM 
and the nucleus in distributing Ca2+ not only from ER but also from the extracellular space (Frieden et al., 
2004-2005; Varadi et al., 2004; Malli et al., 2003). 
Finally, the close connection between ER-mitochondria-plasma membranes, is demonstrated in HeLa cells 
overexpressing the mitochondrial fission protein hFIS1. Here, the absence of mitochondria near the PM leads 
to an increase in Ca2+ cycling through PMCA and CCE with the consequent bent of Ca2+ depletion in the ER 
under low extracellular [Ca2+] conditions (Frieden et al., 2005; Malli et al., 2005). 
 
 
FIGURE 6. Structure and functions of mitochondria (Brault et al., 2013). 
 
As Ca2+ plays such a critical and leading role in the regulation of mitochondrial metabolism and cell 
physiology, it is expected that, on the other side, the derangement of mitochondrial Ca2+ homeostasis 
becomes causal in cell death pathways leading to apoptosis and necrosis (reviewed in Rasola et al., 2011). 
Necrosis have long been associated with major increases in [Ca2+]c, as well as with Ca2+ overload in 
mitochondria. Ca2+ overload causes the opening of the high-conductance PTP, the rapid collapse of the 
membrane potential and the swelling of mitochondria, with consequent loss of cytochrome c. The following 
bioenergetic crisis, characterized by the drop in ATP levels and production of reactive oxygen species 
(ROS), results in necrotic cell death (reviewed in Rizzuto et al, 2003).  
More recently, it became clear that mitochondria also performs a pivotal role in the controlled cell death, in 
particular along the apoptotic intrinsic pathway. Despite the variety of cellular perturbations that can initiate 
the pathway, they all end up with the loss of integrity of the mitochondrial membrane, supposed to be 
mediated by PTP opening triggered by Ca2+ overload, which results in the release of pro-apoptotic factors 
that initiate the caspase cascade (Bernardi, von Stockum, 2012). Of note, in both cases, the causal event that 
causes PTP opening is mitochondrial Ca2+ overload. The outcome appears correlated with the extent of the 
overload (McConkey and Orrenius, 1996), which affects the duration of the PTP opening, which, in turn, 
33 
 
determines the residual ATP availability (Giorgi et al 2008). As ATP is required for apoptosis to progress, 
this will ultimately be the key switch between the two types of cell death. 
[Ca2+]c rises have been also shown to induce morphological modifications in mitochondria that correlates 
with apoptosis: indeed calcineurin-dependent phosphorylation of Drp1 causes its translocation on 
mitochondrial membrane and triggers mitochondrial fission, which leads to cytochrome c release 
(Cereghetti, 2008; Frank, 2001; Breckenridge et al., 2003; Cribbs et al., 2007, Friedman et al., 2011).  
Numerous experimental evidence led to the formulation of an hypothesis for the role of Ca2+ in apoptosis 
(Baffy et al., 1993; Scorrano et al., 2003; White et al, 2005): an apoptotic stimulus leads to the release of 
Ca2+ from the ER, which triggers Ca2+ uptake in mitochondria; an excessive Ca2+ accumulation in 
mitochondria activates the PTP, with consequent release of cytochrome c and other pro-apoptotic factors, 
leading to the activation of the effector caspases cascade. However, evidence exist that in some cell types or 
experimental conditions, overexpression of pro-apoptotic proteins does not cause a reduction of [Ca2+]ER 
(Chen, 2004; Hanson, 2008). An interesting interpretation of this data is that pro- and anti-apoptotic proteins 
could act modulating specific subtypes of the IP3R, thus determining diverse susceptibility in different cell 
types.  
An important role has been proposed for Ca2+ also in the regulation of autophagy. Several evidence suggest 
that elevations of intracellular [Ca2+] can induce autophagy, by a signal transduction pathway that 
comprehend the Ca2+ mediated phosphorylation of Ca2+/Calmodulin-dependent-kinase-β (CaMKK, the 
activation of AMP-activated protein kinase (AMPK) which produces the inhibition of the mammalian target 
of rapamycin (mTOR), the central player of the autophagic pathway (Hoyer-Hansen et al., 2007). However, 
it has also been reported an opposite role for intracellular Ca2+, as an inhibitor of autophagy. It is important to 
note that the relevance of many of these studies is uncertain, since they often analyse [Ca2+] elevations 
induced by ionophores for prolonged periods, a situation far from physiological, where Ca2+ signals are 
usually shorter and milder.  
Another pathway, independent of mTOR, has been identified, implying Ca2+ released from the ER in the 
regulation of autophagy. In particular, it has been shown that inhibition of phosphatidylinositol signalling 
(i.e. decreasing IP3, inhibiting IP3R or decreasing IP3R levels) enhances autophagy (Cardenas et al., 2010). 
Recently, a study reported that upon inhibition of IP3R, autophagy is stimulated in unstressed cells while it is 
inhibited in starved cells (Decuypere et al., 2011). Based on these observations, it has been hypothesized that 
in normal feeding conditions the constitutive Ca2+ transfer from ER to mitochondria is functional to the 
maintenance of an efficient mitochondrial respiration and thus prevents autophagy, whereas during starvation 
cytosolic Ca2+ signals have a dominant role in triggering autophagy. 
Thus Ca2+, accordingly with its early appearance in evolution as prokaryotic intracellular messenger (Case et 
al., 2007) and with the endosymbiotic theory of a prokaryotic origin of mitochondria, plays a fundamental 
role in the internal mitochondrial signalling as well as in signals integrating the organelles in the broader 
cellular context. 
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1.5.3 ER-mitochondrial crosstalk: the microdomains hypothesis and Mitochondria Associated 
Membranes 
As mentioned before, the existence of MCU, responsible for Ca2+ uptake across the electrochemical gradient 
was proved. Using mitochondrial Ca2+ probes, including fusion proteins carrying the Ca2+-sensitive 
photoprotein Aequorin, mitochondrial Ca2+ uptake was directly monitored in living cells showing that, 
following stimulation with a [Ca2+]c raising agonist, the speed and the amplitude of Ca2+ accumulation in 
mitochondria greatly exceed the values that were previously predicted on the basis of MCU properties in 
isolated mitochondria. Indeed, [Ca2+]m rises could reach values above 10 µM in response to cytosolic Ca2+ 
elevations rarely higher than 2-3µM . Taken into account the low affinity of the MCU, these observations 
raised a paradox, which led to formulate the “Ca2+ microdomains hypothesis”: mitochondria placed in close 
proximity to the channels that generate rises in [Ca2+]c (at the ER/SR or PM) are subjected to local [Ca2+] 
higher than those measured in the cytoplasm, giving rise to high and transient accumulation of Ca2+ (Rizzuto 
and Pozzan, 2006). The hypothesis was largely accepted, and supported by an increasing amount of electron 
microscopy (Vance, 1990) and fluorescence microscopy data showing regions of close proximity between 
ER and mitochondrial membranes in different cell types (Csordas et al., 1999; Rizzuto et al., 1998; Hoth et 
al., 1997 and Gilbert et al., 2000). It was only quite recently that the “Ca2+ microdomain” hypothesis has 
been directly confirmed by our group, using Cameleon probes targeted to the OMM (Giacomello et al., 
2010). These experiments have proved the existence of small OMM regions where, upon stimulation of Ca2+ 
release from the ER, [Ca2+] reaches values as high as 15–20 μM. Altogether, these data supports the 
conclusion that microdomains of high [Ca2+]c are sensed by mitochondria that are present in close proximity 
to IP3Rs and RyRs in ER or SR membranes (Giacomello et al., 2010; Korzeniowski et al., 2009), and 
VOCCs and SOCCs located on the PM (Glitsch et al., 2002; David et al., 1998; Young et al., 2008), 
generating rapidly dissipating [Ca2+]m transients. This property allows mitochondria to rapidly sense Ca2+ 
signals and to buffer locally Ca2+ rises, thus modulating the frequency of Ca2+ oscillations, with important 
implications in metabolism, secretion, neurotransmission and cell fate.  
Recently, the existence of a physical link between mitochondria and ER has been demonstrated (see below). 
Many proteins with different cellular activities (i.e. involved in the control of lipid biosynthesis, Ca2+ 
signalling and mitochondrial dynamics and division) have been found to be localized in this specialized 
subdomain, supporting the idea that ER-mitochondria contacts are highly specialized interfaces with an 
essential physiological role. 
The first evidence of the existence of close contacts between ER membranes and the OMM date back to the 
1960s (Robertson, 1960; Ruby et al., 1969; Morré et al., 1971), but the multifaceted significance of these 
appositions has started to be elucidated only more recently. In particular, an ER fraction that is attached to 
mitochondria can be biochemically isolated as mitochondria-associated membranes (MAMs) and it is 
reported to be enriched in enzymes that are involved in lipid synthesis, including phosphatidylserine (PS) 
synthase (Stone and Vance , 2000). This specific subdomains of ER membranes that interact with the OMM 
were defined as tight associations essential for lipid synthesis and exchange between the two organelles 
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(Vance, 1990). The distance between the ER and mitochondria in MAMs have been measured to be 10–30 
nm. This distance is close enough to suggest that the two organelles are tethered together by proteins located 
on the apposing membranes. Moreover, ribosomes are excluded from the ER membrane at this level, thus 
further indicating that contact sites form at specialized ER domains (for a review, see Rowland and Voeltz, 
2012). The presence of trypsin-sensitive proteinaceous tethers between the two membranes is now well 
established (Csordas et al., 2006) and the list of proteins with structural and signalling functions at the 
ER/mitochondria interfaces is constantly increasing, revealing a previously unexpected complexity (for 
recent reviews Filadi et al., 2012 and Raturi and Simmen, 2013). 
Since 90s, different protein have been suggested to be enriched in these compartment (De Brito and 
Scorrano, 2010). In yeast, the ERMES complex (ER-mitochondria encounter structure) is a complex of at 
least four proteins (Mdm10/ Mdm34, which are integral OMM proteins, Mmm1, an integral ER protein and 
the cytosolic Mdm12) whose assemblying favours lipid/metabolite exchange and zippers ER to mitochondria 
(Kornmann et al., 2009). In mammals, the proposed ER-mitochondria tether in mammals is Mitofusin-2 
(Mfn2). Mfn2 is an OMM protein, but a fraction resides also in the ER, particularly at the level of MAMs. 
ER resident Mfn2 has been proposed to engage homo- or hetero-typic interactions with respectively Mfn2 or 
its homologous Mfn1 on OMM, thus mediating a physical tethering between the two organelles that has been 
shown to affect their Ca2+ shuttling (de Brito and Scorrano, 2008). Anyway these latter findings are under 
debate, since Orci’s group demonstrated, using electron microscopy, that MFN2 KO MEFs are characterized 
by an increase in ER and mitchondria juxtaposition compared to wt MEFs, reversing the model propose by 
Scorrano’s group. Moreover, the presence of residual ER-mitochondria apposition in Mfn2 KO MEFs 
suggests that additional tethers should exist (Cosson et al., 2011).  
Of note, also Presenilin 1 and 2, two proteins involved in Familiar forms of Alzheimer's Disease, have been 
found to be highly enriched in MAMs (Area-Gomez et al., 2009). 
 
2. Ca2+ sensors 
 
2.1 Ca2+ measurement in living cells 
An adequate measurement of Ca2+ dynamics in living cells requires tools with sufficient sensitivity and 
spatial-temporal accuracy. Indeed, [Ca2+] inside the cell can change quickly, depending from the cell’s state 
(at rest or stimulated) and the specific subcellular compartment analysed. For example, cytoplasmic Ca2+ 
concentration, [Ca2+]c, can increase from 100 nM (in basal conditions) to peaks of 1-3 M, reached in just a 
few tens or hundreds of ms upon cell stimulation. Over the last decades, many classes of indicators, both 
chemical and protein based, have been developed and can be classified according to their physicochemical 
characteristics and spectral changes occurring upon Ca2+ binding: single wavelength indicators change 
fluorescence intensity without shifting their excitation or emission wavelengths, while ratiometric indicators 
change their excitation and/or emission spectra. Single wavelength indicators are generally brighter and 
facilitate Ca2+ detection when more than one fluorophore is used. Ratiometric dyes can be calibrated very 
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precisely and minimize the most common problems associated with synthetic indicators, including 
heterogeneous dye loading, photobleaching, dye leakage and changes in focal plane (Paredes et al., 2008). 
 
2.2 Synthetic Ca2+ indicators 
The first developed family of Ca2+ sensors is represented by synthetic dyes. Optical measurements of [Ca2+]c 
were performed initially using synthetic molecules that change their fluorescence or absorbance properties 
upon Ca2+ binding. Problems encountered using these indicators included their modest Ca2+/Mg2+ selectivity 
and the variable stoichiometry of cation/dye complexes. The field of Ca2+ imaging moved a significant step 
forward in the 1980s when R.Y. Tsien developed a new class of synthetic fluorescent Ca2+ indicators (among 
them quin2, Fura-2 and Indo-1), combining a fluorophore with the Ca2+ chelator EGTA (Grynkiewicz et al., 
1985). The structural changes induced by Ca2+ binding lead to modifications in the spectral emission and/or 
excitation properties of the probes, thus allowing a rapid and reliable estimation of [Ca2+] variations. The 
first rationally-designed fluorescent Ca2+ indicator was quin-2 (Tsien, 1980). The substitution of two 
methylene groups, with two benzene rings, couples the conformational change due to Ca2+ binding to a 
change in the spectral proprieties of the dye. Improvements of the original polycarboxilate indicators were 
then achieved in the following years in R.Y Tsien laboratory, e.g. the synthesis of indicators with different 
Ca2+ affinities and with excitation wavelengths different from the ultraviolet one (characteristic of the first 
generation of indicators). Key to the success of these indicators was also the discovery of a simple method to 
load these indicators into living cells, thus avoiding the complex procedure of microinjection. An 
acetoxymethyl (AM) ester group was added to the dyes, thus improving their hydrophobicity and 
consequently the permeation through the PM. Indeed, the original dyes had to be microinjected into cells by 
a time-consuming technique, while AM forms can simply be added to the medium. Once in the cytoplasm, 
the AM groups are rapidly hydrolysed by cellular esterases, regenerating the water-soluble indicator within 
the cell and at the same time preventing its release back into the medium.  
Over the years, many Ca2+ indicators were developed based on the same rationale, with different Ca2+ 
affinities and spectral properties, allowing intracellular Ca2+ detection in practically any cell type over a large 
range of concentrations (from <50 nM to >50M). High-affinity indicators are useful to quantify [Ca2+]c 
while lower affinity indicators can be in principle optimized for measuring Ca2+ within subcellular 
compartments with higher concentrations (Paredes et al., 2008). The esterases that cleave the AM groups in 
the fluorescent probes mentioned above are primarily located in the cytosol; accordingly, these indicators 
cannot be targeted to organelles with adequate selectivity. The only exception is Rhod-2, which accumulates 
into mitochondrial matrix thanks to its positive charge (Minta et al., 1989). The results obtainable with this 
dye are far from ideal, and to this end usually genetically encoded Ca2+ probes are preferred for mitochondria 
Ca2+ measurement. One way that has been proposed to overcome the limitation of the specific subcellular 
targeting, is to overexpress esterases in specific subcompartments of the cell (Rehberg et al., 2008). This 
approach, although interesting, is still poorly exploited.  
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2.3 Genetically Encoded Ca2+ Indicators  
The second family of Ca2+ indicators comprises proteins, either chemiluminescent (Aequorin) or Green 
Fluorescent Protein (GFP)-based, both derived from the jellyfish Aequorea Victoria. The most important 
breakthrough in the field of Ca2+ imaging at the subcellular level stemmed from the use those two proteins, 
opening the field of Genetically Encoded Ca2+ Indicators (GECIs). Specific targeting signals can be fused to 
the GECI sequence, achieving selective targeting of the transfected cDNA to organelles or cytoplasmic 
domains. GECIs targeted to practically all subcellular compartments and for measuring different dynamic 
parameters (Ca2+, pH, cyclic nucleotides, ATP, O2 radicals, etc) are now available. GECIs display different 
advantages, since they can be easily modified in their features (such as localization, dynamic range and 
affinity) by simple molecular biology techniques. They can also be placed under the control of tissue-specific 
or inducible promoters, allowing spatial and temporal control of their expression. They are also suitable for 
in vivo measurement of Ca2+ dynamics in intact tissues as well as in whole organisms, since they can be 
delivered via transgenesis, viral injection or in utero electroporation (Mank et al., 2008). Different classes of 
GECIs have been created and specific parameters are usually evaluated to characterize each probe, in 
particular affinity and selectivity for Ca2+, dynamic range and kinetics for Ca2+ binding. Usually, the 
evaluation of these parameters is performed in vitro but, since these probes behave differently in subcellular 
compartments, it is now clear that an in vivo evaluation is also necessary to obtain reliable measurements of 
absolute Ca2+ concentrations. Moreover, the cited parameters must be carefully assessed in order to choose 
the appropriate probe for the designed experiment. Starting from the building blocks Aequorin (Aeq) or GFP, 
it is possible to divide GECIs in two classes:  bioluminescent probes (based on Aeq) and fluorescent probes 
(based on GFP).  
2.3.1 Bioluminescence-based GECIs: Aequorin 
Aeq was the first protein-based Ca2+ indicator used in biology. In the early 1970s, after purification from 
jellyfish, it was usually injected into the cells (Llinás et al., 1972), but after the cloning of its cDNA (Inouye 
et al., 1985) it became the most frequently used probe to measure Ca2+ in different organelles. Aeq is a 22 
kDa Ca2+-sensitive photoprotein produced by the jellyfish Aequorea victoria, with a hydrophobic core that 
binds the prosthetic group coelenterazine and three EF-hand motifs for Ca2+ binding. Upon Ca2+ binding, the 
covalent bond between the prosthetic group and the apoprotein is broken, coelenterazine is oxidized to 
celenteramide and released with the emission of one photon; this reaction is irreversible (Figure 7). 
Importantly, the rate of photon emission depends on the [Ca2+], thus allowing the conversion of the speed of 
emitted light into [Ca2+] through a specific algorithm (Allen et al., 1977; Brini et al., 1995). In particular, 
there is a relationship between the [Ca2+] and the fractional rate of Aequorin consumption (i.e., L/Lmax, 
where L is the light intensity at a given time and Lmax is the total amount of light emitted after that point). 
Since the probe is gradually consumed during an experiment, the [Ca2+] can be obtained only at the end, 
when all Aequorin is consumed and L/Lmax is back calculated for each experimental point.  
The first Aeq variant, called native Aeq or simply Aeq wt, is expressed in the cytosol; the addition of 
targeting sequences for specific intracellular localization allowed the measurements of [Ca2+] in different 
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intracellular organelles. In particular, recombinant Aequorin variants have been reported, targeted to: 
mitochondrial matrix (mt Aeq), mitochondrial intermembrane space (mims Aeq), nucleus (Nu Aeq), ER (er 
Aeq), SR (sr Aeq), subplasmalemmal space (pm Aeq), Golgi apparatus (go Aeq), peroxisomes (perox Aeq) 
and secretory vesicles (vamp Aeq) (for a recent review, see Bonora et al., 2013).  
Then a second variant of Aeq was created by the generation of a point mutation D119A in the EF2 domain. 
The low Ca2+ affinity mutated version of mtAEQwt (mtAEQmut, with the point mutation D119A in the EF2 
domain, see below) was targeted to the mitochondrial matrix and revealed that mitochondrial Ca2+ transient, 
upon stimulation in certain cell type, can rapidly reach the millimolar level. On this line, a recently reported 
mtAEQmut, with an even lower Ca2+ affinity (de la Fuente S. et al., 2012), confirmed the ability of 
mitochondria to accumulate Ca2+ in their matrix up to the millimolar level.  
 
 
FIGURE 7. Schematic model of the irreversible reaction of Aequorin (Brini, 2008) 
 
The first organelle-targeted GECI was developed in 1992, when the mitochondrial pre-sequence of subunit 
VIII of cytochrome c oxidase (COX) was fused to an HA1-tagged native Aeq (mt Aeq) (Rizzuto et al., 
1992). Mt Aeq was particularly important because it was the prototype of the now large family of selectively 
targeted probes and at the same time because it provided the first direct evidence of fast mitochondrial Ca2+ 
accumulation in living cells in response to a physiological stimulus. Other mitochondrial Aeq-based GECIs 
were then produced: of particular relevance is the Aeq fused to glycerol phosphate dehydrogenase, a protein 
of the inner mitochondrial membrane (IMM) with a large C-terminal tail protruding in the mitochondrial 
IMS. This mims Aeq, provided the first direct evidence of the existence of high [Ca2+] microdomains near 
the regions of close contact between mitochondria and ER (Rizzuto et al., 1998).  
The noteworthy advantages of using recombinant Aeqs are: 
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(1) their wide dynamic range (from 0.1M to the low millimolar level), obtained both by modification of 
the native Aeq and through the use of different coelenterazine derivatives; 
(2) the marginal interference with endogenous Ca2+ buffering-proteins; 
(3) the low sensitivity to pH; 
(4) the high signal-to-noise ratio; 
(5) in case of co-transfection (as for the other protein-based indicators), the analysis is restricted to the cells 
expressing the protein of interest, and not to all the cells as with chemical probes; 
(6) the equipment required to perform the measurements is relatively simple and cheap. 
The use of Aeqs also entails some disadvantages, such as:  
(1) the need to transfect the cells or to use stably expressing clones, if compared with chemical probes; 
(2) the need to reconstitute the protein with coelenterazine for at least 1h before the experiment, if compared 
with other protein-based Ca2+ indicators; 
(3) the low amount of light emitted by the photoprotein, making it difficult to use in single cells; 
(4) the irreversibility of the Ca2+ triggered reaction makes Aequorin suitable only for relatively short 
experiment; 
(5) not reliable measurements of Ca2+ levels in compartments with inhomogeneous behaviour, since the 
different affinity for Ca2+ and the Ca2+ binding cooperativity of its three EF-hand domains make 
Aequorin behaviour steeply dependent from Ca2+ concentration; 
(6) the photoluminescence measurements are difficult to calibrate in compartments (or in cell populations) 
with heterogeneous Ca2+ levels (Brini et al., 1995; Brini, 2008; and Bonora et al., 2013).  
In the last years, other constructs containing Aeq have been generated, such as a dual reporter system 
comprising of a GFP mutant fused to Aeq (Baubet et al, 2000) and another named GAP, GFP-Aequorin 
protein (Rodriguez-Garcia et al., 2014). GAP is a fusion of GFP with apoaequorin that does not use the 
bioluminescence of Aequorin (thus, reconstitution is not necessary), but exploits Ca2+ binding to its three EF 
motifs to induce changes in the excitation/emission properties of GFP. The dual-excitation ratiometric 
imaging, the high dynamic range, the insensitivity to pH and Mg2+, the stability to photons and the good 
signal to noise ratio make GAP a promising probe for Ca2+ measurements also in vivo.  
 
2.3.2 GFP-based fluorescent GECIs 
Fluorescent GECIs consist of a fluorescent protein (FP) fused to a Ca2+-binding domain in such a way that 
Ca2+ binding modifies the fluorescence properties of the FP.  
The first discovered FP is the Green Fluorescent Protein (GFP). FPs have tens of application in cell biology 
thanks to their multiple advantages. First of all FPs do not require an external cofactor in order to emit light: 
in the GFP the brilliant chromophore is formed by amino acids 65 to 67 through a mechanism of cyclization, 
dehydration and oxidation. Moreover, the chromophore is located into the α-helix running inside a tight 
structure formed by an 11-stranded β-barrel, and so it is protected against environmental condition’s 
variations, at least in the wild-type form (Tsien, 1998). GFP can be easily modified without affecting its 
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ability to fluoresce: e.g., with the insertion of other proteins in position 145, and with circular permutation, in 
which GFP is spliced in two parts and then the amino and carboxyl-termini are interchanged. Moreover, 
mutations in the amino acids responsible for chromophore formation or located in its proximity allow the 
generation of FPs with new features, i. e. shifting fluorescence emission wavelength from blue to yellow and 
obtaining brighter variants or decreased environmental sensitivity (Shaner et al., 2005).  
GFP-based Ca2+ sensors are useful probes to evaluate Ca2+ dynamics in subcellular compartments, since they 
can be fused with specific targeting sequence, and they seem also to be the most promising for monitoring 
mitochondrial Ca2+ in live animals. Indeed, some examples are now available for in vivo Ca2+ measurements 
mainly with cytosolic probes, since they are better characterized and in general are easier to handle. On the 
contrary, organelle-targeted GECIs require a profound knowledge of both the sensor and the targeted 
organelle, since probes can be profoundly affected by the environmental conditions of each specific 
subcellular compartment. Moreover, in the last years a growing colour palette of FPs has been developed and 
many efforts have been made to red-shift the excitation wavelength of the indicators, reducing phototoxicity, 
background fluorescence and facilitating deep imaging into the tissues. An interesting challenge is the 
combination of differently coloured GECIs targeted to distinct organelles, in order to unravel the 
interconnection of Ca2+ signalling across different organelles, both in physiological and pathological animal 
models. Finally, further efforts should be focused on the amelioration of the signal-to-noise ratio, the 
reduction of pH and temperature sensitivity of the FPs, the decrease of probe’s size, and improvement of the 
kinetics. 
Two strategies have been developed to obtain GFP-based Ca2+ indicators: the first employs GECIs containing 
one fluorescent protein, where binding alters the chromophore environment, inducing a change in the 
intensity or in the wavelength of the emitted fluorescence. The other, takes advantage of Förster (or 
fluorescence) resonance energy transfer (FRET) changes that occur between two FPs in molecular constructs 
where the two proteins are linked through a Ca2+-sensitive peptide. 
Single fluorophore GECIs 
The development of single fluorophore GECIs started with the discovery that GFP (in its different variants) 
tolerates the insertion of relatively long peptides at position 145 in their aminoacid sequence. When a Ca2+-
binding peptide is inserted, the change in protein structure induced by the binding of the ion affects the 
protonation of the chromophore, changing its pKa, resulting in an increase or decrease of the chromophore 
fluorescence when excited at a given wavelength (Baird et al., 1999). The most widely used Ca2+-binding-
protein in these type of constructs is Calmodulin (CaM). One molecule of CaM presents four EF-hand 
domains, each one binding one Ca2+ ion cooperatively.  
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FIGURE 8. Single-fluorescent protein Ca2 + indicator families (Koldenkova and Nagai, 2013) 
 
Different type of single fluorophore GECI has been created (Figure 8):  
(1) Camgaroo. Camgaroos are a family of Ca2+ probes in which the CaM sequence was inserted at position 
145 of a yellow fluorescent protein (YFP), and Ca2+ binding causes a shift of the absorbance peak of the 
FP from 400 nm to 490 nm, thus allowing an estimation of [Ca2+]. Given that excitation at 400 nm does 
not lead to fluorescence emission in YFP, an attempt was made to improve visibility of cells at basal 
Ca2+ concentrations by changing the YFP with another GFP mutant named Citrine, resulting in 
Camgaroo-2 (Griesbeck et al., 2001).  
(2) Pericam. Another important and useful modification of the GFP is the generation of circular permuted 
YFP (cpYFP). The new sensor Pericam was generated fusing the CaM-binding domain of myosin light 
chain kinase, the M13 peptide, to the N-term of cpYFP, and CaM to the C-terminal. Upon binding of 
Ca2+, CaM wraps around the M13 peptide, causing a conformational change in the protein. Point 
mutagenesis and linker insertions generated variants of Pericam with different properties and affinity for 
Ca2+. Three different Pericams were generated: flash Pericam, that becomes brighter upon Ca2+ binding; 
inverse Pericam, that on the contrary decreases its fluorescence upon Ca2+ binding and ratiometric 
Pericam. The latter shows a shift in the excitation wavelength upon Ca2+ binding, allowing ratiometric 
measurements. Mitochondrial matrix targeting of ratiometric-Pericam have been obtained by fusing its 
N-term to the first 12 aminoacids of subunit IV of COX (Nagai et al., 2001) or to one or two copies of 
the first 36 amino acids of subunit VIII of human COX (Filippin et al., 2005). Another variant, called 
Inverse Pericam and characterized by the decrease of fluorescence upon Ca2+ binding has been fused to 
subunit VIII of human COX generating the probe Mitycam (Kettlewell, 2009).  
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(3) G-Camp. A class of sensors that enlarged considerably in the last years was developed starting from G-
Camp, an indicator generated fusing M13 peptide and CaM respectively at N- and C-term of a circularly 
permuted EGFP (Nakai et al., 2001). The first variant showed a suitable affinity for Ca2+ and a good 
dynamic range (4,5 fold change upon Ca2+ binding), however it was affected by some disadvantages, 
such as strong pH sensitivity, low fluorescence at resting state, slow folding and maturation of the 
fluorophore. Extensive structure-guided optimization has been performed to improve the properties of 
this sensor, giving birth to a class of sensors with different spectral properties and Ca2+ affinity, lastly 
leading to the generation of the family G-Camp6, characterised by improved brightness, sensitivity, 
affinity for Ca2+, wider dynamic range and faster kinetics, compared to the previously generated G-
Camp5. In vivo experiments in neurons proved the sensor G-Camp6f to be the fastest GECI available for 
measuring cytoplasmic free Ca2+ in neurons, with a sensitivity comparable to some commercially 
available chemical dyes (Chen et al., 2013). GCamPs targeting to mitochondria has been exploited for 
different sensors. Some attempts have been also made to increase the colour palette of single wavelength 
GECIs.  
(4) CEPIA and GEM-GECO. Recently, new Ca2+ sensor based on G-Camp has been generated. Those new 
probes, called Ca2+-measuring organelle-entrapped protein indicators (CEPIA), are useful to monitor 
simultaneously Ca2+ dynamics in different cellular subcompartments. Indeed CEPIAs with different 
emission wavelength (green, red or blue/green fluorescence) and targeted to organelles are available, 
making it possible, for example, to measure mitochondrial, ER and cytosolic [Ca2+] simultaneously (Iino 
et al., 2014). A ratiometric variant of GEM-GECO called GEM-CEPIA was also generated. It is reported 
to have grater dynamic range but higher photobleaching and photoconversion (Zhao et al., 2011).  
The main drawback of this class of Ca2+ sensor is its pH sensitivity (improved in the last generation of G-
Camp), and the fact that only a fluorescence intensity change is measured, with the exception of ratiometric 
Pericam and GEM-CEPIA. The measurement of [Ca2+] variations as changes in fluorescence intensity is 
prone to errors, since also contractions or shifts in focal plane rise the same effect. 
FRET-based GECIs sensing Ca2+ 
In 1997, Tsien and co-workers (Miyawaki et al., 1997) and independently Romoser’s group (Persechini et 
al., 1997) generated the first class of ratiometric GFP-based Ca2+ sensors, named by Tsien “Cameleons”. 
Cameleon probes are ratiometric GFP-based Ca2+ sensors initially named YCx, while subsequent 
computationally redesigned versions have been referred as Dx (x is the number of the variant). The 
Cameleon structure consists of the two Ca2+-responsive elements CaM and CaM-binding domain of myosin 
light chain kinase M13 connecting two FPs. The working principle of Cameleons is based on FRET changes: 
the direct transfer of energy from an excited donor FP (generally, a blue FP) to an acceptor FP (generally, a 
yellow FP). Ca2+ binding to CaM triggers a conformational change in the molecule, forcing the two FPs 
closer together: this results in an increased FRET efficiency that in turn leads to a decrease in the donor 
fluorescence intensity and an increase in the acceptor fluorescence intensity. It is thus possible to monitor 
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changes in [Ca2+] as changes in the ratio (R) between acceptor and donor fluorescence intensity. (Palmer et 
al., 2006).  
 
 
FIGURE 9. Schematic representation of Cameleon probe (Ko et la., 2011) 
 
In the last years, many improvements have been made to the original Cameleons: fluorophores have been 
replaced or modified to obtain decreased sensitivity to pH and Cl-, decreased photobleaching, variable Ca2+ 
affinity, improved dynamic range of FRET changes upon Ca2+ binding, and reduced interference of the probe 
with endogenous Calmodulin targets (Miyawaki et al, 1999; Palmer et al., 2006; Griesbeck et al., 2001; 
Nagai et al., 2004; Horikawa et al., 2010; Evanko et al., 2005; Truong et al., 2001). In particular, one of the 
issues that have been raised regarding the use of CaM-based GECIs is the possible interference of the probe 
with endogenous CaM targets. The problem has been overcame by Palmer and colleagues in Cameleon 
probes by engineering the binding interface between CaM and M13, thus decreasing the interaction between 
M13 and the endogenous CaM. Another important modification in the perspective of organelle targeting was 
the mutagenesis of Ca2+ binding site and the consequent creation of probes with different Ca2+ affinities. As a 
result of this modification, Cameleon probes with sensitivities that covers a 100 fold range of [Ca2+] 
(evaluated in vitro) are now available (Mank et al. 2006, 2008): D1 (kd= 0.8, 60 µM  ), D2 (kd= 0.03, 3 µM  ), 
D3 (kd=0.6 µM  ), D4 (kd= 64 µM  ). Moreover, different organelle-targeted Cameleons have been generated, 
directing the probe to the nucleus (Miyawaki et al., 1997), PM (Palmer et al., 2006), peroxisomes (Drago et 
al., 2008), mitochondria (Filippin et al., 2003; Palmer et al., 2006), ER (Demaurex et al., 2003; Palmer et al., 
2004; Kipanyula et al., 2012), cis-medial and trans Golgi apparatus compartments (Lissandron et al., 2010; 
Wong et al., 2013).  
As far as mitochondria are concerned, Cameleons were selectively targeted to the mitochondrial matrix and 
thus revealed the Ca2+ level within the lumen of the organelles. The most used mitochondrial targeted 
Cameleon probe is the 4mtD3cpV (and 4mtD1cpV), targeted to mitochondrial matrix thanks to the fusion 
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with 4 sequences of the N-terminal sequence of subunit VIII of human Cytochrome C Oxidase (COX). A 
unique sensor targeted to the OMM by fusing TOM20 N-terminal tail to D1cpV is also presently available, 
named N33D1cpV (Giacomello et al., 2010). 
4mtD3cpV allows Ca2+ dynamics measurement in mitochondrial matrix of different cell types and in 
different conditions, from physiological phenomena to stimulated mitochondrial Ca2+ uptake. 4mtD1cpV 
shows faster kinetics and double affinity for Ca2+. N33D1cpV allows the evaluation of the amplitude and 
dynamics of Ca2+ hotspots at the OMM generated by the release of Ca2+ from the ER or entering the cell 
through PM channels. Both probes can be easily used in vitro and in vivo to visualize mitochondrial Ca2+ 
dynamics. A huge number examples of in vitro application of the probes can be found, ranging from classical 
cell lines to primary cultures such as neurons, cardiomyocytes, lymphocytes and so on. In vivo applications 
have been less exploited, but some examples are present in the literature: Ca2+ uptake into mitochondria of 
mouse skeletal muscle during contraction was studied by using 2mt-YC2 (one of the first variant of 
Cameleon probes) electroporated into hind limb muscles (Rudolf et al., 2004); similarly, mitochondrial Ca2+-
handling in fast skeletal muscle fibres was evaluated employing 4mtD3cpv (Scorzeto, 2013); finally, 
Ivannikov et al., generated a transgenic fly line expressing mitochondrial D4cpV to evaluate mitochondrial 
Ca2+ uptake effects on energy metabolism in motor nerve terminals (Ivannikov and  Macleod, 2013). 
Recently, Arabidopsis transgenic plants expressing 4mt-YC3.6 have been used to unravel Ca2+ dynamics in 
the mitochondria of both guard and root cells in plants (Loro et al. 2012-2013) and a transgenic zebrafish 
expressing mitochondrial targeted YC2.60 was created to analyse embryonic Ca2+ waves that occur after 
fertilization and Ca2+ rises induced by contraction in embryonic myocytes.  
Another subtype of FRET-based Ca2+ sensors is the family of Troponin C (TnC) based indicators, generated 
to overcome the problems related to the use of CaM and in particular to avoid the interaction with CaM-
binding-proteins. To this end, the Ca2+-binding domain of Cameleons was substituted with chicken skeletal 
muscle Troponin C, TnC or human cardiac TnC, generating the sensors TN-L15 and TN-humTnC, 
respectively. The resulting sensor was structurally similar to the Cameleon, with the exception that it lacks of 
a binding peptide (reviewed in Garaschuk et al, 2007). Recently, a new type of FRET TnC-based Ca2+ sensor 
was developed, based on the C-terminal domain of Opsanus Troponin C: the so called 'Twitch' sensors. 
Interestingly, the sensors are endowed with high sensitivity (comparable to that of synthetic Ca2+ dyes), high 
brightness, large dynamic range and linear response properties, proposing them as interesting tools for 
neuroscience and immunology (Thesturp et al., 2014). 
 
2.4 Delivery systems for GECIs: Adeno-associated viruses 
As far as in vivo delivery is concerned, a general limitation of chemical dyes is the difficulty to supply the 
dye to the tissue of interest. On the contrary, GECIs can be delivered by standard approaches such as 
transgenesis, electroporation in situ, and viral infection. Despite these advantages, although some cytosolic 
GECIs have been exploited in vivo, the examples of organelle targeted probes in vivo are still scarce. 
Nonetheless, the in vivo models expressing mitochondrial targeted Cameleon probes described above, 
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ranging from plants to invertebrates to mammals, have contributed to a deeper understanding of Ca2+ 
dynamics in vivo, meaning that further effort should be done to improve the promising in vivo GECIs 
application. 
The protocols classically used for in vivo expression involves principally transgenesis and electroporation in 
situ, two techniques involving time-spending (i.e. for the generation and crossing multiple strains) and 
laborious tasks. An interesting new in vivo delivery technique that permits to overcome the mentioned 
disadvantages, making it possible to expand the possibilities of in vivo GECIs applications, is the viral 
infection. 
They are also useful to improve GECIs expression level, in primary culture resistant to transfection, such as 
neuron and neonatal cardiomyocytes. 
Originally the use of viruses in vivo was thought for gene therapy in genetic pathology, but they become 
soon an interesting approach for more general transgene delivery. Indeed, the possibility to engineering viral 
genome, allows the insertion of the transgene of interest along with different promoters to achieve cell-
specificity, and also the deletion of viral genes to improve safety (Woo et al., 2005). Different type of 
recombinant viruses have been created, form Lentivirus to Adenoviruses. They are mainly different in terms 
of operator's safety, immunogenicity, gene transfer duration, organs tropism and cassette's length (the part of 
the viral genome that host the target transgene). In general Adenovirus, Herpesvirus, and to some extent, 
Lentivirus are characterized by higher immunogenicity (Wright et al., 2001; Vandendriessche et al., 2007), 
while Adeno-Associated Viruses (AAV) vectors are considered safer to the operator, since they need a 
“helper” to infect the host. Moreover AAVs guarantee long-term gene transfer in animal models (Gao et al., 
2002; Arruda et al., 2005; Woo et al., 2005). Another advantage of AAVs is the availability of different 
envelope serotypes conferring distinct organ tropism. Of note is the AAV serotype 9, reported to have a 
strong cardiac tropism via systemic or local injection (Pacak et al., 2006; Bish et al., 2008) and brain tropism 
via intracranial injection (Foust et al., 2009). In the latter case, it is also possible to obtain the transgene 
expression in a specific cell type of the brain, by substituting the classical CMV promoter with a neuronal 
subtype-specific promoter. 
 
2.5 FLIM 
Different methods are available to monitor FRET. The intensity-based approach is one of them and it is the 
most used. Basically, recording the fluorescence intensity, it is possible to calculate variations in FRET. In 
the case of Cameleon probes, for example, it is possible to record simultaneously the fluorescence of CFP 
and of cpV upon CFP excitation. Calculating the fluorescence ratio between the two FPs (cpV/CFP), it is 
possible to follow the Ca2+ dynamics occurring within the sample. Anyway, this approach does not consider 
the contribution of intermolecular-FRET or homo-FRET (see below) that could occur. When protein-protein 
interaction is assessed using inter-molecular FRET-based methods (see Sun et al., 2013), one target is 
labelled with the donor moiety and another one with the acceptor, and thus FRET occurs between two 
different species. On the contrary, intra-molecular FRET happens between FPs that are part of the same 
46 
 
molecule, as in the Cameleon probe. In both cases, an accurate calibration is required, since there is a 
contribution from the acceptor molecule that can be directly excited. Moreover, different stoichiometry 
between donor and acceptor could occur in inter-molecular FRET, raising the possibility of wrong evaluation 
of FRET efficiency (Becker, 2012). Another critical point is to correct the bleed-through between donor and 
acceptor fluorescence (Sun et al., 2013). 
An alternative and promising method is based on the detection, instead of emission intensity, of the 
fluorescence lifetime of the probe. In FLIM (Fluorescence Lifetime Imaging Microscopy), measurements of 
the spatial distribution of probe lifetime is mapped inside living cells. FLIM was developed in the late 1980s 
(Bugiel and König, 1989) and early 1990s (Lakowicz at al. 1992), but it was widely applied in the late 1990s. 
This technique measures the average residence time in the excited state of the fluorophore, before it returns 
to the ground state by emitting a photon. Indeed, when a fluorophore is excited, its molecules are push to an 
excited and high energy state, where the molecule is unstable. Then, to restore the equilibrium, the molecule 
comes back to the ground state. This event happens with a certain probability based on the decay rates 
through a number of different (radiative and/or non-radiative) decay pathways. To observe fluorescence, one 
of these pathways must be by spontaneous emission of a photon. The emission signal typically follows an 
exponential decay function described as: 
 
I(t) = I0e(−t/τ) 
 
Where, t is time, τ is the fluorescence lifetime, I0 is the initial fluorescence at t=0. The characteristic time 
constant of this decay in FPs range from a few picoseconds to several nanoseconds (Lakowicz, 2006). FLIM 
produces images where each pixel represents the probe average lifetime, visualized through a false colours 
plot. This method allows one to distinguish fluorescent species by means of their fluorescence lifetime, 
within the same sample area and with overlapped emission spectra. This is particularly useful for the analysis 
of FRET processes.  
FLIM measurements, compared to intensity-based images, have the advantages of being independent of 
fluorophore concentration, excitation intensity fluctuation, sample thickness, or photobleaching. Indeed, the 
lifetime is independent of initial intensity and of the emitted light intensity. However, FLIM could be 
affected by some environmental parameters, such as pH, ion, oxygen concentration and molecular binding.  
FLIM is applied for studying a broad number of phenomena: 
 In biology, FLIM allows for the separation of multi-colour labelling with similar emission/excitation 
spectrum, but it is also suitable for detection of molecular interactions, for monitoring conformational 
changes in structural studies and for environmental sensing experiments; 
 In medicine, FLIM is used for tissue characterization by autofluorescence analysis; 
 In material science, FLIM is used to characterize and perform quality control on new materials (for 
further details see Becker et al., 2012). 
FLIM can be exploited using two different acquisition modes (Figure 10): 
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FIGURE 10. Schematic representation of time domain and frequency domain FLIM (from Olympus applications). 
 
(1) Time domain measurements. This methods is performed using a femtoseconds or picoseconds pulsed 
laser as a source and the lifetime is measured using Time-correlated Single Photon Counting (TCSPC), 
usually coupled to a laser scanning microscope. TCSPC has a time resolution of sub-ns and it is 
independent on variations in source intensity and photoelectron amplitudes. TCSPC is usually coupled 
with different types of detector, such as a photo-multiplier tube (PMT) or an avalanche photo diode 
(APD), to record the arrival times at which individual photons are detected with respect to the excitation 
laser pulse. These recordings are repeated until the photons collected are sufficient to build a histogram 
representing the number of events over time; the histogram will be fit to an exponential function that 
contains the exponential lifetime decay function of interest (Li et al., 2010). The major disadvantages of 
this technique is the long-acquisition time. Indeed a critical issue is the number of photons collected, 
because it influences the accuracy of the lifetime estimations. This is more critical for bi- or tri-
exponential decay function, requiring at least 10000 photons recorded per pixel. To shorten the 
acquisition time, different approaches can be employed, e. g.: lowering the number of recordings, then 
employing a more rough statistical analysis; using FP with single exponential lifetime, such as 
mCerulean3 and mTurquise2 instead of CFP; using gating-TCSPC, in which after a brief light pulse the 
record of photons is done in consecutive time bins (Ebrecht et al., 2014; Sun et al., 2013). 
 
 
FIGURE 11. Schematic representation of TCSPC method (Picoquant technote). 
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(2) Frequency domain measurements. This method is carried out by a phase-modulated process, using an 
excitation light source that is pulsed or modulated at high frequency and a modulated detector such as an 
intensified camera. The fluorescence lifetime is derived from the decrease in the modulation degree and 
the phase shift of the fluorescence compared to the excitation features. Indeed, in this case the 
fluorescence emission mirrors the modulation pattern of the source and the lifetime is determined from 
the form of the phase shift/delay, since the modulation in the emission signal is generated by the duration 
of the excited state. An advantage of camera-based frequency domain FLIM is its faster lifetime image 
acquisition, compared to TCSPC methods, making it suitable for dynamic and kinetic measurements in 
live cell research (van Munster and Gadella, 2005).  
 
2.5.1 FLIM-FRET 
FRET is a process in which a donor direct transfer energy to an acceptor, through a non-radiative process. 
FRET phenomenon was described in 1948 by Förster and it is defined as a dipole-dipole interaction that 
occurs between two FPs when a partial overlapping between the donor emission spectrum and the acceptor 
excitation spectrum is present. Thus, FRET efficiency depends on: distance between donor and acceptor 
(usually from 1 to 10 nm for FRET to occur), spectral overlap between the two FPs and dipole orientation. 
Mathematically, the FRET efficiency, E, is described as (Lakowicz, 2006): 
 
E= 1/[1+(r/R0)6] = 1-IDA/ID=1-DA/D 
 
Where r is the distance between donor and acceptor, while R0 is the Förster radius that define the distance at 
which the FRET efficiency is 50%. IDA and DA are the donor intensity and fluorescence lifetime in the 
presence of acceptor, and ID and D are those in the absence of acceptor. 
The rate of FRET efficiency (k) is described as: 
 
k= (1/ τD)(R0/r)6 
 
Thus the quenching of the donor by the acceptor is proportional to the FRET efficiency as the fluorescence 
lifetime is proportional to the fluorescence quantum yield of the fluorophore, meaning that variations in 
donor brightness are measurable in terms of lifetime (Ebrecht et al., 2014). Thus, the direct transfer of 
photons between donor and acceptor FPs, produces a decrease in the typical lifetime of the donor only, or it 
could cause also a rise in the time of the acceptor. The FRET efficiency is calculated comparing the 
fluorescence lifetime of the donor in presence and in absence of FRET (Becker, 2012). The donor 
fluorescence is composed by different lifetimes, reflecting the presence of interacting (quenched) and non-
interacting (unquenched) molecule. Only the interacting molecules are able to transfer a photon to the 
acceptor, causing the reduction in the donor lifetime. Usually FRET is described with a double-exponential 
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model, in which the slow lifetime component comes from the non-interacting, while the fast component 
comes from the interacting donor molecules; each lifetime is characterized by an amplitude, which mirrors 
the frequency distribution of each lifetime. From these parameters one can derive: the true FRET efficiency 
for the interacting proteins and the Förster radius, and the ratio of the relative numbers of interacting and 
non-interacting donor molecules (Sun et al., 2011; Becker, 2012; Lakowicz, 2006). It is also possible to 
evaluate the rise time of the acceptor fluorescence in the acceptor channel, allowing the measurement of 
lifetime only on the molecules involved in FRET. Indeed, the rise feature is a consequence of the delay of 
acceptor fluorescence following the energy transfer from donor to acceptor (Borst et al., 2008). Hence, 
FLIM-FRET analysis allows one to distinguish between real FRET (which occurs thanks to the transfer of 
photons between donor and acceptor) and homo-FRET (which occurs between two donors or two acceptors 
(Gautier et al., 2001)) and also between intra- and inter-molecular FRET. All this useful information cannot 
be obtained using most of the intensity-based FRET methods, making the FLIM-FRET analysis a powerful 
approach to study FRET processes. 
 
3. Optogenetic 
 
Optogenetic is an increasingly used technique to manipulate the depolarization state of polarized cells, used 
mainly in brain and to a lesser extent also in heart (reviewed on Entcheva, 2013). It represents a powerful 
tool to modulate ion’s concentration inside the cell, both directly and indirectly (i.e. as consequence of 
unbalance of other ions). Optogenetic is a term coined in 2006 by Deisseroth at el., to indicate the 
combination of optics, genetics and bioengineering used to dissect neural activities. In 2002 Miesenböck’s 
group described the first photoreceptor, called rhodopsin, exploitable to directly stimulate a subset of 
neurons in Drosophila, employing a simply and non-toxic method: the light (Zemelman et al., 2002). This 
discovery opened a new field: it became possible to use light to read out and even control neuronal activity. 
Nature chose this powerful technique as "Method of the Year" in 2010, considered the remarkable 
advantages of using light as an effector. Indeed, light is non-invasive, it allows spatial and temporal precision 
and it is possible to employ simultaneously multiple wavelengths and reach different tissue locations at the 
same time. The possibility of genetically encoded photoreceptors, allow their expression in cells and animal 
models in a very specific way: it is possible to place these genes under the control of specific promoters, 
finely controlling their spatial and temporal expression pattern. All these features make optogenetics a 
powerful tool to explore neuronal activities in the whole brain, in specific neuronal cell types or subcellular 
compartments, but also in order to exploit behavioural experiments and to study neuropathologies exploring 
local circuits and intralayer. 
The first photoreceptor was described in 1949 by Hill and Keynes, but only subsequently, thanks to the work 
of Deisseroth's group, this became a widely used approach (Sahel and Roska, 2013; Häusser, 2014). 40 years 
ago, Stoeckenius and Oesterhelt discovered that bacteriorhodopsin acts as a light-gated ion pump (Oesterhelt 
and Stoeckenius et al., 1971). Six years after the discovery of the microbial opsins, Matsuno-Yagi and 
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Mukohata discovered halorhodopsin, a light gated ion channel permeable to chloride, identifying the future 
most important inhibitory tool in optogenetics (Matsuno-Yagi and Mukohata, 1977). Finally, in 2002 
Hegemann, Nagel and colleagues discovered the widely used Channelrhodopsin (Nagel et al., 2002). 
Briefly, optogenetic tools comprise: 
(1) Channelrhodopsin, a cation channel activated by blue light, thus generating an exciting stimulus; 
(2) Halorhodopsin, a chloride permeable channel, activated by yellow light, able to generate an 
inhibitory stimulus (Deisseroth et al., 2011); 
(3) OptoXRs, a chimeric rhodopsin-GPCR (G-protein coupled receptor) obtained by substituting the 
rhodopsin’s intracellular loop with a specific adrenergic receptor sequence, allowing the exploration 
of biochemical signalling causal impact (Airan et al., 2009). Another type of optoXRs is the recently 
reported bPAC, a bacterial photoactivated adenylyl cyclase (Stierl et al., 2011). 
 
 
FIGURE 12. Schematic representation of channelrhodopsin-2 (ChR2), halorhodopsin (HR), Bacteriorhodopsin (BR) and OptoXR 
(Zhang et al., 2012). 
 
Extensive studies about opsins sequence and structure, allow the generation of fast and slow opening kinetic 
mutants, different light sensitive variants and opsins with bimodal changes in excitability (Deisseroth et al., 
2011). Of note, a variant permeable to Ca2+ called CatCH has been created: the channel is able to induce Ca2+ 
influx, which in turn activates voltage - Na2+ gated channels and causes membrane depolarization (Kleinlogel 
et al., 2011). 
Optogenetics definitely provides a promising tool, however some drawbacks have to be considered when 
using this tool:  
(1) changes in physiologic neural activities are possible, if the spontaneous activity in the target area is 
not simultaneously recorded during the photoactivation;  
(2) the light employed for the photoactivation and the expression level of the channel is heterogeneous, 
thus the possibility to trigger different degrees of inhibition or activation of the target should be 
taken into account; 
(3) it is possible to induce a non-physiological synchronization of neurons population; 
(4) the activation of some axons could lead to uncommon neurotransmitter release; 
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(5) in the absence of probes able to measure specific parameter (ions concentrations, voltage etc..), the 
interpretations of optogenetic data may be difficult; 
(6) using viral expression systems in animals, it is possible to induce toxicity or adaptation changes in 
the cellular physiology, since the expression level is not finely controlled (Häusser 2014). 
Despite the presented drawbacks, optogenetics impacted on the field of neuroscience since its born, 
opening new challenges also in other fields of cell biology with the creation of optoXRs. The 
combination of described optogenetic tools with recently developed fast kinetic GECIs (Chen et al., 
2013; Thestrup et al., 2014) or genetically encoded voltage sensors (Hochbaum et al., 2014), is 
unquestionably pushing forward neuroscience. 
 
3.1 Channelrhodopsin 
In general, rhodopsin are photoreceptors composed by opsins, 7 transmembranes-helix proteins. Opsins are 
linked covalently with the chromophore retinal, a vitamin A-related organic cofactor that undergoes a 
molecular modification, from cis- to trans- configuration, upon light exposure (Deisseroth et al., 2011).  
Two types of opsins have been described: 
(1) type I, present in microbes such as archea, eubacteria, fungi and algae. This group is divided in 3 
sub-types: 
a. Bacteriorhodopsins (BR), light driven proton pumps (Figure 12); 
b. Halorhodopsins (HR), light-driven chloride pumps with neural inhibitory effect;  
c. Channelrhodopsins (ChRs), light driven ion channels, further subdivided, on the bases of 
physical properties, in Channelrhodopsin-1 (ChR1) and Channelrhodopsin-2 (ChR2), both 
derived from Chlamydomonas reinharditii. ChR1 has limited usage because of its low 
conductance at pH 7. 
(2) type II, present in animals, including humans, and able to generate ion currents thanks to their 
coupling with G-proteins (Kato et al., 2012). 
ChR2 is a light-gated cation channel derived from algae, which evokes membrane potential depolarization 
upon photostimulation with blue light in the presence of the chromophore all-trans retinal (Negel et al., 
2002). In mammalian neurons, ChR2 generates sufficient photocurrent to depolarize cells, allowing its use to 
control neuronal activity with very high temporal resolution, thus offering distinct advantages over 
traditional pharmacological or electrical means of perturbation (Boyden et al., 2005). A number of modified 
versions of ChR2 exists, differing in channel properties such as channel conductance, ion selectivity, 
kinetics, desensitization and recovery from desensitized state, light sensitivity, and spectral response 
(Prakash et al., 2012).  
ChR2 is 737 aminoacids protein belonging to the retinylidene photoreceptor family, with the N-terminal 
functional domain of ~ 300 aminoacids able to generate the photocurrent. It is composed by 7 TM domains, 
the N-terminal region faces the extracellular space and the C-terminus faces the cytosol. The structure has 
been recently crystallized. The retinal binding pocket is located on TM7, where the protonate Schiff base 
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form the site where all-trans retinal binding occurs. The electronegative pore, responsible for the channel 
permeability, is formed by TM1, 2, 3 and 7, where TM2 seems to be responsible for ion conductance and 
selectivity (Kato et al., 2012). The wild type ChR2 needs to be stimulated employing high intensity 470 nm-
light, and it is characterized by fast opening rate and slow closing kinetic. It properly traffics along the 
secretory pathway to PM and it shows a mild tendency to aggregate. The main drawback for the use of this 
channel is the high level of desensitization. To overcome it, different variants have been created by 
mutagenesis of specific residues in the original sequence (reviewed in Lin, 2010), among them: 
(1) H134R: compared to wild type ChR2 shows reduced desensitization, increased light sensitivity, 
increased photocurrent, but slower opening and closure kinetic. 
(2) C128T, C128A, C128S: characterized by increased light sensitivity, but also by reduced kinetic and 
photocurrent. This represents the first published step-function or bistable opsin, since its closure 
kinetic can speed up employing orange light. It is used for inducing prolonged sub-threshold 
depolarization.  
(3) D128A: a variant similar to (2), characterized by increased light sensitivity, but also by reduced 
kinetic and photocurrent.  
(4) E123T or ChETA: a variant used for high frequency stimulations, since it shows faster kinetics, but a 
strong reduction in photocurrent and strongly increased desensitization. 
(5) VChR1: a variant of ChR isolated in Volvox carteri. A peculiar feature is the red-shift spectrum. 
However a strong photoactivation is also observed at 400 nm. Moreover, it presents slow kinetics 
(partially increased introducing E123T mutation), incomplete recovery from the desensitized state 
and poor membrane trafficking and expression. 
(6) ChEF: a chimeric variant obtained by fusing ChR1 and ChR2, characterized by increased steady-
state phase response, photocurrent comparable to original ChR2, but also reduction in light 
sensitivity and partial desensitized state recovery. It shows better trafficking to PM compared to wild 
type but higher expression levels that could lead to toxicity. A faster kinetic compared to ChEF, but 
similar to ChR2, was obtained introducing I170V mutation (obtaining a variant called ChIEF). Also 
in this case the H134R mutation increases the photocurrent. 
(7) ChD: another chimeric variant similar to ChEF with improved trafficking and expression. 
(8) SSFO (Step stabilized function opsin), has two variants: 
a. mutations C128S/D156A, give rise to prolonged photocurrents far outlasting (around 30 
minutes) the initiating pulses of light (Yizhar et al., 2011);  
b. mutations C128A/H134R, is a high-photocurrent SSFO variant, that maintains the prolonged 
off-kinetic of the previous C128S/D156A variant and opens with a lower amount of light 
(Prakash et al., 2012). 
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Figure 13. Three-dimensional computer model of ChR2. Mutations of the amino acid residues shown in stick representation are 
known to substantially influence different ChR properties. Color legend: retinal moiety in yellow, residues conserved in all known 
ChR in blue (Hegemann and Möglich, 2011). 
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Aim of the work 
 
Ca2+ signalling exerts a plethora of functions in cells, regulating both physiological and pathological 
conditions. Given its pivotal role, this ion has been widely studied for many years. At the beginning, 
chemical dyes allowed to monitor Ca2+ dynamics only in the cytosol, but thanks to the development of 
genetically encoded Ca2+ indicators (GECIs), the role of subcellular compartments like ER, mitochondria, 
nucleus and Golgi apparatus in Ca2+ handling has been largely unravelled in cells.  
Cameleon probes, belonging to GECI’s family, have been targeted to different cellular subcompartments and 
different studies have been carried out in vitro and in cell cultures. On the contrary, few examples employing 
Cameleon probes in vivo are available and mainly use the cytosolic version of the probe. Hopefully, the 
recent development of viral delivery techniques will speed up the application of targeted GECIs in vivo, 
replacing the complicated and expensive transgenesis system.  
Cameleon probes have the enormous advantages of being ratiometric Ca2+ sensors, a feature fundamental for 
in vivo applications, making the measurement independent of shifts in the focal plane and contraction 
phenomena that could occur (or be induced) in some tissues during the experiment. However, the low 
fluorescence quantum yield of donor fluorescent protein CFP and its multi-exponential lifetime prevent some 
applications, making it difficult to obtain a good signal- to- noise ratio in thick samples and complicating the 
lifetime analysis. Thus, in the first part of my PhD work, I engineered existing Cameleon probes by 
substituting CFP with a more brilliant, more photostable, and with a single-exponential lifetime donor, called 
mCerulean3. This upgrade was performed in cytosolic and mitochondrial Cameleon D3 variants. Further 
modifications of these probes have been done in order to maximize their biophysical performance, to create 
an optimized tool for in vivo Ca2+ measurement.  
Another powerful tool has been developed in the last years exploiting Channelrhodopsins, and a plethora of 
brain cells and tissues features have been explored thanks to the manipulation of neurons membrane 
potential. In order to expand the high potential of this tool, in collaboration with Prof. Sekler’s group (Ben-
Gurion University-Israel), we created a new mitochondria targeted Channelrhodopsin. The new tool 
generated allows to obtain a spatial, temporal and reversible control of mitochondrial membrane potential by 
simply employing light. 
Thus, the first part of my work is aimed at creating two new tools to study mitochondrial physiology, with 
particular attention to mitochondrial Ca2+ handling in vivo. 
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Results 
 
1. Generation and characterization of the new cytosolic and mitochondrial 
Cameleon probes 
 
1.1 The new generated D3mCerulean3 is a functional and brighter probe compared to the original 
D3cpV 
Cameleon probes have the enormous advantage of being ratiometric Ca2+ sensors, a great benefit for in vivo 
applications, making the measurement independent of shifts in the focal plane and contraction phenomena 
that could occur (or be induced) in tissues during the experiment. The low fluorescence quantum yield of 
donor fluorescent protein CFP and its multi-exponential lifetime prevent some applications, making it 
difficult to obtain a good signal-to-noise ratio in thick samples and complicating the lifetime analysis. In 
2011 by site-directed mutagenesis, Rizzo’s group created a new variant of CFP, called mCerulean3. 
Basically, the optimization of residues in strands 7 and 8 of the β-barrel combined with T65S mutation in the 
CFP chromophore improved the quantum yield to 0.87, making this new FP brighter and reducing the 
fluorescence photoswitching behaviour compared to other CFP variants both in vitro and in situ in living 
cells. Another interesting feature of mCerulean3 is the single exponential decay, making mCerulean3 a much 
better choice for FLIM experiments. Other studies reported also promising results using mCerulean3 as a 
FRET donor, coupled with mVenus as acceptor (Markwardt et al., 2011). Given these interesting biophysical 
features of mCerluan3 and considering the described drawbacks of CFP as a FRET donor, we substituted 
CFP with mCerluean3 in the cytosolic Cameleon probe D3cpV. Figure 14A shows the cloning strategy used 
to insert mCeruean3 in the place of CFP in D3cpV inserted in the mammalian expression vector pCDNA3 
(see materials and methods for details). This construct was used to transfect HeLa cells and the cytosolic 
localization of the new D3mCerulen3 was confirmed using confocal microscopy. The performance of the 
new probe was compared to the original one, assessing their ability to detect [Ca2+] changes. HeLa cells 
expressing D3cpv or D3mCerulean3 were perfused with extracellular-like medium and the cytosolic Ca2+ 
rise was induced employing the IP3-generating stimulus Histamine. The ionophore Ionomycin was used 
perfusing extracellular-like medium with 600 µM EGTA, and then perfusing extracellular-like medium with 
5 mM Ca2+, a protocol that allows to obtain the minimum and maximum FRET, respectively. The new probe 
shows similar performance compared to the original one, since both are able to detect the cytosolic Ca2+ rise 
induced by Histamine. 
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FIGURE 14. The new generated D3mCerulean3 is a functional and brighter probe compared to the original D3cpV. (A) Left: 
Schematic representation of the cloning strategy used to substitute CFP with mCerulean3 in D3cpV Cameleon probes. Right: 
Confocal image of the cytosolic D3mCerulean3. (B) HeLa cells transiently transfected with D3cpV or D3mCerluean3, were treated 
with 100 µM Histamine (Hist) and perfused with 600 µM EGTA and then 5mM CaCl2 in presence of 1 µM Ionomycin (Iono), where 
indicated. Representative kinetics of cytosolic Ca2+ uptake in HeLa cells expressing D3cpV (blue) and D3mCerluean3 (red). Data are 
plotted as FRET changes % of maximum. 
 
1.2 Fluorescence improvement and mitochondria targeted D3cpV generation 
One of the main features of mCerulean3 is the brightness improvement. A critical point for in vivo 
application of Ca2+ probes, is the signal-to-noise ratio (SNR), which determines the ability of an indicator to 
properly report Ca2+ transients. The SNR depends on the brightness of each FP presents in the probe: the 
higher is the brightness, the higher is SNR. Moreover, higher brightness provides the possibility of 
illuminating the sample with a lower amount of light, causing a reduction in phototoxicity. To check whether 
the brightness improvement of mCerulean3 was maintained in the new probe, mCerulean3 and CFP mean 
intensity has been measured in D3cpv or D3mCerulean3 expressed in HeLa cells. The fluorescence of cpV, 
present in both the new generated and the original probe, was chosen to normalize for the protein expression 
level (see Materials and methods). A significant fluorescence improvement around 50% (p<0.01) was 
obtained with the substitution of CFP (N=27) with mCerulean3 (N=53) in the D3 cytosolic Cameleon variant 
(Figure 15A). 
 
FIGURE 15. Fluorescence improvement in the new generated Cameleon Probes. The histogram represents the mean±SEM of CFP 
(blue) and mCerulean3 (red) fluorescence, normalize to cpV fluorescence in HeLa cells expressing cytosolic Cameleon probes (A) or 
mitochondrial Cameleon probes (B). N (number of cells) ≥ 27 for each conditions. (* p<0.05; ** p<0.01; *** p<0.0001).  
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The promising result obtained in terms of brightness was exploited in the perspective of improving available 
methods to explore mitochondrial Ca2+ dynamics in vivo, thus also mitochondrial probe has been modified. 
Figure 16A shows the cloning strategy used to insert mCeruean3 in the place of CFP in 4mtD3cpV in the 
mammalian expression vector pCDNA3 (see materials and methods for details). At this stage of the work, 
we decided to optimize also mitochondria localization, acting on the targeting sequence. Indeed, 24 h after 
transfection of the original D3cpv probe, a significant mislocalization to the cytosol was observed. 
Generally the targeting sequence is composed by the first 25 aminoacids of N-terminal signal sequences 
from subunit VIII of human Cytochrome C Oxidase, but longer variants has been used in other constructs. 
To improve the targeting to mitochondrial, each of the four targeting sequences present on 4mtD3cpv was 
elongated adding 5 aminoacids (obtaining sequences of 33 aminoacids) and a Kozak consensus sequence 
was added before nucleotides coding the starting codon. The probe obtained, named 4mtD3mCerulen3, was 
expressed in HeLa cells and imaged by confocal microscopy (Figure 16B). Proper localization was 
confirmed by immunostaining mitochondria using the OMM marker anti-TOM20. The new targeting 
sequence allows a proper mitochondrial localization in 87.5±9 % of cells (mean±SEM, N=27 number of cells 
analyzed in six different fields), compared to 38.6±11% (mean±SEM, N=36 number of cells analyzed in six 
different fields) obtained with the original 4mtD3cpV (p<0.01) (Figure 16C).  
A critical feature of FP is the protonation state of the chromophore. The protonation state of FP, in turn, is 
influenced by environmental pH. Thus, since matrix pH is about 8, while the cytosolic is about 7, the 
brightness improvement of mCerulean3 was tested also in mitochondria targeted Cameleon probes. A 
significant improvement in fluorescence (around 42.5%, p<0.0001) was obtained with the substitution of 
CFP (N=46) with mCerulean3 (N=39) also in the mitochondria targeted variant of Cameleon (Figure 15B). 
The performance of the new probe was compared to the original one, by assessing their ability to detect 
[Ca2+] changes in response to a physiological stimulus. HeLa cells expressing 4mtD3cpv or 
4mtD3mCerulean3 were perfused with extracellular-like medium and the cytosolic Ca2+ rise was induced 
employing the IP3-generating stimulus Histamine. After Digitonin permeabilization, cells have been then 
perfused with intracellular-like medium containing 600 µM EGTA, to obtain a condition of absence of Ca2+, 
and finally with the same medium containing 5 mM Ca2+, to obtain the minimum and maximum FRET, 
respectively. The new probe was able to detect the Histamine induced mitochondrial Ca2+ rise with an 
efficiency similar to the original one (Figure 16 D). 
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FIGURE 16. The new mitochondria targeted Cameleon probe is improved in localization and is a functional probe. (A) Schematic 
representation of the cloning strategy used to substitute CFP with mCerulean3 in 4mtD3cpV Cameleon probes. (B) Confocal images 
of 4mtD3mCeruean3. The mitochondrial localization of the new probe was checked for the co-localization with a mitochondrial 
marker, TOM20. Yellow colour indicates co-localization of the mitochondrial maker and 4mtD3mCeruelan3. (C) The histogram 
represents the mean ±SEM of the number of cells showing a proper mitochondrial localization normalized to the number of cells for 
each field of N ≥ 27 cells for each conditions. (D) HeLa cells transiently transfected with 4mtD3cpV or 4mtD3mCerluean3, were 
treated with 100 µM Histamine (Hist) and perfused with 600 µM EGTA and then 5mM CaCl2 after permeabilization upon 100 µM 
Digitonin (Dig) treatment, where indicated. Representative kinetics of mitochondrial Ca2+ uptake in HeLa cells expressing the 
original 4mtD3cpV (blue) and 4mtD3mCerluean3 (red). Data are plotted as FRET % of maximum. (* p<0.05; ** p<0.01; *** 
p<0.0001).  
 
1.3 Dynamic Range 
One of the most important parameters that must be evaluated both in the creation/modification of a Ca2+ 
indicator and in choosing the proper Ca2+ probe for an experiment, is the dynamic range (DR).  
This parameter is differently calculated depending on the type of GECI. In single fluorophore GECIs, the DR 
indicates how many times brighter is the Ca2+-bound state compared to the Ca2+-free state, and thus it is 
expressed as  
 
DR= Imax/Imin 
 
Where Imax is the maximal fluorescence intensity obtained under Ca2+ saturated condition, while Imin is the 
fluorescence intensity in the absence of Ca2+.  
Similarly, in ratiometric Ca2+ GECIs, the DR expresses how many times the maximal FRET ratio is larger 
than the minimal FRET ratio and thus is calculated as 
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DR=Rmax/Rmin 
 
Where Rmax is the ratio (acceptor/donor) obtained under Ca2+ saturated condition, while Rmin is the ratio in the 
absence of Ca2+ (reviewed in Koldenkova and Nagai, 2013).  
This parameter depends on different conditions: in particular, in FRET Ca2+ probes, it could be modified by 
different factors, such as the alteration in the efficiency of photons transfer between donor and acceptor FPs.  
To test whether the DR was changed by the substitution of CFP with Cerluean3 in the cytosolic probes, 
HeLa cells were transfected with D3cpV and D3mCerulean3. Since permeabilization causes the release of 
the cytosolic probe into the medium, we used the Ca2+ ionophore Ionomycin to impose maximal and minimal 
Ca2+ levels in the intact cells. This approach allows a rough estimation of DR, and the data obtained must be 
confirmed in vitro. 
DR calculated for D3cpV is 2.53±0.08 (mean±SEM, N=23 number of cells analyzed), while for 
D3mCerulean3 is 2.11±0.07 (mean±SEM, N=18); the donor substitution thus causes a significant reduction 
(about 20%, p<0.01) of DR (Figure 17B). A similar negative impact has also been recently reported in 
Twitch sensor, where CFP was substituted with mCerulaen3 or mTuruaise2 (Thestrup et al., 2014).  
Different approaches can be employed to improve the DR. One is the acceptor substitution (Nagai et al., 
2004). We tested the substitution of cpV with citrin or YPet (two YFP variants), but none of them was able 
to recover the DR (data not shown). 
Another approach reported in literature to modify the DR and the sensitivity of the probes to Ca2+ is the 
elongation of the linker between the two Ca2+ responsive elements (Horikawa et al., 2010). Indeed, an 
interesting feature of Cameleons is the presence of two Ca2+ responsive elements, CaM and M13, separated 
by a short glycines linker. We tried to improve DR in mCerulean3 by adding glycine-based linkers of 
different length between CaM and M13. The addition of 16 glycines between CaM and M13 in 
D3mCerulean3 (hereafter called D3mCerulean3+16), allowed not only the recovery but also an improvement 
of DR (Figure 17B). Indeed D3mCerulean3+16 has a DR of about 3.06±0.07 (mean±SEM, N= 20 number of 
cells analyzed), significantly higher (around 20%, p<0.0001) compared to 2.53 of D3cpV. Again, the 
performance of the last generated variant has been tested in HeLa cells expressing D3mCerulean3+16, using 
the same protocol described above (Figure 17C). 
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FIGURE 17. Dynamic range evaluation in cytosolic Cameleon probes. (A) Protocol for DR evaluation in cytosolic Cameleon probe. 
HeLa cells expressing the cytosolic probe has been treated with 1 µM Ionomycin (Iono) and perfused with  extracellular-like medium 
containing 600 µM EGTA and then 5mM CaCl2. Data are presented as ratio (R, acceptor/donor). (B) The histogram shows the DR 
mean ±SEM (normalized to control) of N≥18 cells for each conditions. D3cpV is showed in blue, D3mCerulean3 in red and 
D3mCeruealn3+16 in green. (C) Representative kinetics of cytosolic Ca2+ uptake in HeLa cells expressing D3mCerluean3+16 
employing the same protocol of Figure 14. Data are plotted as FRET % of maximum. (* p<0.05; ** p<0.01; *** p<0.0001).  
 
Since mitochondrial environment differs from that of the cytosol both in term of ions concentration and pH 
(parameters that can modify Ca2+ probes behavior), the DR has been tested also in the mitochondria targeted 
version 4mtD3mCerulean3. In this case, cells permeabilization ensures the possibility to get a real minimum 
and maximal FRET. Thus HeLa cells expressing mitochondrial probes were permeabilized and then perfused 
with intracellular-like medium containing 600 µM EGTA and then with 5 mM Ca2+. Again, the substitution 
of CFP with mCerulean3 induced a decrease of about 20 % in the DR (p<0.0001): 4mtD3cpV displays a DR 
of 2.44±0.03 (N=53), while 4mtD3mCerulean3 has a DR of 1.94±0.03 (N=24). Employing the same strategy 
described above for the cytosolic probe, we generated a 4mtD3mCerulean3 version with the addition of 16 
glycines in the spacer (hereafter called 4mD3mCerulean3+16). The extension of the linker allowed to 
recover the probe’s DR to 2.37±0.03 (n=38) (p>0.1) (Figure 18B). Also in this case the performance of the 
generated variant has been tested in the intact cells expressing 4mtD3mCerulean3+16 (see the protocol 
above) (figure 18C). 
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FIGURE 18. Dynamic range evaluation in mitochondrial Cameleon probes. (A) Protocol for DR evaluation in mitochondrial 
Cameleon probe. HeLa cells expressing the mitochondrial probe has been permeabilized with 100 µM Digitonin (Dig) and perfused 
with intracellular-like medium containing 600 µM EGTA and then 5mM CaCl2. Data are presented as ratio (R) (B) The histogram 
shows the DR mean ±SEM (normalized to control) of N≥24 cells for each conditions. D3cpV is showed in blue, D3mCerulean3 in 
red and D3mCeruealn3+16 in green. (C) Representative kinetics of cytosolic Ca2+ uptake in HeLa cells expressing 
4mtD3mCerluean3+16 employing the same protocol of Figure 14. Data are plotted as FRET % of maximum. (* p<0.05; ** p<0.01; 
*** p<0.0001).  
 
1.4 Photostability of the new probes 
As mentioned above, it has been reported that mCerulean3 shows an improvement in photostability 
compared to CFP and its variants. The primary consequence of higher photostability is a smaller decrease in 
brightness during FP excitation; this makes photostability an important limiting factor in experiments 
requiring prolonged imaging of cells. To check whether mCerulean3 substitution increased D3 Cameleon 
photostability, HeLa cells, expressing the original and modified Cameleon probes, were imaged with the 
same illumination settings (fixed excitation intensity, and exposure time) and acquisition (1 image per 
second for 20 minutes) under conditions of maximal, minimal and basal FRET. The photostability is 
quantified indirectly by monitoring the decrease in the ratio (R) (calculated as the difference between R at 
the beginning of the experiments and R at the end of the experiments). The decrease in the ratio (hereafter 
simply called ratio bleaching) is the result of multiple factors, e. g. single fluorophore bleaching and donor 
de-quenching. The latter takes place when the donor paradoxically emits more photons (instead of less, as 
expected in case of bleaching), since the number of acceptors able to receive photons is decreased as a result 
of their bleaching. Moreover, the linker introduced between CaM and M13 improves the molecule mobility, 
possibly inducing molecular instability that in turn could affect the efficiency of photon transfers between 
donor and acceptor, and thus decreases the photostability of the probe. In basal FRET condition, D3cpV 
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shows a bleaching in ratio of 20±1.9% (mean±SEM, N=24), D3mCerulean3 of 15.4±1.7% (N=32) and 
D3mCerulean3+16 of 7.5±0.9% (N=23). Thus, in basal FRET condition the D3mCerulean3+16 shows 
stronger photostability, since it presents a reduction in ratio bleaching over time (around 64% less, p<0.0001) 
compared to D3cpV (Figure 19A). Similarly, in minimal FRET condition, D3cpV shows a bleaching in ratio 
of 14.7±2.3% (N=17), D3mCerulean3 of 9.8±1.1% (N=29) and D3mCerulean3+16 of 7.4±0.9% 
(mean±SEM, N=23) (Figure 19B). Again, D3mCerulean3+16 show a significant reduction in ratio bleaching 
compared to D3cpV (around 50%, p<0.01). Also in maximal FRET condition the ratio bleaching of 
D3mCerulean3+16 is diminished by about 30% compared to the original Cameleon (p<0.01). In the last 
condition, in fact, D3cpV shows a decreased in ratio of 28.3±1.6% (N=22), D3mCerulean3 of 21.8±2% 
(N=21) and D3mCerulean3+16 of 20±1.19% (N=18) (Figure 19C). 
 
 
 
FIGURE 19. The histogram shows the ratio decreased measured by illuminating the sample each seconds for 20 min in HeLa 
expressing D3cpV (blue), D3mCerulean3 (red) and D3mCerulean3+16 (green) in minimal FRET condition (A); basal FRET 
condition (B); in maximal FRET condition (C). Data are represented as mean ±SEM of N≥17 cells for each conditions. (* p<0.05; ** 
p<0.01; *** p<0.0001).  
 
Also in the case of the mitochondrial targeted Cameleon probes, the photostability was checked in the three 
different FRET conditions. In basal FRET condition, 4mtD3cpV shows a ratio bleaching of 11.4±0.9% 
(N=20), 4mtD3mCerulean3 of 7.7±0.9% (N=20) and 4mtD3mCerulean3+16 of 5±0.49% (N=18, -55% 
compared to 4mtD3cpv, p<0.0001) (Figure 20A). Similarly, in minimal FRET condition, D3cpV shows a 
ratio bleaching of 14.5±1.4% (N=39), 4mtD3mCerulean3 of 8.1±1.15% (N=19) and 4mtD3mCerulean3+16 
of 2.8±0.5% (N=15,-80%, p<0.0001) (Figure 20B). Similar results were obtained under maximal FRET 
conditions: 4mtD3cpV shows a ratio bleaching of 33.7±1.26% (N=23), 4mtD3mCerulean3 of 22.3±1.2% 
(N=30) and 4mtD3mCerulean3+16 of 18.7±0.8% (N=26, -45% p<0.0001) (Figure 20C). 
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FIGURE 20. The histogram show the ratio decreased measured by illuminating the sample each seconds for 20 min in HeLa 
expressing 4mtD3cpV (blue), 4mtD3mCerulean3 (red) and 4mtD3mCerulean3+16 (green) in minimal FRET condition (A); basal 
FRET condition (B); in maximal FRET condition (C). Data are represented as mean ±SEM of N≥ 15 cells for each conditions. 
(* p<0.05; ** p<0.01; *** p<0.0001).  
 
1.5 pH sensitivity  
The proton gradient (pH) across the inner membrane is a key feature of mitochondria, regulating both 
uptake and efflux of ions and metabolites. Generally, matrix pH ranges from 7 to 9 (reviewed in Poburko and 
Demaurex, 2012). Variations in pH can affect the affinity of GECIs for Ca2+ (reviewed in Koldenkova and 
Nagai, 2013). Moreover, since each FPs present a specific pKa, the substitution of CFP with mCerulean3 
could potentially change the probes pH sensitivity. To check whether mitochondria targeted Cameleon 
probes are sensitive to pH in the range of pH that mitochondrial could experience, a fixed pH has been 
imposed within the mitochondrial matrix (protocol described in materials and methods). Figure 21B show 
the average of the R% absolute value (where R% means ratio normalized to ratio at minimal and maximal 
FRET) variation at pH 7, 7.5, 8.5, 9 in HeLa cells expressing the three variants of 4mtD3 Cameleon probes. 
At pH 7, no significant changes were observed (4mtD3cpV, 4±0.2% N=12); 4mtD3mCerulean3, 3.7±0.5% 
(N=8); 4mtD3mCerulean3+16, 3.1±0.5% (N=11)). The same was obtained at pH 7.5 (4mtD3cpV, 3.9±0.7% 
(N=14); 4mtD3mCerulean3, 2.30±0.9% (N=3); 4mtD3mCerulean3+16, 1±0.3% (N=12)), at pH 8.5 
(4mtD3cpV, 1.95±0.4% (N=24); 4mtD3mCerulean3, 2.1±0.3% (N=11); 4mtD3mCerulean3+16, 0.5±0.1% 
(N=19)) and at pH 9 (4mtD3cpV, 4.5±0.7% (N=10); 4mtD3mCerulean3, 2.30±0.9% (N=5); 
4mtD3mCerulean3+16, 1.4±0.3% (N=14)). All the variants thus appear largely insensitive to pH variations 
in the range of interest tested (the observed changes in FRET % of maximum are always lower than 5%). 
Interestingly, 4mtD3mCerulean3+16 proved to be the most stable of the variants assessed. The experiment 
cannot be carried out for D3 cytosolic Cameleon variants, since permeabilizing the cells would cause the 
cytosolic probes to diffuse outside the cell. 
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FIGURE 21. Mitochondrial Cameleon probes are insensitive to pH from 7 to 9. (A) Representative trace of pH sensitivity 
experiments. Representative kinetics of the FRET % of maximum in permeabilized HeLa cells transiently transfected with 
4mtD3mCerulean3+16. All the experiments are carried out in the presence of 5 µM FCCP and 600 µM EGTA, except when the 
maximal FRET is induced by adding 5mM Ca2Cl as indicated by top bars. Where indicated the intracellular medium at pH 8 is 
substitute with pH 7.5. (B) The histogram show the R% absolute values mean±SEM  FRET measured in HeLa cells expressing 
4mtD3cpV (blue), 4mtD3mCerulean3 (red) and 4mtD3mCerulean3+16 (green) at different pH of N≥3 cells for each conditions. (* 
p<0.05; ** p<0.01; *** p<0.0001).  
 
1.6 Ca2+ affinity 
The evaluation of the Ca2+ affinity (Kd), provides an idea of the approximate range of Ca2+ concentrations in 
which a GECIs can effectively function as a [Ca2+] indicator (Koldenkova and Nagai, 2013). Moreover, it 
allows quantitative Ca2+ measurement, since it permits to convert values of R in absolute [Ca2+]. In situ 
calibration of the original and new mitochondrial probes was carried out performing passive Ca2+ loading 
experiments. Calibration experiments were carried out in cells permeabilized with Digitonin using an 
intracellular-like medium supplemented with the uncoupler FCCP and in the absence of energy sources. 
Under these conditions the [Ca2+] within the matrix should equilibrate with that in the perfusing medium (see 
materials and methods for details) (Figure 22A). The experimentally calculated Kd are: Kd1 0.06 µM and Kd2 
10.84 µM in 4mtD3cpV; Kd1 0.03 µM and Kd2 10.7 µM in 4mtD3mCerulean3+16 (Figure 22B-C). The 
fitting data and the Hill coefficient (n) calculated are summarized in Table 1 (see below). 
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FIGURE 22. (A) Titration protocol. Representative kinetics of FRET % of maximum in permeabilized HeLa cells transiently 
expressing the 4mtD3mCerulean3+16. Where indicated, Digitonin-permeabilized cells were bathed with an intracellular-like medium 
without energy source and containing different [Ca2+], in the representative trace is 10 µM CaCl2; 5 mM CaCl2 was finally added to 
reach the maximum value. In situ calcium titration curves of 4mtD3cpV (B), 4mtD3mCerulean3+16 (C), along with corresponding 
fits of the data. Mean ± SEM. Of N ≥ 3 cells for each [Ca2+]. 
 
2. In vitro characterization of new Cameleon probes 
The data shown above originate from in situ evaluations. However, the physiochemical properties of GECIs 
need to be determined also in vitro to allow the comparison of different indicators. Furthermore, the 
cytosolic probes are difficult to characterize in situ, because of the impossibility of permeabilizing cells. 
We first verified that the COX VIII mitochondrial targeting sequence (4mt) is properly cleaved after import 
of the protein in the mitochondrial matrix (Chacinska et al., 2009). Proteins extracted from HeLa cells 
expressing cytosolic and mitochondrial probes were analysed by Western blot. As expected, if the targeting 
sequence is properly cleaved, cytosolic and mitochondria targeted probes display the same MW (Figure 
23A). Accordingly, only D3cpV and D3mCeruelan3+16 (without the mitochondrial targeting sequence) 
cDNA was cloned in a bacterial expression vector carrying a Histidine tag fused to their N-terminus. The tag 
is necessary for the gel agarose binding during the protein purification. These constructs were expressed in 
E.coli and purified with HIS-Select Nickel Affinity Gel (Sigma Aldrich). After proteins purification, the 
presence of contaminants was verified by SDS-page stained with Comassie Blue (Figure 23B).  
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FIGURE 23. (A) HeLa expressing D3cpV, 4mtD3cpV, D3mCerulean3+16 and 4mtD3mCerulean3+16. 24 h after transfection, total 
proteins were extracted and subjected to Western blot analysis with antibodies anti-GFP. (B) Purified D3cpV and D3mCeruelan3 
proteins were resolved by SDS-page and stained with Comassie Blue. 
 
The protein bands appeared quite pure with minimal contaminants: The purified proteins was resuspended in 
intracellular-like medium (see materials and methods) at pH 7, to mimic cytosolic environment, or at pH 8, 
to mimic the mitochondrial environment and the DR and Ca2+ Kd were evaluated. An EnVision® Multilabel 
Reader PerkinElmer was used to record the fluorescence at different [Ca2+] concentrations, after checking the 
proper protein concentration required to get sufficient SNR and to avoid protein precipitation. Preliminary 
data are summarized in Table 1. Of note, just few [Ca2+] concentrations have been tested, hence the 
evaluation of Ca2+ affinity in vitro results in a single Kd. However further experiments are required to clarify 
the discrepancy between in vitro and in situ data. 
 
TABLE 1. In vitro and in situ properties of cytosolic and Cameleon probes. Kd-dissociation constant, n-Hill constant, nd, not-
determined. Data are presented as mean ± SEM of N≥2 independent experiments  
 
3. FLIM 
As mentioned in the introduction, FLIM measurements, compared to intensity-based images, have the 
advantages of being independent of fluorophore concentration, excitation intensity fluctuation, sample 
thickness, or photobleaching. Indeed, the lifetime () is independent of initial intensity and of the emitted 
light intensity. Moreover FLIM-FRET analysis is a unique technique that allows to distinguish between 
homo-FRET, intra- and inter-molecular FRET. These experiments are performed in collaboration with Prof. 
Bozio’s group (Department of Chemical science, University of Padua). 
Prior to the FLIM analysis of Cameleon sensors, time-resolved fluorescence analysis has been performed in 
cells expressing donors or acceptor alone. This will be useful for the calibration of further measurements on 
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Cameleon probes, since in FLIM-FRET analysis is necessary to fix the donor unquenched lifetime in order to 
get a reliable measure. Thus, HeLa cells transfected with cytosolic or mitochondrial Cameleon variants have 
been analyzed and data are summarized in Table 2. The last column of the table reports the amplitude-
weighted lifetime calculated as:  
AMP  Aii
i1
n
 Ai
i1
n
  
where Ai is the pre-exponential factor of the i-th component with fluorescence lifetime i. Basically, this 
value indicates a weighted average of all the lifetimes associated to the fluorophore, simplifying the further 
analysis. Indeed, since the amplitude-weighted lifetime is proportional to the steady-state intensity, it is 
useful also for quantitative analysis of FRET process. 
 
 
TABLE 2. Average lifetimes () obtained from the decay fitting of cells expressing the only donor or acceptor of Cameleon probes 
located in the cytosol or in mitochondria. Values in parenthesis are the relative amplitudes of each decay term. Data are presented as 
mean ± SEM of N≥5 cells 
 
The following figure reports the lifetime histograms of mCerulean3 and CFP proteins localized in the cytosol 
or in mitochondria; the insets are the FLIM images, showing the intensity-modulated average lifetime 
distribution on the cell excluding the nucleus.  
 
FIGURE 24: Fluorescence lifetime histograms of mCerulean3 (on the left) and CFP protein (on the right) expressed in HeLa cells 
and localized in cytosol (black line) or in mitochondria (red line). The insets are the fluorescence lifetime images in a false-color plot 
with the reported lifetime range.   
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As demonstrated by the lifetime histograms, which shows the frequency of the lifetimes measured in the 
sample, the fitting of fluorescence decays of CFP proteins requires a model with two exponential terms, 
while the mCerulean3 decays are mono-exponential. Also cpV protein shows a two-exponential decay 
(Figure 25).  
 
FIGURE 25: Fluorescence lifetime histograms of cpV protein expressed in HeLa cells localized in cytosol (black line) or in 
mitochondria (red line). The insets are the fluorescence lifetime images in a false-color plot with the reported lifetime range.  
 
As already reported in literature (Millington et al, 2008), CFP is characterized by two lifetime components, 
attributed to two different conformations of the chromophore in the protein barrel. The longer lifetime of 
CFP in both cellular environments is shorter than that previously calculated inYC3.60 purified protein (3.57 
ns) (Borst et al., 2010), while the relative amplitudes are similar. This could be due to different local features, 
such as local pH or self-quenching process (homo-FRET). For this reason and because during FRET 
lifetimes fitting it was impossible to carried out the analysis fixing such a long lifetime, the longer lifetime 
will be further fixed at 3,57 ns for the fitting of Cameleon sensors data. For cpV it is more difficult to 
measure the emission decay since its absorption cross-section is low at 400 nm excitation. It is anyway 
evident the need of a bi-exponential model for the fitting of cpV decay curves. 
On the contrary, mCerulean3 protein is characterized by a mono-exponential decay, with fluorescence 
lifetime similar to that reported by Rizzo’s group (Markwardt et al., 2011). In mitochondria, mCerulean3 
shows a reduced lifetime, probably caused by the higher probe concentration with respect to the cytosol 
environment, which could favor homo-FRET phenomena (but also the alkaline mitochondrial pH could 
affect the lifetime). The mono-exponential decay is an advantage in FLIM-FRET characterization, since the 
data analysis is less complicated and more accurate.  
Preliminary FLIM investigation has been also performed in cells expressing cytosolic and mitochondrial D3 
Cameleon probes. For cytosolic probes some attempts have been carried out at physiological [Ca2+] (meaning 
extracellular-like medium containing 1 mM Ca2+) in order to calculate lifetime by acceptor photobleaching 
and collating photons from both donor (CH donor) and acceptor channel (CH acceptor) (Figure 26), since 
usage of saturable ionophore (Ionomycin) prevent the possibility of maintain a fixed Ca2+ concentration in 
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the time-window necessary for FLIM acquisition (over 3 minutes). Data are summarized in Table 3 (see 
below). 
 
 
FIGURE 26: FLIM images of D3mCerulean3+16 collected in the donor channel before and after the acceptor photobleaching. 
 
For the mitochondria, we have tested the minimum and maximum FRET condition. The results reported are 
preliminary data, concerning minimum FRET, and future work will be devoted to the definition of the better 
methodology for the analysis of FLIM data for FRET efficiency determination.  
First of all, in case of 4mtd3mCerulean3+16 sensor at minimal FRET condition, the decay in the channel of 
donor clearly shows the presence of a second component lifetime, as depicted in figure 27. At the same time, 
the decay collected in the cpV channel (green line in figure 27) shows a rise on the initial part of the decay, 
as a consequence of the time-dependent increase in acceptor fluorescence intensity due to energy transfer 
process from donor to acceptor. 
 
FIGURE 27: Fluorescence decay of 4mtD3mCerulean3+16 (minimum FRET) expressed in HeLa cells. Red and green curves are the 
emission decay collected in the channel of mCerulean3 and cpV respectively.  
 
In this condition, the probe seemly assumes an “open configuration” (with the two end proteins far away 
from each other), thus reducing the intra-molecular energy transfer. Other adversary processes are the inter-
molecular FRET, involving energy transfer between proteins of different probes, or the homo-FRET, which 
produce the self-quenching due to the re-absorption of donor moiety emission. To get more information 
about the processes involved, acceptor photobleaching experiments have also been performed in HeLa cells 
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expressing the mitochondria targeted Cameleon probes. The lifetimes obtained for the decay fitting of curves 
collected before and after the 10 minutes irradiation for bleaching are reported in table 4.  
 
 
TABLE 3. Average lifetimes () obtained from the decay fitting of cell expressing D3mCerulean3+16 or D3cpV. Values in 
parenthesis are the relative amplitudes of each decay term.  indicate the lifetime measured in the acceptor channel. 
 
 
TABLE 4. Average lifetimes () obtained from the decay fitting of cell expressing 4mtD3mCerulean316 or 4mtD3cpV. Values in 
parenthesis are the relative amplitudes of each decay term.  indicate the lifetime measured in the acceptor channel. 
 
For fitting of decays in the mCerulean3 channel, 1 is fixed at 3.8 ns and 3.53 ns for the probe expressed in 
cytosol and in mitochondria respectively, as calculated in cells expressing only the donor. In case of CFP 
based sensors, 1 is fixed at 3.57 ns, as calculated in the purified protein (Borst et al., 2010). This lifetime 
gives a fitting with lower residuals than those using the lifetimes calibrated with CFP alone in our 
experiments in situ. This discrepancy could be related to homo-FRET phenomena of CFP that could occur 
more frequently in living cells, rather than in purified proteins. For mCerulean3 donor protein this effect is 
less evident, since it is characterized by smaller overlapping area between the absorption and emission 
spectra, with respect to the CFP protein (Markwardt et al., 2011).  
All other parameters are kept free for the fitting. 
Regarding the emission decay collected in the acceptor channel, we consider: the contribution of cpV with 
main lifetime 2 = 3 ns, partial bleed-through of donor emission in the acceptor channel (1 = 3.8 or 3.53 ns) 
and a third free contribution (3). Before photobleaching, the amplitude of the short lifetime 3 is negative for 
all the experiments, confirming the partial energy transfer process. Since only proteins involved in pure 
FRET process produce the rise of acceptor fluorescence intensity, it is possible to estimate the FRET 
efficiency from the rise time, which is equivalent to the donor fluorescence lifetime in the presence of 
acceptor. Unfortunately, the difficulty in accurately measuring rise times makes complicate a detailed 
analysis of the data. Future work will be devoted to a precise definition of the IRF (Instrumental Response 
Function) and accurate models for the fitting of decays in the acceptor channel.  
After acceptor photobleaching, the contribution of donor gets larger and, as a consequence, AMP increases. 
Figure 28 shows the comparison of FLIM images of 4mtD3mCerulean3+16 sample before and after cpV 
bleaching.  
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FIGURE 28: FLIM images of 4mtD3mCerulean3+16 collected in the donor channel before and after the acceptor photobleaching. 
 
For all probes, the additional lifetime of donor, necessary to fit the donor decay of the Cameleon sensor, is 
still present, even if the negative contribution in the acceptor channel seems to disappear. This residual could 
be the effect of homo-FRET.  
 
4. In vivo delivery of the new probes 
In vivo expression is usually carried out via transgenesis and electroporation in situ, two techniques 
involving time-spending laborious tasks. An interesting new in vivo delivery technique that permits to 
overcome the mentioned disadvantages is the viral infection. Since our aim is to explore mitochondrial Ca2+ 
dynamics in heart and brain in vivo, we took advantage of adeno-associated viral (AAV) injection. In 
particular, we decided to generate AAV serotype 9, reported to have a strong cardiac tropism via systemic or 
local injection (Pacak et al., 2006; Bish et al., 2008) and brain tropism via intracranial injection (Foust et al., 
2008).  
Thus, in collaboration with Dr. Zentilin (International Centre for Genetic Engineering and Biotechnology 
ICGEB Trieste, Italy) AAV9 containing the transgene of the mitochondrial and the cytosolic variants of 
Cameleon described so far, has been created. To obtain the probe expression in the heart, a CMV promoter 
was used, while to get neuronal specific expression, the synapsin promoter was substituted to CMV in the 
AAV9 vector (generating AAV9syn). Indeed the human synapsin 1 (syn) gene promoter has been shown to 
provide a neuron specific expression both in vivo and in vitro (Kügler et al., 2001). 
The performance of AAV9 created have been tested in primary cultures. Cortical neurons 72 h after infection 
with AAV9syn-4mtD3cpV (AAV9syn-D3cpV is still in production) and AAV9syn-D3mCerulean3+16 or 
AAV9syn-4mtD3mCerulean3+16 have been tasted to check the functionality of the Cameleons. In a typical 
experiment, we induced mitochondrial Ca2+ uptake by inducing neurons depolarization (Figure 29).  
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FIGURE 29. Neonatal cortical neurons. Representative traces of cytosolic or mitochondrial Ca2+ rise induced by neurons 
depolarization with 30mM KCl in iso-osmotic extracellular-like medium, where indicated, and expressing AAV9syn-4mtD3cpV (A) 
AAV9syn-D3mCerulean3+16 (B), AAV9syn-4mtD3mCerulean3+16 (C). Data are presented as FRET changes % of maximum or as 
R as reported. 
 
Similarly, AAV9-D3cpV or AAV9-4mtD3cpV and AAV9-D3mCerulean3+16 or AAV9-
4mtD3mCerulean3+16 has been infected in neonatal rat cardiomyocytes. 96 h after transfection, spontaneous 
mitochondrial Ca2+ oscillations has been measured. Figure 30 shows representative traces of the experiments 
described, demonstrating the correct functionality of the AAV9 created.  
 
73 
 
 
FIGURE 30. Neonatal rat cardiomyocytes. Representative traces of cytosolic or mitochondrial spontaneous Ca2+ oscillations 
expressing (A) AAV9-D3cpV, (B) AAV9-4mtD3cpV, (C) AAV9-D3mCerulean3+16 and (D) AAV9-4mtD3mCerulean3+16. Data 
are presented as R (cpV/CFP or cpV/mCerulean3).  
 
To check if AVV9 are able to induce a sufficient expression level of Cameleon probes for in vivo, just one 
attempt has been done injecting intra-peritoneally 0-1 day newborn mice. Preliminary data obtained in acute 
heart and brain slices, confirm that intra-peritoneal injection is suitable to obtain Cameleon expression in 
heart tissue, but is not sufficient to reach expression levels suitable for in vivo experiments in live brain 
(Figure 31). Further attempts to improve brain expression will be carried out, performing intra-cranial 
injection of AAV9 encoding for Cameleon probes. 
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FIGURE 31. (A) Confocal images of acute heart slices of inject mouse with AAV-D3mCerulea3+16 (left) and mouse with AAV-
4mtD3mCerulea3+16 (right). (B) Confocal images of single cells from acute heart slices of inject mouse with and mouse with AAV-
D3mCerulea3+16 that co-localized with TMRM. (C) Western blot form whole heart, brain and liver stained with anti-GFP antibody 
to detect Cameleon expression. (D) Confocal image of acute brain slices of inject mouse with AAV-4mtD3mCerulea3+16  
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5. A new mitochondria targeted Channelrhodopsin 
 
Since mitochondrial membrane potential can modulate diverse mitochondria activities, like regulation of 
Ca2+ homeostasis, oxidative stress response, apoptosis and innate immune response, putting the organelle in 
central position in controlling cellular function and fate (Contreras et al., 2010), an interesting tool to 
manipulate its activity has been exploited. 
Channelrhodopsin-2 (ChR2) is a light-gated cation channel, which evokes membrane potential 
depolarization upon photostimulation with blue light in the presence of all-trans retinal, being able to 
generate sufficient photocurrent to depolarize cells. In optogenetic, this channel is used to optically stimulate 
and control neuronal activity with very high temporal resolution, offering distinct advantages over traditional 
pharmacological or electrical techniques of perturbation (Häusser, 2014). Thus a mitochondria targeted 
ChR2 has been created and investigate in order to create a method able to induced mitochondrial 
depolarization in a temporary-controlled, reversible and cell-specific manner. 
 
5.1 The targeting to mitochondria 
In order to target ChR2-YFP to the IMM Prof. Sekler’s group fused the signaling peptide of the 
Mitochondrial Calcium Uniporter (MCU) (De Stefani et al., 2011) as well as multiple N-terminal signal 
sequences from subunit VIII of human Cytochrome C Oxidase (2mt, 4mt) to the N-terminus of 
Channelrhodopsin, since attaching multiple signal sequences has been shown to improve specific localization 
of fluorescent probes to the mitochondria (Filippin et al., 2005). Initial experiments with different 
mitochondria targeting signal showed a poor targeting efficiency for ChR2. Upon transfection into human 
embryonic kidney (HEK293) cells, all constructs that included full sequence of ChR2 (MCU-ChR2-YFP, 
2mtChR2-YFP, 4mtChR2-YFP) were still localized mainly in the PM (Figure 32A) suggesting the presence 
in the ChR2 protein of a strong internal targeting signal. Indeed, deleting of the initial 24 amino acids from 
ChR2 N-terminus dramatically changed subcellular localization of the resulting construct. We refer to this 
shortened form of the channel as ChR2B (Figure 32A). Among tested 2mt, 4mt and MCU signaling 
sequences 4mtChr2B appeared to be the best construct in terms of mitochondrial localization and the lack of 
adverse effects. Fluorescence signals of mitoCherry, a mitochondria marker, and 4mtChR2B-YFP merged 
well in confocal images (Figure 32A). The same mitochondrial localization was obtained in different cell 
lines (HEK293 and HeLa, Figure 32B) and primary neurons (Figure 32C). To verify the absence of residual 
4mtChr2B channels in the neuronal plasma membrane, we recorded neuronal currents during illumination 
with blue light (Figure 32C). No blue light-sensitive currents were detected during these tests. 
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FIGURE 32. 4mtChR2B but not 4mtChR2 is expressed in the IMM. (A) Confocal microscope images of 4mtChR2-YFP (left, in 
HEK 293 cells) and 4mtChR2B-YFP (right, in human melanoma GA cells) co-expressed with a mitochondria targeted mitoCherry. 
The structure of constructs is shown on top. Yellow color indicates co-localization of the mitochondrial marker and the YFP tagged 
channel. (B) Confocal image examples of HEK293 and HeLa cells expressing several 4mtChR2B-YFP mutated versions. Co-
localization of the mitochondria marker with 4mtChR2B-YFP results in a yellow color. (C) In neuron, light does not elicit PM 
depolarization (right) indicating no residual 4mtChRB activity in the plasma membrane, while delivering current via the patch pipette 
to the same neuron causes firing (left). Colocalization of 4mtChR2B-YFP with mitoCherry in primary hippocampal neuron (upper 
right panel).  
 
5.2 The new mitochondria targeted Channelrhodopsine display the correct topology in the IMM 
Fluorescence quenching experiments were then employed to verify the topology of 4mtChR2B-YFP 
insertion in the mitochondrial membrane. If 4mtChR2B(SSFO)-YFP (hereafter indicates as SSFO-YFP) is 
properly inserted in the IMM, the C-terminal YFP tag should face the mitochondrial matrix. Indeed we found 
that: 1) application of proteinase K to Digitonin permeabilized cells did not cause a significant reduction of 
SSFO-YFP signal, while it completely abolished that of N33D3cpv (a probe in which the YFP moiety is 
located on the cytoplasmic surface of the OMM); 2) Trypan blue addition, that is permeable across the 
OMM, but not the IMM, did not affect the fluorescence of SSFO-YFP or of the matrix located Cameleon 
4mtD3cpv (Figure 33B red and blue lines), while completely abolishing that of a YFP-Cytochrome C (not 
shown and see Giacomello et al., 2010) (Cartoon of quenching protocol in Figure 33A). The 4mtD3cpv 
fluorescence, however was totally lost after alamethicin application that permeabilizes both mitochondrial 
membranes (Figure 33C, green line) and releases all matrix proteins into the medium (Hoffman et al., 2013). 
On the contrary, the fluorescence of SSFO-YFP was not affected by the latter treatment as expected for a 
membrane bound protein. Taken together these data are consistent with a proper IMM localization of our 
construct with YFP tag being inaccessible from the cytoplasm or the inter membrane space. Functional 
experiments below further support the notion that 4mtSSFO-YFP is correctly located in the IMM. 
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FIGURE 33. (A) Schematic representation of the protocol used to investigate the topology of the expressed channel. HeLa cells 
were plated and transfected with 0.5 µg of SSFO-YFP cDNA. The experiments were performed after 48 or 72 h and the cells were 
perfused with different buffers: 
(1) Perfusion of extracellular-like Ca2+-free medium with proteinase K 20 µg/uL in order to cut any YFP facing the extracellular 
space and to check if any ChR2B was located in PM in a wrong conformation. 
(2) PM of HeLa cells were pre-permeabilized with 100 µM Digitonin for 1 minute in intracellular-like medium. 
(3) Cells were perfused with intracellular-like Ca2+ free medium with proteinase K 20 µg/uL, which could cut YFP facing the 
cytosol, but it’s not able to pass through the OMM. In this way we were able to detect if any ChR2B is located in PM or in 
OMM with the C-terminus facing the cytosol. 
(4) Cells were perfused with intracellular-like medium with Trypan blue 0.5 mg/mL, which is able to pass the OMM and quench 
any YFP facing the inter membrane space allowing us to check if 4mtChR2B-YFP in incorrectly located in OMM, IMS or IMM 
with the C-terminus facing the IMS. 
(B) HeLa cells expressing either SSFO-YFP, N33D3cpv or 4mtD3cpv were first treated with extracellular proteinase K, then, 
following Digitonin permeabilization, with intracellular proteinase K, and finally with Trypan blue as indicate in top bars and arrows. 
(C) In another experiment cells expressing 4mtChr2B-YFP or 4mtD3cpv were permeabilized with Digitonin in an intracellular-like 
medium, then treated with alamethicin, which permeabilizes mitochondrial outer and inner membranes. Traces represent YFP 
fluorescence in arbitrary units (AU) normalized to initial fluorescence. 
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5.3 Mitochondria depolarization 
The new mitochondrial 4mtChR2B constructs were tested in situ for their capacity to change the 
mitochondrial membrane potential in response to light. Sekler’s group used several mutated ChR2B forms 
with different properties and finally we choose the so called stable step-function opsin ChR2 (SSFO). It has 
been shown that the mutations C128S/D156A, gives rise to prolonged photocurrents far outlasting the 
initiating pulses of light and ChR2(C128) (Yizhar et al., 2011), mutations C128A/ H134R, is a high-
photocurrent SFO variant (Prakash et al., 2012). For the last two ChRs, photocurrents can be precisely 
initiated and terminated with different colors of light (blue and red respectively, see below), but these 
currents operate at vastly longer time scales than in conventional ChR. SFOs have inactivation time 
constants in the order of tens of seconds or more instead of milliseconds. All these constructs are activated 
by blue (~460 nm) light and then return to a non-conductive state spontaneously; the closing process could 
be speeded up by red light for ChR2B(SSFO) and ChR2B(C128). To create a nonfunctional control channel 
we exploited the fact that for activation opsins require binding of retinal, a vitamin A–related organic 
cofactor. A truncated form ChR2B(TR) lacking the last two helixes and thus not able to bind retinal was 
constructed. 
Since the immediate effect of the opening of a channel inserted into the IMM should be mitochondrial 
membrane potential (Δψm) collapse, the effects of the blue light on the fluorescence signal of the membrane 
potential probe TMRM has been tested. TMRM is used in the redistribution mode to assess Δψm, and 
therefore a reduction in TMRM fluorescence represents Δψm depolarization. In cells transfected with void 
vector or ChR2B(TR), as controls, or SSFO-YFP the exposure to blue light caused depolarization only in the 
last case (measured as a decrease in the TMRM fluorescence, N=17, Figure 34A). No depolarization was 
induced by blue light in control cells and in cells expressing the truncated version of ChR2B (Figure 34A, 
N=11 in both controls and ChR2B, p>0.2). The rate of depolarization appears, however, quite slow. One 
explanation of this low kinetics could be that the light used to monitor TMRM signal is able to counteract the 
channel opening, for example by inducing a partial closure. It could be also possible that the power of light 
used during TMRM acquisition (which is at the minimum power possible to get good signal-to-noise ratio), 
is not sufficient to trigger the total closure of all the channels, meaning that the low amount of light used 
during the experiments starts the closure process, but slowly or partially. To check if 540 nm- light is able to 
interfere with the opening kinetics we develop another protocol in which after the blue light pulse, the 
TMRM recording is started with one minute of delay after the blue light flash, avoiding interference of the 
red light with the opening kinetic. With this protocol the TMRM signal decreased by about 60% after 
photoactivation only in cells expressing SSFO-YFP (N=57, p<0.0001 compared to ChR2B(TR) (N=40) or 
void vector (N=38)), while in the experiments carried out recording TMRM signal immediately after the blue 
light pulse, the TMRM signal decreased by about 30% in one minute. Although we did not obtain direct 
evidence of channel closure following exposure to red light, indirect data indicate that green light interfere 
with the opening kinetics (Figure 34B).  
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FIGURE 34. Exposure to blue light (460±7.5 nm) induces changes in the mitochondrial membrane potential and mitochondria 
function in cells expressing 4mtChR2B. (A). Left: The mitochondrial membrane potential measured as TMRM fluorescence 
decreased following blue light exposure for 10 seconds (cyan bar) in HeLa cells expressing SSFO-YFP but not in cells expressing 
void vector and a mitochondrial targeted YFP and in cells expressing ChR2(TR) and a mitochondrial targeted YFP. Right: The 
histogram represents the TMRM signal measured before FCCP addiction normalized to ctrl. Data are represented as mean ±SEM; N 
(number of cells) ≥ 11 for each conditions. (B). Left: The mitochondrial membrane potential measured as TMRM fluorescence 
decreased following blue light exposure for 10 seconds (cyan bar) in HeLa cells expressing SSFO-YFP but not in cells expressing 
void vector and a mitochondrial targeted YFP and in cells expressing ChR2(TR) and a mitochondrial targeted YFP. In these case the 
TMRM recording started one min after the photoactivation of the channel. Right: The histogram represents the TMRM signal 
measured before FCCP addition normalized to ctrl. Data are represented as mean ±SEM; N (number of cells) ≥ 38 for each 
conditions. (* p<0.05; ** p<0.01; *** p<0.0001).  
 
5.4 Mitochondrial depolarization results in mitochondrial Ca2+ uptake inhibition  
Given that Ca2+ uptake in mitochondria is strictly dependent on membrane potential, we analyzed in more 
detail the Ca2+ uptake characteristics in the presence of the mitochondria targeted SSFO, using two 
genetically encoded probes, 4mtD3cpv and mt-Aeq. Figure 35A shows that in cells co-transfected with 
SSFO and the matrix located fluorescent Ca2+ probe 4mtD3cpv, the amplitude of the mitochondrial Ca2+ rise 
observed upon stimulation of HeLa cells with Histamine was drastically reduced (N=62, p<0.0001) by a 460 
nm LED pulse, while those of controls (N=40) and of cells expressing the truncated form of the channel 
(N=43) were indistinguishable (p>0.2). The peak of the mitochondrial rise in cells expressing SSFO were 
similar to those of control cells treated with the classical mitochondrial uncoupler FCCP (N=21, p>0.2) (data 
not shown). The use of a co-transfection protocol insures that at least in 80% of cases the cells expressing the 
Ca2+ probe also expresses the channel.  
We also co-transfected SSFO-YFP and SSFO with mitochondrial targeted Aequorin, mt Aeq. In this case, 
given that Aequorin is a chemiluminescent protein and emits light at 460 nm upon a rise in Ca2+ levels, the 
80 
 
prediction is that the light emitted by Aequorin during mitochondrial Ca2+ uptake should be sufficient in 
itself to open (at least in part) the channel and thus to reduce the amplitude of the mitochondrial Ca2+ rise. To 
trigger maximal mitochondrial Ca2+ rise and thus maximize Aequorin emission, a mixture of stimuli has been 
used. Indeed the data of Figure 35B confirm that this is the case: the peak amplitude of the agonist induced 
Ca2+ rise was significantly diminished (about 25-40%) in cells expressing SSFO (N=7) or SSFO–YFP (N=7) 
compared to controls (ctrl, N=8; ChR2B(TR), N=7) and this effect was strengthened by pre-illuminating the 
sample with blue-light, resulting in a decrease in Ca2+ rise in HeLa cells expressing SSFO (N=6) or SSFO-
YFP (N=5) about 40-50% compared to ctrl (N=6) and ChR2b(TR) (N=3) (Figure 35C, p<0.01).  
 
FIGURE 35. Reduction of mitochondrial Ca2+ uptake in HeLa cells expressing the new mitochondrial targeted SSFO. (A) HeLa 
cells transiently transfected with void vector, SSFO or ChR2B(TR) and co-transfected with 4mtD3cpV, were treated with 100 µM 
Histamine where indicated. Left: Representative kinetics of mitochondrial Ca2+ uptake in control (blue), SSFO (green) and 
ChR2B(TR)(brown) cells. Data are plotted as R/R0. Right: The histogram represents mean ±SEM [Ca2+]m increase caused by 
Histamine treatment of N ≥ 40 cells for each conditions. (B) HeLa cells transiently transfected with empty vector, SSFO, SSFO-YFP 
or ChR2B(TR), were analysed for [Ca2+]m changes obtained employing a mix of stimuli by mt-Aeq. Left: Representative kinetics of 
[Ca2+]m in control (blue), ChR2B(TR)(brown), SSFO (green), and SSFO-YFP (violet) cells. Right: The histogram represents mean 
±SEM (normalized to ctrl) [Ca2+]m increase. caused by a mix of stimuli (100 µM Histamine, 100 µM ATP and 20 µM CPA) of N ≥ 7 
experiments for each conditions (C) HeLa cells transiently transfected with empty vector, ChR2B(TR), SSFO, and SSFO-YFP, were 
analysed for [Ca2+]m changes upon the application of a mix of stimuli by mt-Aeq after a blue light pulse. Left: Representative kinetics 
of [Ca2+]m after a blue light pulse in control (blue), ChR2B(TR) (brown), SSFO (green), and SSFO-YFP (violet) cells. Right: The 
histogram represents mean ±SEM (normalized to ctrl) [Ca2+]m increase.caused by a mix of stimuli N ≥ 3 experiments for each 
conditions. (* p<0.05; ** p<0.01; *** p<0.0001).  
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To confirm that the reduction in mitochondrial Ca2+ peak is not due to an intrinsic toxicity of the channel, but 
depends on the depolarization induced by light induced SSFO opening, we induced a much smaller Ca2+ rise 
in mitochondria by activating mitochondrial Ca2+ uptake through CCE. Given that Aequorin light emission is 
not linearly but exponentially related to the Ca2+ concentration, a 10 fold reduction in the Ca2+ peak (as for 
CCE compared to IP3 producing agonists) the reduction in light emitted is over 100 fold (Figure 36A). As 
expected, thus, in the case of CCE dependent Ca2+ influx, the peak amplitude of the mitochondrial Ca2+ rise 
was indistinguishable in SSFO–YFP or SSFO expressing cells compared to controls (Figure 36B, p>0.2).  
 
 
FIGURE 36. Absence of mitochondrial toxicity in HeLa cells expressing mt-Aeq the new mitochondria targeted SSFO. (A) HeLa 
cells transiently expressing void vector, were analysed for mitochondrial Ca2+ uptake changes by mt-Aeq in low-light emitting 
condition. The number of photons emitted per second normalized to the total photon emitted by stimulating a maximal mitochondrial 
Ca2+ uptake is higher than mitochondrial Ca2+ uptake induced by a mixture of stimuli (grey) or CCE (black) activation, lowering the 
SSFO opening probability. The traces represent the photon emitted during mitochondrial Ca2+ uptake induced by the application of a 
mix of stimuli or by inducing CCE. (B) HeLa cells transiently transfected with empty vector, SSFO, SSFO-YFP or ChR2B(TR) and 
mt-Aeq were first treated with 100 nM thapsigargin in Ca2+ free EGTA containing medium, to deplete the stores and then perfused 
with medium containing 2 mM CaCl2 to activate CCE, where indicated. Left: Representative kinetics of [Ca2+]m in control (blue), 
ChR2B(TR) (brown), SSFO (green) and SSFO-YFP (violet) cells. Right: The histogram represents the mean ±SEM (normalized to 
ctrl) [Ca2+]m obtained in Aequorin experiments by inducing mitochondrial Ca2+ uptake through CCE activation of N ≥ 7 experiments 
for each conditions.  
(* p<0.05; ** p<0.01; *** p<0.0001).  
 
Last, but not least, we also measured the cytosolic Ca2+ changes in controls or SSFO (with or without YFP 
tag) expressing cells using both a mix of stimuli (Figure 37A) or CCE induced Ca2+ increases (Figure 37B). 
No differences between control cells and cells expressing SSFO were observed. Nevertheless, we also assess 
if the light employed during photoactivation could damage mitochondria by testing their ability to take up 
82 
 
Ca2+ in the presence of a mix of stimuli in HeLa cells transfected with mt Aeq and void vector employing or 
not the pre-illumination. No differences were observed between them (Figure 37C). 
 
FIGURE 37. Absence of cellular toxicity and photo-toxicity in HeLa cells expressing cyt-Aeq and the mitochondria targeted SSFO. 
(A) HeLa cells transiently transfected with empty vector, SSFO, SSFO-YFP or ChR2B(TR) and cyt-Aeq were treated with a mix of 
stimuli (100 µM Histamine, 100uM ATP, 20uM CPA). Left: Representative kinetics of [Ca2+]c in control (blue), ChR2B(TR) 
(brown), SSFO (green) and SSFO-YFP (violet) expressing cells. Right: The histogram represents mean ±SEM (normalized to ctrl) 
[Ca2+]c increase caused by a mix of stimuli of N ≥ 3 experiments for each conditions. (B) HeLa cells transiently transfected with 
empty vector, SSFO, SSFO-YFP or ChR2B(TR) and cyt-Aeq were first treated with Thapsigargin (100 nM) in Ca2+ free, EGTA 
containing medium, to deplete the stores and then perfused with medium containing 2 mM CaCl2 to activate CCE. Left: 
Representative kinetics of [Ca2+]c in control (blue), ChR2B(TR) (brown), SSFO (green) and SSFO-YFP (violet) expressing cells. 
Right: The histogram represents mean ±SEM (normalized to ctrl) [Ca2+]c increase of N≥ 4 experiments for each conditions. (C) 
Control HeLa cells transiently expressing mt Aeq with or without pre-illumination for 10 sec at 470 nm and treated with the mixture 
of stimuli as in panel A. The histogram represents mean ±SEM (normalized to ctrl) [Ca2+]c increase. Caused by a mix of stimuli with 
or without pre-illumination of N ≥ 6 experiments for each conditions. (* p<0.05; ** p<0.01; *** p<0.0001).  
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5.5 The mitochondria targeted Channelrhodopsin is able to suppress the spontaneous beating in 
neonatal rat cardiomyocytes 
SSFO-YFP was expressed in neonatal rat cardiomyocytes and imaged in bright field. After 10 seconds of 
blue light pulse, spontaneous beatings were almost immediately blocked only in cardyomyoscytes expressing 
SSFO-YFP. Contraction was monitored only morphologically in bright field since the co-transfection (SSFO 
and 4mtD3cpV) efficiency is too low in this cell type. To avoid the possibility that the contraction of 
neighbor cells could mask the effect in the single transfected cell only isolated and beating cardiomyocytes 
expressing SSFO were analyzed. As control, cardiomyocytes expressing void vector or ChR2B(TR) were 
used. SSFO opening resembled quantitatively and kinetically the effect of FCCP (Figure 38). 
 
 
FIGURE 38. The histogram represents the quantification of the beats/second after the blue light pulse employed to photoactivate 
SSFO, normalized to the frequency of beating measured before the pulse for each condition. The histogram represents mean 
frequency ±SEM of N=4 number of cells or each conditions. The addition of FCCP in cardiomyocytes expressing void vector or 
truncated-SSFO again resembled quantitatively and kinetically the effect of SSFO photoactivation. 
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Discussion 
Ca2+ exerts many different functions in cells, in both physiological and pathological conditions. Given its 
pivotal role, this ion has been widely studied for many years. At the beginning, chemical dyes allowed to 
monitor Ca2+ dynamics only in the cytosol, but more recently, thanks to the development of genetically 
encoded Ca2+ indicators (GECIs), the role of subcellular compartments has been largely unravelled.  
Cameleon probes have the enormous advantages of being ratiometric Ca2+ sensors, thus they are independent 
of shifts in the focal plane and contraction phenomena that could occur (or be induced) in some tissues 
during the experiments. This feature is particularly relevant for in vivo applications as movement artefacts 
are unavoidable (blood flux, heart beating, and respiration). In addition the low fluorescence quantum yield 
of the donor fluorescent protein CFP and its multi-exponential lifetime reduce signal-to-noise ratio in thick 
samples and complicate lifetime analysis (FLIM).  
In 2011 Rizzo’s group developed a new variant of CFP, called mCerulean3, characterized by improvements 
in quantum yield and brightness, a single exponential decay and a reduced fluorescence photoswitching 
behaviour, compared to other CFP variants (Markwardt et al., 2011). Given these interesting biophysical 
features of mCerluean3, together with the described drawbacks of CFP as donor, the latter has been 
substituted with mCerluean3 in the cytosolic D3cpV and mitochondrial 4mtD3cpV Cameleon probes. The 
new probes created maintained the brightness improvement observed for mCerulean3. Moreover, it showed 
proper localization and Ca2+ changes responsiveness both in the cytosol and in mitochondria. This features 
lead to an improvement of SNR and lowers the levels of inducible phototoxicity in the sample. Despite these 
promising results, the donor substitution caused a reduction of about 20% in the dynamic range (DR) of both 
D3mCerulean3 and 4mtD3mCerulean3. This negative impact has also been reported in Twitch sensor, where 
CFP was also substituted with mCerulaen3 Thestrup et al., 2014).  
To overcome the drawback of DR range reduction different approaches were tested. An advantage of 
Cameleon probes, compared to Twitch based sensor, is the presence of two Ca2+ responsive elements 
separated by a short linker, meaning the possibility to intervene on the mobility of the two FPs, modifying in 
turn their ability to sense [Ca2+] changes. Eventually, the extension of the linker between the two Ca2+ 
responsive elements CaM and M13 by addition of 16 glycines, resulted in the recovery of the DR in both 
cytosolic and mitochondrial-targeted probes. Indeed, the DR was even increased in D3mCerulean3+16, 
compared to the original Cameleon.  
The increase in photostability of the single FP mCerulean3 led also to an improvement in the photostability 
of the probes D3mCerulean3+16 and 4mtD3mCerulean3+16, evaluated in basal, minimal and maximal 
FRET conditions. The primary consequence of this improvement is a smaller decrease in FPs brightness 
during repetitive excitation, which represents an important limiting factor for experiments requiring large 
numbers of images or the usage of high excitation light intensity.  
Another critical point to address was the pH sensitivity of the probes. Since each FPs are characterised by a 
different pKa, the substitution of CFP with mCerulean3 could change the probes pH sensitivity. Indeed, cpV 
has a pKa = 6, being the more sensitive to physiological pH, while CFP has a pKa=4.7 (Schaner et al., 2005) 
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and mCerulean3 a pKa=3.2 (Markwardt et al., 2011); thus we expected mCerulean3 to be less sensitive to 
pH variations in the range found in the mitochondrial matrix, compared to CFP. Of course the pH can 
modify the efficiency of photons transfer between donor and acceptor, thus a minor pH sensitivity of the 
donor could compensate the brightness variation caused by the acceptor pH sensitivity. Moreover, proton 
gradient within mitochondria can change as a result of modifications in mitochondrial membrane potential 
and in mitochondrial and cytosolic [Ca2+]. Since pH can affect the affinity of GECIs for Ca2+ in vivo, the pH 
sensitivity of mitochondrial variants was tested in situ. All the variants are insensitive to pH variations in the 
range tested and 4mtD3mCerulean3+16 appears the more stable variant.  
Finally, the evaluation of the Ca2+ affinity (Kd), was carried out in situ, resulting in a Kd1 of 0.06 µM and Kd2 
of 10.84 µM in 4mtD3cpV and a Kd1 of 0.03 µM and Kd2 of 10.7 µM in 4mtD3mCerulean3+16. 
Since the cytosolic probes can be poorly characterized in situ and generally a comparison of GECIs 
physiochemical features is based on in vitro characterization, we analysed the features of purified Cameleon 
variants in vitro. In particular, we calculated DR and Kd values for D3cpV and D3mCerulean3+16 variants, 
mimicking intracellular environment (intracellular-like medium at pH 7) and mitochondrial matrix 
environment (intracellular-like medium at pH 8). Since we have demonstrated that the cleavage of 
4mtD3cpV and 4mtD3mCerulean3+16 targeting sequences occurs inside mitochondria, we produced these 
proteins for in vitro evaluation without 4mt sequence. Up to now only preliminary data have been obtained, 
however a comparison of in situ and in vitro data suggests that the DR calculated for cytosolic probes is 
around 3, while that for a mitochondria like environment is about 2.5. The major difference between in situ 
and in vitro DR values was observed for D3cpV. This discrepancy could have different explanations. First, 
concerning the cytosolic probes, the imprecise minimum FRET assessment performed in situ using the 
ionophore Ionomycin could account for the discrepancy. Second, intra-molecular FRET or homo-FRET 
could occur and preliminary FLIM data suggest that this phenomena are predominant in the presence of CFP 
(see below). Generally, it seems clear that alkaline pH, rather than affecting the ratio (as discussed before), 
causes a reduction of DR in all the Cameleon variants analysed, since it is decreased at pH 8 compared to the 
one calculated at pH 7 both in vitro and in situ. 
Concerning the Ca2+ affinity, just few [Ca2+] concentrations have been tested so far, therefore all the 
mitochondrial and cytosolic probes display a single Kd. However, further experiments are required to 
confirm the in vitro calculated Kd. Indeed, given the preliminary nature of the in vitro results presented, any 
other consideration would only be a pure speculation.  
One of the reasons that led us to substitute CFP with mCerulean3 is also the single exponential lifetime of 
the latter. To better characterize biophysically the original and new Cameleon probes, lifetime evaluations 
have been carried out.  
FLIM measurements, compared to intensity-based images, have the advantages of being independent on 
fluorophore concentration, excitation intensity fluctuations, sample thickness, or photobleaching. Moreover, 
FLIM-FRET allows to distinguish between different types of FRET: homo-FRET, intra- and inter-molecular 
FRET. Thus, FLIM-FRET will provide a method to calculate FRET-efficiency and to estimate the presence 
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and the extension of FRET phenomena that do not participate in the detection of a Ca2+ transient, such as 
homo and inter-molecular FRET. The transfer of energy from donor to acceptor induced the appearance of a 
shorter lifetime(s), besides the classical longer lifetime of the unquenched donor. This phenomenon is 
measured in the donor channel.  
The lifetime of the donor in the presence of the acceptor (DA) and the lifetime of the only donor (D) are 
required to calculate the FRET-efficiency. Usually to obtained D, acceptor photobleaching is performed to 
mimic the absence of FRET condition. However, the bleaching phenomenon is still poorly understood and it 
could generate acceptor’s fragments that are still able to quench the donor, preventing the possibility to get a 
real absence of FRET. In 2008 Borst et al, reported a methodology to measure FRET efficiency with FLIM, 
which consists in the recording of photons in acceptor channel. In this case only the molecule involved in 
FRET are measured and FRET is visualize as rise time of acceptor fluorescence. This rise time is a 
consequence of the time-dependent increase in acceptor fluorescence intensity due to energy transfer process 
from donor to acceptor (Borst et al., 2008).  
Our goal is to evaluate FRET-efficiency in Cameleon probes, comparing different techniques to evaluate the 
bona fide of Ca2+ changes measurement obtained employing these Ca2+ sensors. 
First of all, lifetimes of the single FPs have been measured, since they are required for the calibration of the 
further measurements on Cameleon probes. Indeed, in FLIM-FRET analysis is necessary to fix the donor 
unquenched lifetime in order to get a reliable measure.  
CFP and cpV show a double exponential decays, while mCerulean3 shows a mono-exponential decay. The 
mono-exponential decay is an advantage in FLIM-FRET characterization, since the data analysis is less 
complicated and more accurate. Usually, an average lifetime is required for the analysis of bi-exponential 
decay. Of note, both CFP and mCerulean3 show shorter lifetime(s) in the mitochondrial environments. This 
effect could be due to phenomena of homo-FRET or to the differences in pH between cytosol and 
mitochondria.  
Preliminary FLIM investigations have also been performed in cells expressing cytosolic and mitochondrial 
D3 Cameleon probes. For cytosolic probes some attempts have been carried out at physiological [Ca2+], 
while for the mitochondrial Cameleon, we have only tested the minimum FRET condition. In both cases the 
longer lifetime, referred to the unquenched donor, has been fixed based on the lifetimes calculate in cells 
expressing the single FP, with the only exception of CFP. Indeed, FRET-lifetimes fitting analysis were 
impossible to perform using the CFP lifetime observed in situ, thus the longer lifetime has been fixed at 3.57 
ns for the fitting of cytosolic and mitochondrial D3cpV data. This lifetime has been calculated in the purified 
protein (Borst et al., 2008), suggesting that the lifetime calculated in situ could be strongly affected by homo-
FRET phenomena. In mCerulean3 donor protein this effect is less evident. This hypothesis is also supported 
by the fact that mCerulean3 is characterized by smaller overlapping area between the absorption and 
emission spectra, with respect to the CFP protein (Gautier et al., 2001; Markwardt et al., 2011).  
Concerning FLIM experiments on cytosolic Cameleon probes, the presence of a second or third lifetime in 
D3mCerulen3+16 and D3cpV respectively, recorded in the donor channel, underlines that FRET is occurring 
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in HeLa expressing both cytosolic probes. This data, further confirmed by the presence of the negative 
lifetime amplitude recorded in the acceptor channel (related to the rise time of cpV), was expected, since 
these measurements have been carried out in basal FRET condition. To get minimal FRET we exploit 
acceptor photobleaching technique, since the usage of saturable ionophore is not compatible with the 
acquisition time required in FLIM experiments. In both D3mCerulean3+16 and D3cpV a reduction in the 
amplitudes of the shorter lifetimes (referred to the quenched donor) and a parallel increment of the 
amplitudes associated to longer lifetime (referred to the unquenched donor) were observed in donor channel 
recordings. Moreover, the negative component measured in the acceptor channel disappeared, meaning that 
the absence of FRET was obtained. These preliminary data allow us to conclude that acceptor 
photobleaching can be a suitable alternative to explore FRET efficiency in cells expressing cytosolic probes.  
Similarly, in HeLa cells expressing mitochondria targeted Cameleon probes, the lifetimes of 4mtD3cpV and 
of 4mtD3mCerulean3+16 in minimal FRET condition have been evaluated in both donor and acceptor 
channel. Shorter lifetimes in the donor channel and a negative component of the amplitude associate to 
lifetime measured in the acceptor channel have been observed in both probes, underlining the occurrence of 
energy transfer. Thus, since the absence of Ca2+ was not sufficient to get absence of FRET, acceptor 
photobleaching has been carried out. After bleaching, the acceptor time rise disappear in both cases, the 
amplitude related to donor longer lifetime increase and the amplitude related to the shorter lifetime decreased 
as expected when FRET does not occur. Taken together these preliminary results suggest that in Ca2+ free 
condition, other phenomena besides intra-molecular FRET occur. Furthermore, mCerulean3 substitution 
seems to be less affected by them, providing more accuracy in [Ca2+] detection. Future experiments will be 
required to clarify these points and to evaluate FRET efficiency at different [Ca2+]. Lifetime measurements 
will be carried out also with the purified proteins.  
In summary, data obtained so far make mCerulean3-based Cameleon variants an interesting and promising 
choice to exploit mitochondrial Ca2+ dynamics in vivo, since the new probes are brighter, more photostable, 
less pH sensitive compared to the original probes. Moreover, based on FLIM data, probes containing 
mCerulean3 seem to be less prone to homo-FRET, making them more accurate in [Ca2+] evaluation.  
Thanks to these positive results, some attempts have been performed to get Cameleon expression in vivo. 
In vivo expression is usually carried out via transgenesis and electroporation in situ, time-spending and 
laborious tasks. Recently, viral infection has been proposed as an efficient in vivo delivery technique that 
permits to overcome this disadvantages. AAVs serotype 9, characterized by cardiac and brain tropism (Pacak 
et al., 2006; Bish et al., 2008; Foust et al., 2008), have been generated for the expression of each of the 
mitochondrial and the cytosolic variants of the Cameleons described. After testing the ability to detect Ca2+ 
changes of both neurons and cardiomyocytes primary cultures with the new viruses, a first attempt was made 
to obtain in vivo expression. Preliminary data obtained in heart and brain acute slices, shows that intra-
peritoneal injection is suitable to get Cameleons expression in heart tissue, but it is not sufficient to obtain a 
good expression in the brain. Indeed the latter seems to require intra-cranial injection of AAVs. 
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In parallel, we create a tool to modulate mitochondrial activities in collaboration with Professor Sekler’s 
group. The creation of ChR2, a light-gated cation channel, allow the generation of sufficient photocurrent to 
depolarize cells, providing the possibility to optically stimulate and control neuronal activity with very high 
temporal resolution and offering distinct advantages over traditional pharmacological or electrical means of 
perturbation (Häusser, 2014). Since mitochondrial membrane potential can modulate diverse mitochondria 
activities, a mitochondria targeted ChR2 has been created and investigated. A variant of ChR2 called ChR2B 
was generated, deleting 24 amino acids from N-terminus of ChR2 and fusing the new N-terminal to four 
signal sequences from subunit VIII of COX, to target the protein to the inner mitochondrial membrane 
(IMM). Mitochondrial localization was confirmed with both confocal microscopy in different cell lines 
(HEK293, HeLa and primary neurons), and with electrophysiological recordings performed in the neuronal 
plasma membrane, to verify the absence of residual 4mtChr2B channels in PM. The proper IMM localization 
and topology has been further confirmed in fluorescence quenching experiments employing Trypan blue and 
proteinase K, two reagents differently permeable through the mitochondrial membranes, and alamethicin, 
able to create pores in IMM. The new mitochondrial 4mtChR2B constructs were then tested in situ for their 
capacity to change the mitochondrial membrane potential in response to light. Different ChR variants has 
been tested and the so called stable step-function opsin ChR2(SSFO) has been chosen, because of its ability 
to give prolonged photocurrents far outlasting the initiating pulses of light at 460 nm. Moreover, in this 
variant the closing process could be speeded up by red light when expressed in PM (Yizhar et al., 2011; 
Prakash et al., 2012). Since the opening of a channel in IMM should trigger mitochondrial membrane 
potential collapse, allowing a massive influx of cations, the effects of the blue light on the fluorescence 
signal of the mitochondrial potential probe TMRM has been tested, confirming the ability of the 
mitochondrial targeted SSFO-YFP to induce mitochondrial depolarization, although with a slow kinetic. A 
different approach, recording TMRM signal with a minute of delay after ChR photoactivation has been 
employed, demonstrating that 540 nm wavelength interferes with the opening kinetic, maybe causing a 
partial closure. However, no direct evidence of channel closure following exposure to red light has been 
obtained so far. For sure further efforts should be done testing different wavelengths in the red light spectra 
at different light power and with different light pulse duration, in order to clarify if SSFO maintains its 
reversibility in mitochondrial membrane. Indeed ChRs are highly voltage-sensitive channel, thus it is not 
excluded the possibility of a change in their biophysical properties due to the higher potential across 
mitochondrial membrane compared to PM. 
Given that Ca2+ uptake in mitochondria is strictly dependent on membrane potential, we analyzed in more 
detail the Ca2+ uptake characteristics in the presence of the mitochondria targeted SSFO, using Cameleon 
probe 4mtD3cpV. The amplitude of the mitochondrial Ca2+ rise observed upon stimulation with Histamine of 
SSFO expressing cells was drastically reduced by a 460 nm light pulse. Similar results were obtained with 
mt-Aeq and this effect was strengthened by pre-illuminating the sample with blue-light. Of note, a complete 
abolishment of Ca2+ uptake has been never observed. Concerning FRET experiments, this fact could be 
explained firstly by the usage of a high affinity Ca2+ probe. Indeed, also FCCP treatment show a passive 
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influx of Ca2+ in mitochondrial matrix through the MCU (data not shown). Moreover, the co-transfection of 
Cameleon and SSFO, tested in confocal microscopy, reveals an efficiency of about 80% (data not shown), 
thus also cells expressing 4mD3cpv but not SSFO are considered in the analysis. Similarly in mt-Aeq 
experiments, a cell population analysis has been exploited; thus, since the SSFO-YFP is usually expressed in 
50% of cells while mt-Aeq has higher efficiency of transfection (confocal microscope analysis, data not 
shown), the average peak included also cells expressing Aequorin but not SSFO. Furthermore, it is well 
known that bioluminescence generate a low amount of 460 nm light (Brini, 2008), causing an incomplete 
channel’s photoactivation. Nevertheless, mitochondrial membrane potential collapse strongly depend on the 
generated photocurrent, which in turns has an amplitude dependent on the number of channel expressed in 
IMM (that could vary), on the light intensity and on the pulse duration employed during the channel 
photoactivation. 
Aequorin experiments confirmed that the reduction in mitochondrial Ca2+ peak was not due to an intrinsic 
toxicity of the SSFO expression, but depends on the depolarization induced by SSFO photoactivation. In 
particular, when a much smaller Ca2+ rise (and thus less light emitted by aequorin) was induced in 
mitochondria by activating mitochondrial Ca2+ uptake through CCE, no difference was observed between 
controls and SSFO expressing cells. Also cytosolic Ca2+ rises were unaffected by SSFO expression compared 
to controls. Finally, SSFO-YFP expressed in neonatal rat cardiomyocytes after channel photoactivation, was 
able to block spontaneous beatings, resembling quantitatively and kinetically the effect of FCCP.  
Taken together this data demonstrated that the new generated mitochondria targeted SSFO is functional and 
non-toxic. The variant is able to mediate mitochondrial membrane potential depolarization and in turn it can 
modulate diverse mitochondria activities in a temporary-controlled, and cell-specific manner, offering an 
approach to quantitatively investigate its role in a large variety of critical cellular processes. Although more 
information on the channel kinetics and on its closure when expressed in the mitochondria membrane is 
required to achieve better time-resolved control of the mitochondrial membrane potential and functions, this 
tool offers an entirely new way to test the role of mitochondria in fast processes such as Ca2+ ion transport 
and their influence on excitable cells activity.  
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Materials and Method 
 
1. Generation and characterization of new Cameleon probes 
 
Constructs generation 
mCerulean3 was kindly gifted by Rizzo M. A. (Department of Physiology, University of Maryland School of 
Medicine, Baltimore, Maryland, United States of America). CFP has been substituted inserting mCerluan3 
cDNA between KpnI and SphI sites in D3cpV-pcDNA3. Restriction sites has been generated by PCR using 
specific primers: 5’-CGGGGTACCGCCACCATGGTGAGCAAGGGC-3’ as forward and 5'- 
ACATGCATGCGCTTGTAC AGCTCGTCCATGCC -3' as reverse;  
The addition of the Kozak consensus sequence (GCCACC) and of the 33 aminoacids N-terminal sequence 
derived from COX VIII at 5’, as well as the insertion of EcoRI and AgeI sites between CaM and M13 in 
4mtD3cpV has been obtained by chemical synthesis (GeneArt Gene Synthesis service from Life 
Technology). In the mitochondria targeted Cameleon obtained, mCerulean3 has been substituted between 
BamHI and SpHI sites, generated by PCR using specific primers: the forward was 5‘-
GCGGATCCGCCACCATGGTGAGCAAGGGC -3’ and the reverse was 5'- ACATGCATGCGCTTGTAC 
AGCTCGTCCATGCC -3’. 
Glycines spacer addition between CaM and M13 was obtained by insertion of annealed oligonucleotides 
between EcoRI and AgeI restriction sites.  
Oligonucleotides 5’-AATTCGTGCAGATGATGACCGCCAAGGGCGGCGGCGGCGGCGGCGGCGGCG 
GC GGCGG CGGCGGCGGCGGCGGCGGCAGCAAGAGAAGATGGCAGAAAA-3’ (Forward), and 3’- 
CCGGTTTTCTGCCATCTTCTCTTGCTGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCC
GCCGCCGCCGCCCTTGGCGGTCATCATCTGCACG-5’ (Reverse) has been synthesized by Invitrogen.  
For protein purification, D3cpV and D3mCerulean3+16 cDNAs have been cloned in the E. Coli expression 
vector pQE30 (QIAGEN) between KpnI/ HindIII restriction sites. 
For AAV9 generation, D3cpV and 4mtD3cpV cDNAs were cloned in pAAV and AAVs were produced by 
Vector Biolabs. D3mCerulean3+16 and 4mtD3mCerulean3+16 cDNAs were cloned in pAAV between 
BamHI and HindIII sites; 4mtD3cpV, D3mCerulean3+16 and 4mtD3mCerulean3+16 cDNAs were cloned in 
pAAV-Syn (Plasmid #58880, Addgene) between HindIII and KpnI restriction sites and AAVs were 
produced by Dr. L. Zentilin. 
4mt-mCerulean3 has been amplified by PCR from 4mtD3mCcerluean3-pcDNA3, using the following 
primers: forward, 5’-ATGGTACCGCCACCATGAGCGTG-3’; reverse 5’-GGCATGGACGAGCTGTAC 
AAGTAACTCGAGCA-3’. The PCR product was then cloned in pcDNA3 between KpnI/XhoI sites.  
cpV has been amplified by PCR from 4mtD3mCerluean3, using the following primers: forward, 5’-
CGCGGATCCATGGATGGCGGAGTC-3’; reverse 5’-CACAATATCGAGTAACTCGAGCGG-3’. The 
PCR product was then cloned in pcDNA3 between BamHI/XhoI sites for cpV, or between BamHI/XhoI in 
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4mtD3mCeruelan3-pcDNA3 to get 4mt-cpV.4mt-CFP and CFP in pcDNA3 were already present in the 
laboratory. 
 
Cell Culture and Transfection 
HeLa cells were grown in Dulbecco’s Modified Eagles medium containing 10% Fetal Calf Serum, 
supplemented with L-glutamine (2 mM), penicillin (100 U/ml) and streptomycin (100 µg/ml), in a 
humidified atmosphere containing 5% CO2. Cells were seeded onto glass coverslips (13-mm diameter for 
Aequorin experiments, 18-mm diameter for FRET measurements and 24-mm for FLIM) and transfection 
was performed at 60% confluence using TransIT®-LT1 transfection reagent (Mirus Bio LLC, Bologna, 
Italy) with 1 µg of DNA in 13-mm and 18-mm coverslips, 2 µg in 24-mm coverslips. FRET or FLIM 
measurements and confocal imaging were usually performed 24-48 h after transfection.  
 
Neonatal cortical neurons 
Primary cortical neurons were obtained from 0-1 day newborn mice (4-6 pups). Cells from mice neonatal 
cortices were dissociated in trypsin (0.8 mg/ml) for 10 min at 37 °C and digestion was blocked by the trypsin 
inhibitor (6.3 μg/ml) plus DNAse I (40 μg/ml). Cells were gently suspended in pre-warmed supplemented 
Minimum Essential Media (MEM; in mM: 20 glucose, 0.5 L-glutamine, 0.0036 biotin, 1 pyruvic acid, also 
containing 1% N2 supplement, 0.5% B27 supplement, 25 µg/ml penicillin, 25 µg/ml streptomycin, 50 µg/ml 
neomycin and 10% horse serum). Cells were seeded on poly-L-lysine (100 µg/ml) coated glass coverslips of 
15 or 18 mm diameter at a density of 0.5 x 106 cells/coverslip. After 24 h, the growth medium was replaced 
with serum- and antibiotic-free Neurobasal-A medium, containing B27 (2%) and L-glutamine (0.5 mM). 
Fresh medium (1/5 of total volume) was added every 5th day. At 8 DIV, cells has been infected with 1011 GC 
(genomic content) of AAV9syn-D3cpV, AAV9syn-4mtD3cpV, AAV9syn-D3mCerulean3+16 or AAV9syn-
4mD3mCerulean3+16 and Ca2+ imaging was performed 96 h after infection. To trigger mitochondrial and 
cytosolic Ca2+ rises, a typical experiment has been performed as follows: after perfusion with extracellular-
like medium (see below) containing 1 mM Ca2+, neurons depolarization is triggered with K+-based medium 
(see below). Finally neurons are permeabilized for 30 seconds in intracellular-like medium containing 50 µM 
digitonin and 600 µM EGTA to record minimum FRET. Maximum FRET was reached adding 5 mM CaCl2. 
 
Neonatal cardiomyocytes 
Cultures of cardiomyocytes were prepared from ventricles of rats (0–3 days after birth). The heart was 
removed and rapidly placed in ice-cold HEPES-buffered saline containing in mM: 116 NaCl, 0.8 NaH2PO4, 
5.3 KCl, 0.4 MgSO4, 5 glucose and 20 HEPES, pH 7.4. Atria were discarded and ventricles were submitted 
to four subsequent digestions with 0.45 mg/ml collagenase and 5% pancreatin. The first supernatant 
containing cell debris and blood cells was discarded. Cell suspensions from the three subsequent digestions 
(20 min each) were centrifuged and the pellet was resuspended in 2 ml of newborn calf serum. Cells were 
pooled and resuspended in a complete medium DMEM/Medium 199 (4:1) supplemented with 2 mM 
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glutamine, penicillin (100 U/ml), streptomycin (100 mg/ml), 5% newborn calf serum and 10% horse serum. 
Cells were then incubated for 1 h at 37°C, allowing a selective attachment of non-myocytes. The unattached 
cells were plated at a density of 0.6 × 106 cell/ml onto 24 mm diameter coverslips coated with laminin 
(1 µg/cm2). Immediately after plating, cardiomyocytes have been infected with 1011 GC of AAV9-D3cpV, 
AAV9-4mtD3cpV, AAV9-D3mCerulean3+16 or AAV9-4mD3mCerulean3+16. From DIV1, cells were 
maintained in DMEM/Medium 199 (4:1) medium containing 5% horse serum and 0.5% newborn calf serum 
for 3 days. Experiments has been carried out 96 h after infection. Spontaneous Ca2+ oscillations have been 
measured in extracellular-like medium (see below) containing Ca2Cl 2mM. To evaluate the DR of the probe, 
cardiomyocytes have been permeabilized for 45 seconds in intracellular-like medium containing 50 µM 
digitonin and 600 µM EGTA, to record minimum FRET. Maximum FRET was reached adding 5 mM CaCl2. 
 
Immunocytochemistry 
Cells were fixed in Phosphate Buffered Saline (PBS) containing 4% paraformaldehyde for 15 min, incubated 
with 50 mM NH4Cl for 20 min, permeabilized with 0.1% Triton X-100 in PBS for 3 min and then blocked 
with 2% BSA and 0.2% gelatine for 30 min; mitochondria were stained using a anti-TOM20 antibody (Santa 
Cruz Biotechnology, Dallas Texas, USA) (1:100). Alexa Fluor 555 conjugated goat anti-rabbit (Molecular 
Probes Invitrogen, Eugene) was applied for 1 hour at room temperature. Coverslips were mounted using 
Mowiol (Sigma-Aldrich Saint Louis, MI). Images were collected at Leica TCS-SP5-II confocal system, 
equipped with a PlanApo 100×/1.4 numerical aperture objective. For all images, pinhole was set to 1 Airy 
unit. The Argon laser line (488 nm) was used to excite FPs of the Cameleon sensors and the He/Ne 543 nm 
laser was used to excite the AlexaFluor555 antibody. Confocal microscopy imaging was performed at 
1024×1024 pixels per image, with a 200Hz acquisition rate. Images were elaborated with ImageJ program 
(Wayne Rasband, Bethesda, USA).  
 
Confocal analysis of mCerulen3 fluorescence and mitochondrial targeting  
HeLa cells expressing D3cpV/D3mCerulean3 or 4mtD3cpV/4mtD3mCerulean3 were fixed and then 
analysed with a Leica SP5 confocal system (DM IRE2) using the Ar/ArKr 458-nm laser line 
(CFP/mCerulean3) and He/Ne 512-nm laser line (cpV). In order to compare the absolute fluorescence of 
CFP and of mCerulean3, the measured intensity was normalized to the cpV recorded fluorescence, 
maintaining the records parameters constant between the acquisitions. Indeed, cpV is present in both probes, 
thus it was possible to use its fluorescence as a parameter to evaluate the protein expression level in each cell 
analysed. Confocal microscopy imaging was performed as reported above.  
To evaluate the targeting efficiency between old (29 aminoacids) and new (33 aminoacids) optimized 
mitochondrial targeting sequence, six different fields has been acquired for each condition. The averaged 
ratio between the number of cells showing the proper mitochondrial localization of the probe and the total 
number of cells per field expressing the probes has been calculated. 
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Fluorescence microscope settings for FRET experiments  
Live cells expressing the fluorescent probes were analysed using a DM6000 inverted microscope (Leica, 
Wetzlar, Germany) with a 40X oil objective (HCX Plan Apo, NA 1.25). Excitation light produced by a 
410nm LED (Led Engin #LZ1-00UA00 LED) was filtered at the appropriate wavelength (425 nm) through a 
band pass filter, and the emitted light was collected through a beam splitter (OES s.r.l., Padua, Italy) 
(emission filters HQ 480/40M (for CFP) and HQ 535/30M (for cpV-YFP); dichroic mirror 515 DCXR). The 
beam splitter permits the collection of the two emitted wavelengths at the same time, thus preventing artefact 
due to movement of the organelles. All filters and dichroics were from Chroma Technologies (Bellow Falls, 
VT, USA). Images were acquired using an IM 1.4C cool camera (Jenoptik Optical Systems) attached to a 12-
bit frame grabber. Synchronization of the excitation source and the cool camera was performed through a 
control unit run by a custom-made software package, Roboscope (developed by Catalin Dacian Ciubotaru at 
VIMM, Padua, Italy). Exposure time varied from 100 ms to 200 ms, depending on the intensity of the 
fluorescent signal of the cells analysed. Frequency of image capture depends on the speed of fluorescence 
changes we were detecting: usually images are acquired every 2-3 seconds, with the only exception of 
photostability experiments in which 1 image per second is acquired. 
During the experiment, cells were mounted into an open-topped chamber and maintained in the proper 
medium. The extracellular-like medium is composed by modified Krebs-Ringer Buffer, mKRB; in mM: 135 
NaCl, 5 KCl, 1 MgCl2, 0.4 KH2PO4, 1 MgSO4, 20 HEPES, 11 glucose, pH 7.4 at 37°C (or at 22°c for FLIM 
experiments), while intracellular-like medium contains in mM: 130 KCl, 10 NaCl, 1 MgCl2, 2 succinic acid 
and 20 HEPES, 7.0 pH at 37°C. For evaluating pH sensitivity, titration and dynamic range of the probe in 
mitochondria, a modified intracellular-like medium (called IC) deprived of energy sources has been used: 
succinic acid was removed. Moreover, HEPES is substituted with 20 mM Tris to get pH 8 at 37°C or 22°C 
for FLIM experiment. 
All media were perfused through a temperature controller (Warner Instruments, TC-324B) to maintain a 
constant temperature of 37°C in the chamber. Pre-incubations were also performed at 37°C.  
Functionality experiments: classical experiments started in extracellular-like medium containing 1 mM 
CaCl2; after perfusion with 600 µM EGTA, cells were stimulated by perfusion of 100 µM histamine; 
thereafter: 
-  in HeLa cells expressing cytosolic probes, the Ca2+ ionophore ionomycin (1 µM) was applied 
in Ca2+-free medium containing 600 µM EGTA to completely empty the stores; then 5mM CaCl2 
was applied in extracellular-like medium containing 1 µM ionomycin, to reach high [Ca2+] inside the 
cell;  
-  HeLa cells expressing mitochondrial probes were permeabilized using 100 µM digitonin in 
Ca2+-free intracellular-like medium for 1 minutes; then a saturating CaCl2 concentration (3 mM) was 
applied. 
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Data are presented as ratio (R, acceptor/donor) or as FRET changes % of maximum, calculated as:  
R%= (R-Rmin)/Rmax-Rmin) x100. 
Dynamic range: minimal and maximal FRET condition has been obtained as described above. DR has been 
calculated dividing maximal ratio (cpV/CFP or cpV/mCerulean3 fluorescence intensity at saturated [Ca2+]) 
by minimal ratio (cpV/CFP or cpV/mCerulean3 fluorescence intensity in Ca2+-free medium containing 600 
µM EGTA). 
pH sensitivity: HeLa cells expressing 4mtD3cpV, 4mtD3mCerulean3 or 4mtD3mCerulean3+16 has been 
permeabilized with 100 µM digitonin in IC Ca2+-free medium containing 600 µM EGTA and the uncoupler 5 
µM FCCP (Carbonil cianuro-p-trifluorometossifenil idrazone) for 1 minutes at the physiological 
mitochondrial pH (pH 8); then cells have been perfused with the intracellular Ca2+-free medium at different 
fixed pH (7, 7.5, 8.5, 9). Data are presented as FRET % of maximum. Changes in R due to pH has been 
calculated as the average of absolute values of R in 5 frames normalized to Rmin and Rmax at pH 8. 
Probes titration: HeLa cells expressing 4mtD3cpV, 4mtD3mCerulean3 or 4mtD3mCerulean3+16 has been 
pre-permeabilized with 100 µM digitonin in IC Ca2+-free medium containing 600 µM EGTA and the 5 µM 
FCCP for 1 minutes and then incubated in the same medium without digitonin. Cells were then perfused with 
IC containing known Ca2+ concentrations. At the end of each experiment, saturating CaCl2 concentration (5 
mM) was applied. Data are presented as FRET % of maximum. IC supplied with 500 µM BAPTA free acid 
(Molecular Probes, Life Technology) has been used to achieve [Ca2+] <1 μM for Kd evaluation. In solutions 
with [Ca2+] >1 μM, the amount of Ca2+ contaminant is calculated with Calcium Green-5N, Hexapotassium 
Salt (described below). 
The data obtained are plotted as log10[Ca2+] (x-axis) and FRET % of maximum (y-axis) and fitted using 
Origin 8 SR5 (OriginLab Corporation). 
The fitting was made using the following equation (Palmer et al., 2004): 
  
R = Rmax1/(1+(Kd1/ [Ca2+])n1)+Rmax2/(1+(Kd2/ [Ca2+])n2) 
 
where R represents the fluorescence intensity ratio cpV/CFP, Rmax corresponding to the titration end points at 
5mM CaCl2, Kd is affinity constant and n is the hill coefficient. 
Photostability experiments: HeLa cells expressing the different variants of cytosolic or mitochondrial probes 
have been illuminated every second using the same laser intensity; images were acquired for 20 minutes in 
three different FRET conditions. For cytosolic Cameleon probes we analyzed: maximal FRET, obtained in 
extracellular-like medium supplied with 1 µM ionomycin and 5 mM CaCl2; minimal FRET, obtained in 
extracellular-like medium containing 5 µM Ca2+ chelator BAPTA-AM; basal FRET, obtained in 
extracellular-like medium supplied with the physiological 1mM [Ca2+]. 
For mitochondrial cameleon probes, after permeabilization with 100 µM digitonin, we analyzed: minimal 
FRET, obtained incubating permeabilized cells in intracellular-like Ca2+-free medium containing 600 µM 
EGTA; maximal FRET, obtained incubating cells in intracellular-like like medium containing 5 mM CaCl2; 
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basal FRET, obtained incubating cells in extracellular-like medium in the presence of physiological 1 mM 
CaCl2. 
 
Buffer titration with spectrofluorometer 
To evaluate [Ca2+] in IC medium used for the titration experiments, 1 µM of Calcium Green-5N, 
Hexapotassium Salt (Molecular Probes) was added to the solution and fluorescence was evaluated using a 
PerkinElmer LS50B spectrofluorometer (excitation and emission wavelengths of 505 and 535 nm, 
respectively) equipped with magnetic stirring at 37°C.  
[Ca2+] concentration is calculated as: 
 
 [Ca2+]free = 32* [(F-Fmin)/(Fmax-F)] 
 
Where 32 is the dissociation constant (Kd) of Calcium Green-5N calculated in our experimental conditions, F 
is the fluorescence of the indicator at experimental calcium levels, Fmin is the fluorescence in the absence of 
Ca2+ and Fmax is the fluorescence of the calcium-saturated probe .  
To measure [Ca2+] in IC Ca2+-free containing BAPTA free acid, 1 µM of Fura2-free acid (Molecular Probes) 
has been added to the solution and fluorescence is evaluated using either the PerkinElmer LS50B 
spectrofluorometer equipped with magnetic stirring (display 340 and 380 excitation intensity, 510 nm 
emission) at 37°C.  
[Ca2+] concentration is calculated as: 
 
[Ca2+]free = 224* Q [(R-Rmin)/(Rmax-R)] 
 
where 224 nM is the Fura-2 Kd, R represents the fluorescence intensity ratio Fλ1/Fλ2, in which λ1 (~340 nm) 
and λ2 (~380 nm) respectively. R corresponding to the titration end points are denoted by the subscripts 
indicating the minimum and maximum Ca2+ concentration. Q is the ratio of Fmin to Fmax at λ2 (~380 nm).  
 
Western Blot 
HeLa cells expressing D3cpV, 4mtD3cpV, D3mCerulean3+16 or 4mtD3mcerulean3+16 were solubilized in 
RIPA buffer (50 mM Tris, 150 mM NaCl, 1% Triton X-100, 0.5% deoxycholic acid, 0,1% SDS, protease 
inhibitor cocktail, pH 7.5) and incubated on ice for 30 min. Insolubilized material was spun down at 4000 x g 
for 5 min at 4°C. 35 μg of protein were loaded onto polyacrylamide gels (10-12%) and immunoblotted. 
Proteins were resolved by TruPAGE™ Precast Gels 4-12% (Sigma Aldrich) in TruPAGE™ TEA-Tricine 
SDS Running Buffer (Sigma Aldrich), blotted onto a nitrocellulose membrane and probed with -GFP 
antibody (Rabbit monoclonal; Cell signaling technology, 1:1000).   
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Protein Purification and imaging 
Cameleon probes in pQE30 were transformed in BL21 E. coli (NEB), grown at 37°C. Bacteria were induced 
with 250uM IPTG (Isopropil-β-D-1-tiogalattopiranoside) over-night at 16°C and lysed in a buffer containing 
50 mM sodium phosphate, 0.6 M sodium chloride, triton X-100 0.1%, glycerol 10% and a cocktail of 
protease inhibitor (EDTA-free, Roche) at pH 8.0. Proteins of interest were selectively bound to HIS-Select 
Nickel Affinity Gel (Sigma Aldrich) via an N-terminal 6×Histag. The gel with bound proteins was washed 
with 50 mM sodium phosphate, 0.6 M sodium chloride, 10 mM imidazole, glycerol 10% at pH 8. The 
protein was eluted in 50 mM sodium phosphate, 0.3 M sodium chloride, and 250 mM imidazole at pH 8. 
Protein concentration has been determined with Bicinchoninic Protein Assay Kit (Euroclone) and measuring 
absorbance on the plate reader Infinity M200 (Tecan) at 540 nm. To verify the presence of contaminants and 
the stability of the protein at 4°C, 5uL of the purified proteins were resolved by TruPAGE™ Precast Gels 4-
12% (Sigma Aldrich) in TruPAGE™ TEA-Tricine SDS and stained with Comassie Blue. Fluorescence 
measurements were conducted on PerkinElmer EnVision plates (excitation filter: 430/24, emission filter: for 
CFP/mCerulean3 EM=470/24+535/30 for cpV) at 37°C using a protein concentration of 1.2 μM. DR has 
been calculated in IC containing 600 µM EGTA or 5 mM CaCl2. IC supplied with 500 µM BAPTA free 
acids has been used to achieve [Ca2+] <1 μM for Kd evaluation. In solutions with [Ca2+] >1 μM, the amount 
of Ca2+ contaminant is calculated with Calcium Green-5N, Hexapotassium Salt (described below). 
 
FLIM 
FLIM measurements are carried out using the time-correlated single-photon counting (TCSPC) method. The 
experimental apparatus is based on a scanning confocal microscope (Olympus IX-71) coupled with a 
PicoHarp 300 TCSPC electronics (PicoQuant) and two single-photon counting avalanche photodiodes 
(SPAD, MPD, Italy). Excitation is provided by a frequency doubled Ti:Sapphire fs laser system (Coherent, 
Mira900-F, 400 nm, 76 MHz), focused onto the sample using a 60× water immersion microscope objective. 
The laser power on the sample is typically around 50-200 W. The scan area dimension is selected on the 
microscope software in order to map single cell in each analysis. The acquisition time is set to 3-5 minutes to 
collect around 104 count in the peak channel.     
The fluorescence signal is split in two channels by a 40/60% beam-splitter for the detection of donor 
emission (Semrock, 482/25 bandpass filter) and of mainly acceptor fluorescence (Semrock, 542/25 bandpass 
filter). The data acquisition is performed in reverse start-stop mode, with each detected photon assigned to 
one of the 820 channels with 16 ps width. Lifetime decays, extracted from a ROI, are analyzed with the 
Symphotime software (PicoQuant) using a model with increasing number of exponential terms until it 
brought no significant improvement of the quality of the fit. For each decay curve, the instrumental response 
function (IRF) is obtained by the IRF reconstruction script of the Symphotime software. Its FWHM (Full 
width at half maximum) is typically of 150-200 ps.  The FLIM analysis is performed using a pixel-by-pixel 
tail-fitting procedure.  
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Acceptor photobleaching experiments are performed using an Argon laser (Melles Griot, IMA101040ALS) 
at 514 nm, coupled to the second port of the confocal microscope. FLIM analysis is performed before and 
after each photobleaching exposure (up to 15 minutes for entire cell) in order to test the effectiveness of the 
acceptor bleaching.  
All experiments are conducted at room temperature at 22 °C.  
 
AAV9 in vivo expression 
Mice used were C57Bl/6 littermates. The mother (singly housed) of each litter to be injected was removed 
from the cage. The postnatal-day-1 pups were rested on a bed of ice for anesthetization and then 
intraperitoneal injections has been performed. Vector solution was drawn into a 3/10 cc 30 gauge insulin 
syringe. Virus injections were in a total volume of 10 μl of PBS and a total of 1011 GC of AAV9-Cameleon 
probes were injected. After the injection, pups were returned to their cage and the mother was then 
reintroduced to the cage. Neonatal mice were euthanized 30 days post-injection, hearts and brains were 
extracted, rinsed in PBS, and then immersion fixed in a 4% paraformaldehyde solution.  
All experimental procedures were authorized by the Italian Ministry of Health; all efforts were made to 
minimize the number of animal used and their suffering. Coronal cortical-hippocampal slices were obtained 
as previously described (Luvisetto et al., 2004). Briefly, brain was removed and put into ice-cold cutting 
solution containing (in mM): 120 NaCl, 3.2 KCl, 1 KH2PO4, 26 NaHCO3, 2 MgCl2, 1 CaCl2, 10 glucose, 2 
Na-pyruvate, and 0.6 ascorbic acid at pH 7.4 (with 5% CO2/95% O2).  
Briefly, heart was removed and put into ice-cold cutting solution containing (in mM): 118.5 NaCl, 25.0 
NaHCO3, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 1.8, 11 glucose, 11.2 BDM (2,3Butanedione Monoxime). 
Slices were obtained by cutting with a Leica Vibratome VT1000S (Mannheim, Germany) 100-150 μ 
thickness for brain slices and 300 μ for heart slices and imaged in Confocal SP5 as described above after 
loading with 200 μM TMRM. 
Western Blot 
Proteins from whole heart tissue has been extracted in lysis buffer containing in mM: 50Tris pH 7,5; 150 
NaCl; 10 MgCl2; 0,5 DTT; 1 EDTA; Glycerol 10 %; SDS 2 %; Triton-X 1 %; protease inhibitor Complete 
mini EDTA-free (Roche). Protein has been quantified. 40 µg of protein per lane. α-GFP (Cell Signalling) 
1:500. Secondary antibody .α-rabbit HRP (Biorad) 
 
Materials 
Restriction and modification enzymes were purchased from Fermentas Thermo Scientific. FCCP and 
digitonin were purchased from Sigma-Aldrich; ionomycin were purchased from Calbiochem; Neurobasal-A 
medium, MEM, N2, B27 supplement, trypsin, L-glutamine, penicillin, streptomycin and neomycin,  
BATPA-Free Acid, Ca2+-green 5N and Fura-2/AM were purchased from Invitrogen (Carlsbad, CA, USA). 
All other materials were analytical or of the highest available grade.  
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Statistical analysis 
Off-line analysis of FRET experiments was performed with ImageJ software (National Institutes of Health). 
cpV and CFP/mCerulean3 images were subtracted of background signals and distinctly analyzed after 
selecting proper regions of interest (ROIs) on each cell; subsequently, a ratio between cpV and CFP (or 
mCerulean3) emissions was calculated (R=F530/F430).  
Data are presented as a normalized ΔR/R0 %, where R0 is the R value at the beginning of the experiment (t0) 
and ΔR is the R value at each time (t) of the experiment minus R0, or as FRET changes % of maximum. 
All data are representative of at least three different experiments. Unless otherwise stated, numerical values 
presented throughout the text refer to mean ± SEM (n=number of independent experiments or cells;  = 
p<0.05, =p<0.01,  = p<0.001, unpaired Student’s t test) 
 
2. Channelrhodopsin experiments 
 
Cell Culture and Transfection 
HeLa cells were grown and transfected as mentioned before. Aequorin and FRET measurements were 
usually performed 48-72 h after transfection. Co-transfection with cDNA of 4mtChR2B(SSFO)/void 
vector/ChR2B(TR) and Ca2+-probes (Aequorin or Cameleon) was performed in molar ratio 5:1. 2 µM All 
Trans Retinal (ATR, Sigma) was, routinely, added overnight. 
 
Topology experiments 
HeLa cells expressing 4mtChR2B(SSFO)-YFP or 4mtD3cpV (localized in the mitochondrial matrix) or 
N33D3cpV (localized  on OMM) were analyzed using a DM6000 inverted microscope (Leica, Wetzlar, 
Germany) with a 40X oil objective (HCX Plan Apo, NA 1.25). Excitation light produced by a 460 nm LED 
(Led Engin LZ1-10DB05 LED) was filtered at the appropriate wavelength (470 nm) through an excitation 
filter ET470/24, and the emitted light was collected through a long pass filter 515 nm and a dichroic mirror 
510 DCXR. All filters and dichroics were from Chroma Technologies (Bellow Falls, VT, USA). Images 
were acquired using an IM 1.4C cool camera (Jenoptik Optical Systems) attached to a 12-bit frame grabber. 
Synchronization of the excitation source and cool camera was performed through a control unit ran by a 
custom-made software package, Roboscope. Images were collected with 0.2 or 0.3 Hz frequency and with 
200-ms exposure per image. 
Cells were mounted in an open-topped chamber thermostated at 37°C and maintained in an extracellular-like 
Ca2+-free medium. To cut any YFP facing the extracellular space, cells were perfused with extracellular 
Ca2+-free medium in the presence of Proteinase K 20 µg/µL (Sigma). Plasma membranes permeabilization 
was performed with 100 µM Digitonin (Sigma) in an intracellular-like medium. Afterwards, to cut YFP 
facing the cytosol, cells were perfused with intracellular Ca2+ free medium added with proteinase K 20 µg/uL 
and finally, to quench any YFP facing the inter membrane space, HeLa cells were perfused with intracellular 
medium added with Trypan Blue 0.5 mg/mL (Sigma).  
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For alamethicin experiments, plasma membranes of HeLa cells were pre-permeabilized with digitonin (as 
described above). Alamethicin (20 μg/ml, Sigma) was added in intracellular-like medium to trigger OMM 
and IMM permeabilization. 
Off-line analysis of topology experiments was performed with ImageJ (Wayne Rasband, Bethesda, USA). 
The YFP fluorescence intensity (subtracted of background signal) was analyzed after selecting proper ROIs 
on each cell; the intensity was expressed as % of the initial YFP fluorescence. These experiments are carried 
out without adding ATR, since it has an overlapped spectrum with YFP. A representative scheme of the 
protocol is presented in Figure 33. 
 
Mitochondrial Transmembrane Potential Measurements (TMRM Assay)  
Mitochondrial membrane potential was determined by tetramethyl rhodamine methyl ester (TMRM) 
fluorescent dye. Cells were loaded for 15-30 minutes, at room temperature, with 20 nm of TMRM in MEM 
without phenol red (GIBCO, life technology). TMRM fluorescence was viewed using an inverted 
microscope (Zeiss Axiovert 100) with a ×40 oil objective (Fluar, NA 1.30). Excitation light at 540±7.5 nm 
was produced by a monochromator (polychrome V; TILL Photonics) and passed through a Zeiss TRITC 
filter (Emission 573-613 nm) and a dichroic mirror (565 DCXR). Images were acquired using a cooled CCD 
camera (SensicamQE PCO, Kelheim, Germany). All filters and dichroics were from Chroma Technologies 
(Bellow Falls, VT, USA).  
Images were acquired each 10 seconds (50 ms exposure). For blue light exposure a 460+15 nm produced by 
a monochromator (polychrome V; TILL Photonics) has been used. Obtained images data were exported for 
analysis in ImageJ (Wayne Rasband, Bethesda, USA). ATR (2μg/ml final concentration) was added into the 
culture medium 12hr before experiments. 
 
Fluorescence Ca2+ Imaging  
HeLa cells expressing the mitochondrial Cameleon probe (4mtD3cpv) co-transfected with SSFO or void 
vector or ChR2B(TR) were analyzed using a DM6000 inverted microscope (Leica, Wetzlar, Germany) (see 
above). 
Cells were mounted into an open-topped chamber thermostated at 37°C and maintained in an extracellular 
medium. Classical experiments started in 1 mM CaCl2; after perfusion with 600 µM EGTA, cells were 
stimulated by applying 100 µM histamine. Cells were pre-illuminated to trigger SSFO opening by employing 
460 nm LED (Led Engin LZ1-10DB05 LED) for 10 seconds and the FRET measurements start 1 minute 
after the illumination.  
For off line analysis of FRET experiments see above. Data are presented as a R/R0 values (where R is the 
change of the cpV/CFP emission intensity ratio at any time, R0 is the fluorescence emission ratio at the time 
0). Numerical values presented throughout the text refer to mean±SEM (N=number of cells;  = p<0.05, 
=p<0.01,  = p<0.001, unpaired Student’s t test).  
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Aequorin Ca2+ Measurements  
             HeLa cells (0.5 × 105) plated on coverslips (13 mm diameter), after 24 h were transfected and then used for 
Ca2+ measurements 48-72 h after transfection. Cells were incubated at 37°C with coelenterazine (5 µM) for 1 
h in extracellular medium and then transferred to the perfusion chamber. All the luminescence measurements 
were carried out in extracellular medium at 37°C. The experiments were terminated by cell permeabilization 
with digitonin (100 µM) in a hypotonic Ca2+-rich solution (10 mM CaCl2 in H2O) to discharge the remaining 
unused Aequorin pool. The light signal was collected as previously described (Brini, et al. 1995). 
For mitochondrial Ca2+ uptake induced by employing a mix of stimuli, the protocol used is the following. 
Experiments start in extracellular-like medium containing 1mM CaCl2, after perfusion of 2 minutes with 600 
µM EGTA, cells were stimulated by applying a mix of stimuli: histamine (100 µM), CPA (20 µM) and ATP 
(100 µM). In the indicated cases, cells were pre-illuminated to trigger SSFO opening by employing 460 nm 
LED (Led Engin LZ1-10DB05 LED) for 10 seconds; the aequorin measurements started 1 minute after 
illumination. 
For CCE activation, cells were pre-treated with the irreversible SERCA inhibitor thapsigargin (100 nM) for 6 
minutes in a Ca2+-free, EGTA (600 μM)-containing medium; cells were then perfused with the same medium 
without the inhibitor and challenged with CaCl2 (0.75 mM). 
 
Statistical analysis 
All data are representative of at least three independent experiments. Data were analysed using Origin 7.5 
SR5 (OriginLab Corporation) and ImageJ (National Institutes of Health). Unless otherwise stated, numerical 
values presented throughout the text refer to mean±SEM (N=number of independent experiments or cells;  
= p<0.05, =p<0.01,  = p<0.001, unpaired Student’s t test) 
 
Materials 
Restriction and modification enzymes were purchased from Fermentas Thermo Scientific. Histamine, ATP 
and digitonin were purchased from Sigma-Aldrich, while CPA from Calbiochem. All other materials were 
analytical or of the highest available grade.  
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PART-II  
SINGLE ORGANELLE FRET-BASED ANALYSIS OF 
INTRACELLULAR CALCIUM: EFFECTS OF 
PRESENILINS CARRYING FAMILIAL 
ALZHEIMER’S DISEASE MUTATIONS ON 
CAPACITATIVE CALCIUM ENTRY 
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Introduction 
4. Alzheimer’s disease 
Alzheimer’s disease (AD) was first described more than 100 years ago and it represents the most common 
cause of dementia with an estimated prevalence of 30 million people worldwide, a number that is expected to 
quadruple in 40 years (Holtzman et al., 2011). Old age is closely linked to AD, but environmental factors and 
enrichment, diet and hyperlipidemia has been proposed to have an additional role in the onset of the 
pathology (Förstl and Kurz, 1999). 
Although many efforts have been carried out to unravel the causes of this pathology, currently no effective 
treatments are available and palliative treatments are used to partially slow down the progression of dementia 
symptoms (Holtzman et al., 2011). 
 
4.1 The pathology 
Dementia is an acquired syndrome characterized by a loss or decline in memory and other cognitive 
disabilities. Around 70% of dementia's cases are classified as AD (Barker et al., 2002), an irreversible 
neurodegenerative disorder of the central nervous system clinically characterized by the following features: 
(1) in the early stage of the pathology: mild impairment in cognitive function, behavioural alterations 
and slight short-term memory deficits; 
(2) in the late stage of the pathology: personality disorders, severe recent memory impairment, learning 
deficits, language dysfunction, visuo-spatial difficulty, loss of insight (Holtzman et al., 2011); 
(3) in the final stage of the pathology (after 5-10 years from the first symptoms): impairment of long-
term memory, loss of the ability to recognize familial faces, hallucinations, aggressive behaviour, 
ambulatory regression, aphasia and impairment of daily living (e.g., dressing, bathing, grooming) 
(Förstl and Kurz, 1999).  
Two forms of AD are defined: 
(1)  the most common “late onset” (LOAD) form, that affects people > 65 years old; 
(2) “early onset” (EOAD) form, which arises in 30-60 years old patients, represents around 5% of total 
AD cases. Among them, around 15%  are hereditary cases (FAD), thus less than 1% of total AD 
cases, and are caused by autosomal, dominantly inherited mutations in amyloid precursor protein 
(APP) (Levy et al., 1990), presenilin-1 (PS1) (Levy-Lahad et al., 1995) or presenilin-2 (PS2) 
(Sherrington et al., 1995). PS1 mutations are associated with a more severe phenotype compared to 
those in PS2. 
Morphologically, AD has a peculiar signature: brain specimens from AD patients show a modest degree of 
cerebral cortical atrophy, especially at the level of the fronto-temporal cortex and the parietal lobe, and a 
more significant atrophy of the hippocampus. The loss of brain tissue is generally associated to a dilation of 
the lateral ventricles. Studies performed using new neuroimaging techniques (such as 18F-FDG PET able to 
reveal regional brain hypometabolism of glucose) and fluid biomarkers, suggest that AD could be detected 
pre-clinically, although up to now there is not yet consensus on their diagnostic use (Perrin et al., 2009).  
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Alois Alzheimer first pointed out in 1907 that the disease, which would later bear his name, has distinct and 
recognizable neuropathological features (Figure 39): 
(1)  Senile plaques or Amyloid plaques. These plaques are extracellular accumulations of molecules in 
the brain, mainly due to the aggregation in fibrils and oligomers of hydrophobic products of APP, 
called amyloid-β peptides (Aβ, see below) (Kayed et al., 2003). The plaques are often surrounded by 
dystrophic neurites, microglia and reactive astrocytes (cells involved in the inflammatory response). 
Two theories have been formulated about the role of the inflammatory response in AD: one proposes 
that inflammation contributes to brain injury, the other suggests viceversa that glial cells play a 
protective role (Lucin and Wyss-Coray, 2009). Other proteins have been reported to be present in 
these plaques, such as heparan sulfate glycoproteins, apolipoprotein E, complement proteins, and 
alpha-1-antichymotrypsin (Perl, 2010).  
(2) Neurofibrillary tangles (NFTs). NFTs are intracellular structures localized in neuronal cell bodies. 
Ultrastructurally, they are composed by a geometrical structure of abnormal fibrils measuring 10 nm 
in diameter that occur in pairs and are wound in a helical fashion with a regular periodicity of 80 nm 
(Perl, 2010). They are composed predominantly of aggregated forms of the microtubule binding-
protein (tau) hyperphosphorylated. Tau is synthesized and produced in neurons and in glia, where is 
deputed to bind tubulin and stabilize microtubules. In AD, tau hyperphosphorylation causes its 
dissociation from microtubules and its tendency to self-aggregate. Data strongly suggest that 
neurofibrillary pathology contributes to neuronal dysfunction and correlates with the clinical 
progression of AD (Holtzman et al., 2011). Also in this case, a number of other proteins have been 
found to be associated with tangles, such as ubiquitin, cholinesterases, and beta-amyloid (Braak H. 
and Braak E., 1997).  
 
 
FIGURE 39: a) Two amyloid plaques surrounded by dystrophic neurites and a neurofibrillary tangle between them in the cortex of 
an AD patient; b) Immuno-histochemical techniques allow to visualize amyloid plaques (modified from Perl, 2010). 
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4.2 -secretase   
-secretase, is a large enzymatic complex composed of four different integral membrane proteins, 
responsible for the generation of A from the C-terminal fragment of APP. -secretase is an aspartyl-
protease that cleaves a number of different substrates, with low specificity (Tolia and De Strooper, 2009). 
Among them there are APP, Notch, Delta1, E- and N-cadherins, CD44, Nectina-1, ErbB4 and the 2 
subunit of the voltage dependent Na+ channel (McCarthy et al., 2009). The secretase complex has the 
peculiar ability of mediating intra-membrane protein cleavage, ability shared with only few other enzymes, 
called intramembrane-cleaving proteases (I-CLiPs).  
Four secretase components have been identified, and they form a complex with a stoichiometry that seems 
to be 1:1:1:1 (Figure 40). These components are: 
(1) Presenilin (either PS1 or PS2), that constitutes the catalytic core of the enzyme (see below for further 
details) (Tolia and De Strooper, 2009). 
(2) Nicastrin (NCT), an 80-130 kDa (depending on the glycosylation state) type I glycoprotein, with the 
TM domain that interacts with other components of the secretase complex, Aph-1 and PSs (Yu et 
al., 2000). NCT undergoes a glycosylation/maturation process that causes a conformational change 
in its ectodomain. This domain is crucial for the incorporation into the secretase complex and 
contains a DAP (DYIGS and peptidase homologous region) domain thought to be critical for the 
initial binding of the enzyme to substrates. Mature NCT can bind to the ectodomain of APP C-
terminal fragment derived from the α-/β-secretase cleavage (see below) and may act as a substrate 
receptor of γ-secretase (Shirotani et al. 2003). 
(3) Antherior Pharynx-defective 1 (Aph-1), is a 7 TM domains protein of 30 kDa with its N-terminus 
protruding in the lumen and a cytosolic C-terminus. In humans there are two genes coding for Aph-
1: Aph-1a and Aph-1b. These variants, together with the two forms of PS, make the composition of 
the secretase complex highly variable, since different isoforms can participate to its configuration. 
The GxxxG motif located in its TM4, is necessary for the interaction with Pen-2 and PS. Aph1 
interacts with immature NCT and PS to form a relatively stable pre-complex which is then 
translocated from the ER/cis-Golgi to the Trans-Golgi, for further maturation. Its role is not 
completely understood, but it seems to work as an initial scaffold for the proper assembly of the 
entire complex (Lee et al., 2002).  
(4) Presenilin Enhancer-2 (Pen-2), is a small hairpin-like protein of about 101 aminoacids with two TM 
domains and both the N- and C-termini toward the ER luminal side, facing the cytosol. The N-
terminus is important for the interaction with PS, while the C-terminus and the TM1 domain are 
necessary for the endoproteolysis and the following activation of PS, although the mechanism is not 
clear (Luo et al., 2003). 
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FIGURE 40. Schematic representation of secretase complex (Parks et al., 2007) 
 
Additional proteins might be involved in the regulation of the activity or in the subcellular localization of the 
complex, and great efforts have been made to determine the precise secretase structure. Despite this, being 
a membrane-embedded protein complex harbouring at least 19 membrane-spanning domains, crystallization 
of the purified secretase complex has not been obtained yet (De Strooper et al., 2012).  
About the assembly of the complex, different steps are involved in the mature tetramer formation: 
(1) NCT and Aph-1 form an initial sub-complex within the ER membrane (De Strooper et al., 2012).  
(2) NCT then interacts with PS and Pen-2 sub-complex, which results in the maturation/proteolytic 
cleavage of PS1 or PS2, to generate its active structure (Kim et al., 2007).  
(3) A large amount of these complexes cycles between the ER and Golgi apparatus, but only a small 
percentage (probably less than 10% of the total) of -secretase complexes seems to be active, and 
reaches endosomes and PM. The final destination of this complex is reached only after the Golgi-
mediated glycosylation of NCT (Kaether et al., 2006a and b; Chyung et al., 2005).  
As mentioned, γ-secretase has different substrates and their cleavage occur in specific subcellular 
compartments: APP is mainly cleaved in the TGN and early endosomal domains, whereas Notch is primarily 
cleaved at the PM (Tarassishin et al., 2004). Thus a disturbance in the localization of the γ-secretase complex 
may play a role in abnormal Aβ generation and AD pathogenesis (Zhang et al., 2011). 
Since -secretase plays an essential role in the pathogenesis of AD, being the producer of the A peptide, 
many efforts have been done to develop -secretase inhibitors. However, most of the inhibitors, despite the 
effectiveness on APP cleavage, displayed toxicity consequently to a non-substrate-specific enzymatic 
inhibition, due to the large variety of -secretase substrates (De Strooper et al., 2012). The non-specific effect 
is probably due to an impairment in the signalling pathway of Notch, a well-known transmembrane receptor 
involved in a plethora of cellular pathways, such as neurogenesis. 
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4.3 Presenilins 
Presenilins (PSs) were identified and cloned in the middle of the 1990s (Levy-Lahad et al., 1995; 
Sherrington et al., 1995). PS1 and PS2 are homologous membrane proteins of about 50 kDa, located mainly 
in the ER and GA, while they are less abundant in the PM and endosomes. They are highly expressed in the 
brain, although their expression is detectable in most adult human tissues (Brunkan and Goate, 2005). PS1 
and PS2 share an identity of around 65% and they are considered the catalytic core of the -secretase 
complex, since its enzymatic activity is abolished in MEF knockout (KO) for both PS1 and PS2 (Herreman 
et al., 2000). Structurally, they are characterized by the presence of 10 hydrophobic domains and 9 TM 
domains, with the N-terminus facing the cytosol and the C-terminus located in the lumen of the organelle 
(Figure 41). The two catalytically active parts of PSs in the -secretase complex are the N-terminal fragment 
(NTF) and a C-terminal fragment (CTF). NTF of ~ 30 kDa and CTF of ~ 20 kDa are generated from the 
immature holo-protein by an autocatalytic cleavage within the 7th hydrophobic domain (which is part of a 
large cytosolic loop) that occurs once PS1 (or PS2) is incorporated into the enzymatic complex  forming a 
dimer. The two aspartate residues critical for the activity of -secretase are located into the TM domains 6 
and 7; indeed, mutations of these residues lead to the complete inactivation of the enzyme (Kimberly et al., 
2000). Despite the cleavage of PS is autocatalytic, PS maturation needs other molecular partners and it is a 
saturable process. The accumulation of non-mature form of PS, called full length (FL) PS, leads to its 
proteasomal degradation. Because of this degradation, FL-PSs has a very short half-life, around 1.5 h, 
compared to half-life of 24 h of the mature form (Kim et al., 1997). 
 
 
FIGURE 41. Cartoon of the predicted membrane topology of PS1: demarcations for TMs are labelled in green, catalytic aspartates 
are highlighted in red, substrate recognition sequence PALP is shown in magenta (adapted form Li et al., 2012) 
 
As mentioned before, PSs are the catalytic core of the -secretase complex that cleaves APP generating A 
peptides of different lengths. Among them, the most hydrophobic and, thus, the most prone to aggregate is 
A To date, 185 mutations in PS1 and 13 in PS2 have been associated to the onset of FAD 
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(http://www.molgen.ua.ac.be). Initially, in different cell models and in transgenic mice carrying FAD-PS 
mutations, an increased production of A associated to an augmentation of the -secretase activity it has 
been reported, suggesting a gain-of-function mechanism of action for FAD-PS mutations (Scheuner et al., 
1996; Citron et al., 1997). Recently, however, studies in different experimental AD models have proposed a 
loss-of function of the -secretase activity linked to FAD-PS mutations. Indeed, these studies reported an 
increase only in the A42/A ratio, as a consequence of a drop in the production of A40, suggesting an 
overall decreased activity of the -secretase complex (Florean et al., 2008; Walker et al., 2005; Shimojo et 
al., 2007). This issue is still under debate, however it is a critical point in AD pathogenesis, since A42 is 
thought to initiate the oligomerization of all the Aspecies.  
Despite their well-established role in -secretase activity, PSs have also pleiotropic independent functions, 
ranging from regulation of Ca2+ homeostasis (see below), neurite outgrowth, apoptosis, autophagy, synaptic 
functions and tumorigenesis (reviewed in De Strooper and Annaert, 2010; De Strooper et al., 2012). 
 
4.4 The “amyloid cascade hypothesis”   
In the 1980s, AD associated amyloid plaques were first purified, clarifying their identity of multimeric 
aggregates of Aβ polypeptides containing about 40 aminoacid residues (Glenner and Wong, 1984). By 
cloning Aβ peptide complementary DNA (cDNA), it was demonstrated that Aβ is derived from APP (Tanzi 
et al. 1987). The APP encoding gene, localized on the long arm of chromosome 21, consists of 18 exons and 
undergoes tissue-specific splicing, generating different isoforms ranging from 365 to 770 aminoacids: the 
APP695 isoform is predominant in neurons (Matsui et al., 2007).  
The APP consists of a large extracellular portion, a hydrophobic TM domain and a short C-terminus that 
designates the APP intracellular domain (AICD). It is a member of the family of type I transmembrane 
proteins, which in mammals includes APP and the APP-like protein 1 and 2 (APLP1/2). These proteins 
contain different well conserved domains, particularly the extracellular domains E1 and E2 and the 
intracellular domain, while APP is the only one containing the Adomain. Despite this latter difference, the 
functions of the three proteins appear redundant, as demonstrated by combined KO studies (Wolfe and 
Guènette, 2007). Despite the fact that it is not clear which one is the primary function of these proteins, APP 
and APP-like proteins have been proposed to be involved in different cell processes: brain tropism, cellular 
adhesion, cell signalling, axonal transport, transcriptional regulation, synapse formation, neuronal plasticity, 
iron export and cell migration (reviewed in Guo et al., 2012). One explanation for such a heterogeneous set 
of functions can be found considering the extensive post-translational modifications of APP that lead to the 
generation of different peptides. Indeed APP can undergo glycosylation, phosphorylation, sialylation, 
and tyrosine sulfation, as well as many types of proteolytic processing to generate several peptide fragments. 
APP has been found in different subcellular compartments, e.g., ER, GA, PM, endosomes, autophagosomes 
and lysosomes and it (or its fragments) can be transported to mitochondria, cytosol, nucleus etc. (Reviewed 
in Muresan and Muresan, 2015).  
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APP can undergo two distinct and competitive maturation pathways, one amyloidogenic and the other non-
amyloidogenic (Thinakaran and Koo, 2008) (Figure 42). The latter is predominant and is mediated by the -
secretase cleavage in the 17th aminoacid of A peptide, generating: 
(1) a soluble N-terminal fragment, released in the extracellular space (sAPP),  
(2) a C-terminal fragment (C83), that remains bound to the membrane, further cleaved by the γ-secretase 
complex (see below) (Zhang et al., 2012).  
The amyloidogenic pathway is responsible for the generation of the toxic A peptide: APP is firstly cleaved 
by the -secretase at the 11th residue (so called β’ site) of the future A peptide, generating: 
(1) a soluble N-terminal fragment released in the extracellular environment (sAPP) 
(2) a C-terminal domain bound to the membrane (C99) (Cole and Vassar, 2007).  
C83 and C99 can be further processed by -secretase in the region corresponding to the TM domain of APP, 
generating: 
a.  from C83: an extracellular non-pathogenic peptide P3 and an intracellular AICD, that may 
migrate to the nucleus to regulate transcription 
b. from C99: the amyloidogenic A peptide, which is released in the extracellular space, and 
again an AICD (Thinakaran and Koo, 2008).   
 
 
FIGURE 42. Schematic representation of APP processing by secretases (Zheng and Koo, 2011). 
 
Of note, different cleavage sites for -secretase are present on APP, thus peptides of different lengths can be 
generated, ranging from 38 to 49 aminoacids. The most abundant is A40 while about 10% of the total is 
represented by A42, more hydrophobic and more susceptible to oligomerization. 
Three type I integral membrane proteins, called the α-disintegrin and metalloproteinase (ADAM) type 9, 10 
and 17, have been proposed to be components of the α-secretase. ADAMs belong to the zinc protease super 
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family and are implicated in the control of cytokine and growth factor shedding. ADAM10 is widely 
expressed in the brain and in other tissues and different evidence, both in cells (Kojro et al. 2001) and mice 
(Postina et al. 2004), shows that its over-expression is able to cause an increase in sAPPα levels, while 
reducing Aβ generation/plaque formation. Moreover, the expression of a catalytically-inactive form of 
ADAM10 increases the size and number of amyloid plaques in mouse brains (Postina et al. 2004). Thus, 
ADAM10 seems to be responsible for constitutive α-cleavage activity. Conversely, ADAM9 and ADAM17 
are more likely involved in the regulation of the α -cleavage of APP, since sAPPα generation is not affected 
in ADAM9/17 knockdown in cells or in ADAM9/17 KO mice, while the over-expression of ADAM9/17 
increases the level of sAPPα (Zhang et al, 2012). 
The protagonist in Aβ generation is the so called β-site APP cleaving enzyme 1 (BACE1), identified and 
characterized in 1999 (Sinha et al., 1999). Knocking out BACE1 prevents Aβ generation and completely 
abolishes Aβ pathology in mice expressing the Swedish mutation of human APP (Cai et al. 2001). BACE1 is 
a 501 amino acids type I transmembrane aspartyl-protease with its active site located on the luminal side of 
the membrane. It is predominantly expressed in perinuclear post-Golgi membranes, vesicular structures and 
PM (Ehehalt et al., 2002).  
The amyloid cascade hypothesis (Figure 43) proposes that neurodegeneration observed in AD is due to a 
series of events generated by the altered processing of APP and subsequent production of the A peptide 
(Hardy and Selkoe, 2002). Indeed, different studies have demonstrated that A42 is more susceptible to 
oligomerization and can form the initial nucleus for subsequent A40 deposition, leading to the formation of 
fibrils found in amyloid plaques (Chen and Glabe, 2006). Moreover, FAD-linked APP, PS1 and PS2 
mutations are able to promote the amyloidogenic pathway, favouring the APP processing mediated by 
and secretases. Different mechanisms have been proposed to explain the pathogenic activity of A, 
among them: alteration of Ca2+ homeostasis, mitochondrial and energy metabolism dysfunctions, formation 
of cationic channels on PM, oxidative stress due to ROS over-production, cytoskeletal and axonal transport 
alterations, inflammatory processes, increase susceptibility to pro-apoptotic and pro-necrotic stimuli (Parihar 
and Hemnani, 2004; Fiala, 2007; LaFerla et al., 2007; Gandy, 2005; Querfurth and LaFerla, 2010). 
However, since the number of senile plaques does not correlate with AD progression, and they are, indeed, 
also present in the brain of old healthy subjects, it has been proposed that Asoluble oligomers, and not the 
insoluble fibrils, are the toxic form at the basis of synaptic dysfunctions (Haass and Selkoe, 2007). The latter 
hypothesis is sustained mainly by the following evidence: 
(1) the level of soluble A forms correlates with the degree of cognitive impairment,  
(2) one of the best known process involved in memory formation, called long term potentiation (LTP), is 
inhibited by A soluble oligomers (Walsh et al., 2002), despite no proved mechanistic explanations 
has been found.  
Many possibilities are still open: plaques could represent inert aggregates of A, or they could form a 
reservoir of smaller, soluble species, or even they could sequester the oligomers, protecting the brain.  
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FIGURE 43. The amyloid cascade hypothesis (Hardy and Selkoe, 2002). 
 
4.5 The hyperphosphorylated tau hypothesis 
AD belongs to a group of neurodegenerative diseases collectively designated as ‘‘tauopathies’’, 
characterized by the mechanism of abnormally phosphorylated tau protein aggregation (Martin et al., 2011). 
Tau protein was identified in 1975 (Weingarten et al., 1975) as a microtubule-associated protein, able to 
stabilize the cytoskeleton. Exclusively found in higher eukaryotes, it is highly conserved, with a preferential 
expression pattern in neurons.  
Tau protein is characterized by four regions: an acidic region in the N-terminal part, a proline-rich region, a 
microtubule-binding domain containing “four repeat” domains and a C-terminal region. The phosphorylation 
site is a serine, located in the conserved consensus motif KXGS of each repeat domain (Ozer and Halpain, 
2000). Various kinases and phosphatases regulate tau phosphorylation, with each tau phosphorylation site 
subjected to the action of one or more protein kinases. This phosphorylation is the basic mechanism by 
which tau function is regulated. Tau kinases are grouped into three classes: proline-directed protein kinases 
(PDPKs), protein kinases non-PDPKs and protein kinases specific for tyrosines. The consequence of tau 
hyperphosphorylation is a decreased affinity for microtubules, which results in the destabilization of the 
neuronal cytoskeleton (Sengupta et al., 1998). Moreover, phosphorylation specifically promotes tau self-
aggregation (Martin et al., 2011).  
The “tau hypothesis” considers tau hyperphosphorylation as the initial event that causes tau accumulation as 
paired helical filaments that in turn aggregate into masses within nerve cell bodies (known as neurofibrillary 
tangles) and dystrophic neurites associated with amyloid plaques. Moreover cytoskeleton destabilization is 
well known to impair important cell functions, including axonal growth, vesicle and organelle transport as 
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well as nervous signal propagation along the nerve network (LaPointe et al., 2009). This hypothesis is 
supported by the fact that alterations in the expression and/or the activity of tau kinases such as GSK3β, 
CDK5, DYRK1A, p38 and CK1 have been reported in the brains of AD patients, suggesting that one or 
several of them could be involved in tau hyperphosphorylation (Chung, 2009). 
 
4.6 The “Ca2+ hypothesis” 
The pathogenesis of AD is very complex and involves many molecular and cellular events, including the 
accumulation of β amyloid and the hyperphosphorylation of tau. However, the poor correlation between 
senile plaques and A levels, together with the observation that plaques and NFTs appear evident only in late 
stages of the pathology, cast doubts about the validity of the two previously exposed hypotheses. Another 
mechanism has been proposed, suggesting an early, central role for Ca2+ in the pathogenesis of AD, leading 
to the formulation of the Ca2+ hypothesis (Figure 44). 
As discussed in the first part of the thesis, Ca2+ is one of the most important and versatile intracellular second 
messenger, particularly relevant at neuronal level, where processes such as excitability, neurotransmitters 
release, long term synaptic plasticity and gene transcription depend on intracellular [Ca2+] (Berridge, 1998). 
The Ca2+ hypothesis proposes that neurodegeneration observed in AD is due to a sequence of events linked 
to alterations in intracellular Ca2+ handling.  
 
 
FIGURE 44. Scheme of possible links between Ca2+ handling alterations and AD (Yu et al., 2009). 
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Mutations in PSs have been variably correlated to alterations in Ca2+ signalling and different molecular 
targets have been identified, suggesting a physiological role for these proteins in Ca2+ homeostasis. In 1988 
Khachaturian firstly proposed sustained alterations in Ca2+ homeostasis as responsible for AD degeneration. 
After few years, evidence supporting this hypothesis was provided: studies in fibroblasts from asyntomathic 
but FAD-PS expressing patients, reported an increased IP3-mediated Ca2+ release from the ER, suggesting 
alterations in Ca2+ homeostasis as an early event in AD pathogenesis (Ito E. et al., 1994; Etcheberrigaray R. 
et al., 1998). These studies represent the starting points of what will become the “Ca2+ overload” hypothesis. 
This hypothesis sustains the idea that FAD-linked PS mutations, by increasing stored Ca2+ content, cause 
excessive Ca2+ release from the ER, increase sensitization to Aβ and produce exocitotoxic stimuli, eventually 
leading to cell death via Ca2+-dependent mechanisms (Zampese et al., 2009). 
Different data (reviewed in Honarnejad and Herms, 2012) support this hypothesis: 
(1) different FAD-PS1 cell models, including neurons, and FAD-PS1 transgenic mice present an 
increased ER Ca2+ release upon activation; 
(2) FAD-PS1 and FAD-PS2 mutations induce a potentiation of ER Ca2+ release from RyRs, probably 
due to an increased expression level of the RyR itself; 
(3) FAD-PS1 and FAD-PS2 mutations increase ER Ca2+ release via IP3; 
(4) wt PS holoprotein forms passive Ca2+ leak channels on planar lipid bilayers and FAD-PS mutants 
impaire this leak activity, leading to an increased ER Ca2+ content. 
Recently, conflicting data against the Ca2+ overload hypothesis, together with alternative explanations of old 
data, emerged, thus opening a new scenario. In particular, new studies prove that: 
(1) An increase in the ER Ca2+ release is observed also in the absence of ER Ca2+ overload, due to the 
hyperactivity of ER releasing Ca2+ channels (Cheung et al., 2008; Green et al., 2008; Cheung et al., 
2010). 
(2) FAD-linked PS1 mutations lead to an unchanged, or even attenuated, ER Ca2+ level (McCombs et 
al., 2010). 
(3) No evidence, in agreement with predictions made by the hypothesis that PS1 holoproteins function 
as ER Ca2+ leak channels, was found (Shilling et al., 2012) 
(4) The FAD-linked PS2 mutations M239I and T122R reduce Ca2+ release in both fibroblasts from FAD 
patients and cell lines stably or transiently expressing the PS2 mutants (Zatti et al., 2004; Giacomello 
et al., 2005).  
(5) [Ca2+] measurements in different cell lines expressing FAD-linked PS1 mutations do not show an 
increase in the Ca2+ level in the ER and GA (Zatti et al., 2006); on the contrary, expression of FAD-
linked PS2 mutations causes a reduction in [Ca2+] within the stores, due to the inhibition of the 
SERCA pump (Zatti et al., 2006; Brunello et al., 2009). Recently in our laboratory, it has also been 
demonstrated that neurons from FAD-PS2 transgenic mice present a reduced Ca2+ response to IP3-
generating stimuli, but an increased one to the RyR activator caffeine (Kipanyula et al., 2012);  
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Although the impairment in store Ca2+ handling seems a common effect of a heterogeneous group of FAD-
linked PS mutations, the absence of an ER Ca2+ overload suggests that the enhanced Ca2+ release, reported 
before upon expression of various FAD-linked PSs, might depend on different mechanisms, not linked to an 
increased amount of Ca2+ within the stores (Zampese et al., 2009).  
Moreover, PSs have been reported to physically interact with SERCA2b, IP3Rs and RyRs (reviewed in 
Honarnejad and Herms, 2012), thus revealing a complex and multifaced role of PSs in the modulation of 
Ca2+ homeostasis. Some attempts to clarify the PSs role in Ca2+ homeostasis have been carryied out using 
MEF cells double KO for both PS1 and PS2. However, inconsistent results have been obtained, describing 
either attenuated (Kasri et al., 2006) or amplified (Tu H. et al., 2006) Ca2+ release from the ER.  
Furthermore, an enrichment of PSs at Mitochondria-Associated Membrane (MAM) level has been recently 
reported (Area-Gomez et al., 2009). Since mitochondria are often called into question as involved in AD 
pathogenesis, our group has investigated the role of PSs in mitochondria-ER Ca2+ connection. We showed 
that over-expression of PS2, but not PS1, is able to increase the mitochondrial Ca2+ transfer from the ER, 
while PS2 knockdown reduces it. Indeed, when PS2 is over-expressed, an increase in mitochondrial-ER 
contacts occurs, which in turn could exacerbate neuronal dysfunction, stimulating apoptosis. However, the 
increase in organelles’ contacts could have instead a protective role, mitigating the energetic defect linked to 
the partial ER Ca2+ depletion associated to PS2 over-expression (Zampese et al., 2011).  
In addition to the Ca2+ handling impairment described so far and the modulation of CCE that will be 
discussed below, other mechanisms have been implicated in PSs-linked FAD pathogenesis, on the basis of 
their either physical or functional interaction with proteins involved in cellular Ca2+ handling (Zampese et al., 
2009), such as sorcin (Pack-Chung et al., 2000), calsenilin (Buxbaum et al., 1998) and calcindin (Guo et al., 
1998). Moreover, mRNA levels of several genes involved in the maintenance of Ca2+ homeostasis are altered 
in cerebral tissue from AD patients (Emilsson et al., 2006). 
As reported before, amyloid metabolism can influence synaptic plasticity and neuronal apoptosis. According 
to the Ca2+ hypothesis, these cellular events are due to the remodelling of Ca2+ signalling through two main 
pathways:  
(1) A oligomers trigger Ca2+ entry through different proposed mechanisms: the formation of cationic 
channels in PM, the direct/indirect activation of PM Ca2+ channels, or the peroxidation of membrane 
lipids that results in the disruption of the membrane integrity (Berridge, 2012). 
(2) A oligomers increase Ca2+ release from ER, through three proposed mechanisms:  
a. Enhancing the sensitivity and gating of IP3R and RyR channels (Demuro and Parker, 2013; 
Oules et al., 2012); 
b. Increasing the expression of RyRs (Supnet et al., 2006);  
c. Altering the IP3/DAG pathway, by destabilizing the phosphatidylinositol-4,5-bisphosphate 
metabolism (Berman et al., 2008).  
Recently, in our lab, using different Ca2+ probes to monitor [Ca2+]c and [Ca2+]ER in cortical neurons, it has 
been shown that: 
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 acute application of Aβ42 (monomers or oligomers) at near-physiological levels (0.5-1 µM) does not 
cause neither Ca2+ influx nor Ca2+ release; 
 incubation of neurons with Aβ42 oligomers (0.5 μM) causes the reduction of Ca2+ release mediated 
by IP3-generating agonists, while increasing Ca2+ release mediated by caffeine (a RyR agonist). Both 
effects do not depend on alterations of the total store Ca2+ content (Lazzari et al., 2014). 
Finally, Aβ is reported to affect LTP by interfering with NMDA and AMPA receptors (two ionotropic 
glutamate receptors) activity (Haass and Selkoe, 2007; Querfurth and LaFerla, 2010).  
The data reported suggest the possibility of an interconnection between the “amyloid cascade” and the “Ca2+ 
hypothesis” in AD pathogenesis. 
Recently, also a single nucleotide polymorphism in CALHM1 (a newly discovered Ca2+ channel) has been 
reported to modulate the permeability of the channel to Ca2+; CALHM1 polymorphism has been considered a 
risk factor for sporadic AD (Dreses-Werringloer et al., 2008), although different recent studies argued 
against this finding (reviewed in Supnet and Bezprozvanny, 2010). 
All the described evidence makes the AD Ca2+ hypothesis an interesting field to explore, in order to unravel 
the cellular alterations taking place in the initial stages of the pathology. Indeed, despite many efforts have 
been done to clarify these processes, a huge debate is still open, requiring further deeper investigations. 
 
5. Capacitative Ca2+ entry 
As extensively discussed in the introduction of PART-I, two are the main mechanisms causing [Ca2+]c rises: 
the release of Ca2+ from intracellular Ca2+ stores and the influx of Ca2+ from the extracellular space. The 
latter mechanism represents, in non-excitable cells, the so called Capacitative Ca2+ Entry (CCE) or Store-
Operated Ca2+ Entry (SOCE). Its activation involved different steps (Figure 45): 
(1) A stimulus, such as a hormone or neurotransmitter, triggers the release of Ca2+ from the ER, through 
IP3Rs o RyRs. An alternative pathway to empty the store is the inhibition of SERCA pump that 
prevents ER Ca2+ re-entry. 
(2) A sensor, called STIM (STromal Interaction Molecule), is able to sense the [Ca2+]ER thanks to its EF-
domain. Ca2+ release from the ER decreases the concentration of this ion in the organelle, which is 
sensed by STIM that thus oligomerizes. 
(3) STIM, moving along microtubules, reaches the PM, where it forms punctae interacting with Orai (or 
CRAC channel, where CRAC means Ca2+ release-activated Ca2+), a protein located in the PM and 
able to form a Ca2+-channel. In particular, four Orai1 molecules create the pore-forming subunit of 
the channel that opens upon stimulation by STIM1, via interaction of the C-terminus of STIM1 with 
the N-terminus of Orai1 (Lewis, 2007).  
(4) Ca2+ enters the cell and refills the ER (Clapham, 2007).  
Mutations in the main actors of CCE, STIM and Orai, are associated with severe phenotypes in both animals 
and humans: e.g., Severe Combined ImmunoDeficiency (SCID) syndrome is due to mutation in Orai1 or 
STIM1 genes (Feske, 2009). 
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Many regulators (scaffolds, Ca2+ binding-proteins and chaperones) has been reported to interact with STIM 
and Orai, to finely tune their activities (reviewed in Shim et al., 2014). Moreover, CCE is inhibited by an 
intrinsic negative feedback called CDI (Ca2+-dependent inactivation), whose molecular mechanism is still 
poorly understood (Muik et al., 2012).  
 
 
FIGURE 45. Model for STIM1 activation and coupling to Orai1 (Muik. et al., 2012). 
 
Recently, it has also been reported that CCE activation occurs properly only if mitochondrial Ca2+ uptake is 
functional. Indeed, by knocking down MCU and UCP2, it has been shown that mitochondrial ability of 
shaping IP3-generating Ca2+ microdomains is essential to trigger STIM1 oligomerization. Moreover, it has 
also been reported that the mitochondrial buffering of Ca2+ influx is crucial for the maintenance of SERCA-
inhibition-induced CCE (Deak et al., 2014). 
Furthermore, recently, it has been demonstrated that other Ca2+ influx pathways are regulated by ER/SR Ca2+ 
depletion, involving Orai and STIM. Two studies (Park et al., 2010; Wang et al., 2010) reported an 
interesting role of STIM1 in the regulation of a particular type of VOCCs, called Cav1.2. The latter is an L-
type channel expressed in neurons, heart and skeletal muscle, excitable tissues in which CCE is supposed to 
have a marginal role in the regulation of [Ca2+]C. Both studies reported that over-expression of STIM1 
inhibits Cav1.2, while its knockdown enhanced Cav1.2 activity. Whang and colleagues speculate an 
involvement of Orai1 in this pathway. Recently, also another type of VOOCs, the T-type (essential in 
cardiomyocytes) is reported to be inhibited by STIM1 (Nguyen et al., 2013). These discoveries underline the 
possibility that, upon ER/SR depletion, STIM and Orai play different roles in excitable and non-excitable 
cells, inhibiting VOCCs in the former, while activating CCE in the latter. 
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5.1 STIM 
STIM1 was firstly identified as regulator of CCE in 2005 (Liou et al., 2005; Roos et al., 2005). Two forms of 
STIM are present in mammals, called STIM1 and STIM2. STIM1 is required for CCE activation, while 
STIM2 seems to be needed to maintain the correct [Ca2+]ER (Kar et al., 2012). STIM2 derives from an 
alternative translation of STIM1 and both are ubiquitously expressed in human tissues.  
STIM1 is a 77 kDa phosphoprotein, and includes a single TM domain located in the ER in resting cells. 
Structurally it can be divided in: 
(1) an N-terminal part, located in the ER, and formed by a single EF-hand Ca2+-binding motif acting as a 
luminal ER Ca2+ sensor (Liou et al., 2005) and a SAM (Sterile Alpha Motif) domain that regulates 
STIM oligomerization occurring after [Ca2+]ER depletion (Baba et al., 2006). The EF-hand Ca2+ 
affinity is around 200 µM for STIM1 and around 400 µM for STIM2, making STIM2 more sensitive 
to changes in ER Ca2+ content (Brandman et al., 2007). Moreover, STIM2 EF-domain has slower 
unfolding and aggregation kinetics, making this protein less efficient in triggering CCE (Zheng et al., 
2008; Stathopulos et al., 2009). 
(2)  A single pass TM motif, which is one of the most conserved part between the two STIM isoforms 
(Williams et al., 2001), which separates the N-terminal from the C-terminal part. 
(3) The C-terminal part organized in different modules: 
a.  A domain of the cytosolic loop (located at the C-terminus) of STIM1, also called CAD 
(CRAC activation domain) or coiled-coil domain, responsible for Orai1 binding and 
activation. CAD is a dimer that comprises two regions, called CC2 and CC3. One recent 
model suggests that CC2 domain interacts with Orai1, triggering CAD dimerization and a 
STIM1 structural modification in order to accommodate Orai1 (Stathopulos et al., 2008). 
b. Another domain located near the CAD, called CC1, reported to play an inhibitory role in 
STIM1 activation. A model proposes that, upon ER Ca2+ depletion, CC1, normally not self-
associated, dimerizes, triggering the release of CAD from CC1, and allowing CAD to 
interact with Orai1 (Zhou et al., 2013).  
The C- terminus of the protein is crucial for CCE activation, since it mediates the interaction with 
Orai1 and the PM thanks to its enrichment in polybasic residues. This part of the molecule is highly 
divergent between STIM1 and STIM2, since the latter contains a strong ER retention signal and less 
affinity for Orai1 binding, underlying the functional difference between the two proteins (Shim et al., 
2015).  
 In resting cells, STIM1 is a dimer uniformly distributed within the ER membrane, and binds to the 
microtubule-plus-end-tracking-protein EB1, at whose sites microtubule ends contact the ER (Grigoriev et al, 
2008). The decrease in [Ca2+]ER causes a conformational change in STIM1 that oligomerizes, forming 
clusters, called punctae, nearby the PM (Liou et al., 2007). The proper composition and molecular identity of 
the ER domains associated to PM is still poorly understood, while it is known that the domain responsible for 
STIM localization at those site are polybasic sequences present in the C-terminus of both STIM1 and STIM2 
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(Zhou et al., 2013). STIM1 is temperature-sensitive: above 37°C, STIM1 moves into the ER-PM junction, 
activating CCE, while over 37°C, STIM1 forms clusters, inhibiting CCE activation. Other factors regulate 
STIM1 activation: S-glutathionylation of a cysteine in position 56 (close to the EF-hand domain) causes 
CCE activation independently from ER/SR depletion; hypoxia, with the consequent cytosolic acidification, 
induces the uncoupling of STIM1 and Orai (Muik et al., 2012). 
 
5.2 Orai 
In 2006 another molecular component of CCE was discovered: Orai1 (Feske et al., 2006; Vig et al., 2006; 
Zhang et al., 2006). Indeed, it is the direct molecular interactor of STIM1 (Cahalan, 2009). Orai1 is the pore 
forming subunit of the CRAC channel and consists of 4 TM domains and N- and C-termini able to interact 
with STIM1. The TM1 and in particular the aminoacid E106, forms the central part of the pore (McNally et 
al., 2009; Zhou et al, 2010). The functional CRAC channel is a tetramer of Orai1, while in resting conditions 
it is organized in six subunits, in which TM domains are located concentrically around the TM1 pore. TM2 
and TM3 has been proposed to surround TM1, while TM4 seems to be the lipid exposed segment. Further 
structural investigations reveal that the middle region of Orai1 host the idrophobic region and the gating site, 
while the cytoplasmic membrane proximal N-terminus contains several basic residues as well as the CAD-
binding site of STIM1 (McNally et al., 2009). These basic residues have been proposed to coordinate anions 
in order to keep the channel close at resting conditions (Hou et al., 2012).  
The C-terminus of Orai1 has been reported to interact with STIM via coiled-coil packing (Stathopulos et al., 
2010), while less is known about the interaction site of STIM1 with the Orai1 N-terminus, which seems to be 
involved in the channel gating since it is enrich in positive charges (Li et al., 2007). 
Three forms of Orai are known, called Orai1, Orai2, and Orai3. Less is known about the latter two, but it 
seems they can also form a STIM-responsive CRAC channel. However, overexpression of both STIM1 and 
Orai3 is not linked to an increase in CCE activation (phenomenon that happened with the co-overexpression 
of STIM1 and Orai1 or Orai2), but it can rescue the CCE decrease due to Orai1 knockdown (Mercer et al., 
2006). Orai1 is inhibited by 2-APB (2-amonoethyldi-phenyl borate), but Orai2 and Orai3 show different 
sensitivity to this compound. Also different sensitivities to the inhibitory mechanism CDI (that seems to be 
mediated by the second cytosolic loop of Orai) are reported: Orai 3 is rapidly inactivated by CDI, while 
Orai2 and Orai1 are less sensitive, in this order, to this mechanism (Muik et al., 2012). Finally, Orai channels 
show permeability to other cations (as Ba2+ and Na2+) and differences in permeability has been found 
between the three isoforms (see Lis et al., 2007). 
 
5.3 Presenilins and CCE 
Different FAD-linked PS1 mutations have been reported to alter CCE:  
(1) M146L mutation was demonstrated to decrease CCE in MEFs (Yoo et al., 2000) and HeLa cells 
overexpressing the mutant PS1 and in human FAD fibroblasts carrying the mutation (Zatti et al., 
2006); 
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(2) M146V is associated to a CCE reduction in knock-in transgenic mice (Leissering et al., 2000); 
A246E is ineffective in SH-SY5Y overexpressing cells, while it decreases CCE in HeLa cells (Zatti 
et al., 2006) and also in M146V transgenic mice (Hermes et al., 2003); 
(3) HeLa cells overexpressing the L286V mutation show decreased CCE (Zatti et al., 2006); 
(4) delta E9 PS1 expression in SH-SY5Y causes a diminished CCE (Smith et al., 2002); 
(5) Human P117L-FAD fibroblasts show no alteration in CCE, but the overexpression of the PS1 mutant 
exerts an inhibitory effect in HeLa cells (Zatti e al., 2006);  
(6) MEFs overexpressing the loss of function D257E and D385A mutations show increased CCE (Yoo 
et al., 2000).  
PS2-FAD mutants as well have been reported to modify CCE:  
(1) T122R expression is reported to cause a CCE reduction in HeLa (Zatti et al., 2006), HEK293 cells 
and human FAD fibroblasts (Giacomello et al., 2005), but not in SH-SY5Y cells (Zatti et al., 2006);  
(2) in MEF cells (Yoo et al., 2000) and in HeLa cells (Zatti et al., 2006), the expression of the N141I 
mutation induces a decrease in CCE;  
(3) M239I expression causes a decreased CCE when overexpressed in HeLa cells (Zatti et al., 2006) but 
it is without effect in human FAD fibroblasts (Zatti et al., 2004); 
(4) The loss of function D366A mutation expression causes a decrease in CCE in HeLa overexpressing 
cells. Since this mutant form of PS2 lacks a key aspartate residue, preventing the endoproteolysis of 
PS2 (meaning its impossibility to become part of γ-secretase complex), this PS2 effect on CCE is 
likely independent from γ-secretase activity (Zatti et al., 2004). 
Moreover, Ca2+ imaging in SH-SY5Y cells and primary neurons reveals that CCE is attenuated upon 
expression of FAD-linked PS1 and PS2 mutations, while it is potentiated as a result of PS KO or deficiency 
(Yoo et al., 2000; Herms et al., 2003). Finally, Bojarski et al. found increased expression levels of STIM1 
and decreased level of STIM2 in PS-DKO MEFs and patient-derived B-lymphocytes expressing FAD-PS 
mutations (Bojarski et al., 2009). 
Altogether, the results reported so far, with just few exceptions, are consistent with the idea that PSs are 
negative modulator of CCE. Further investigations are needed to better understand the molecular 
mechanisms at the basis of this phenomenon, and also to address the pathophysiological role of such 
alterations in neurons. The recently reported inhibitory effect of STIM1 on VOCCs is an interesting open 
perspective that could shed new light on the role of PSs on CCE. 
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Aim of the work 
 
Alzheimer’s disease (AD) is the most frequent form of dementia. A small percentage of cases is inherited 
(Familial AD, FAD) and is due to dominant mutations on three genes, encoding for Amyloid Precursor 
Protein (APP), Presenilin-1 (PS1) and Presenilin-2 (PS2). PS1 and 2 are the catalytic core of the γ–secretase 
complex, an enzyme involved in the process of amyloid plaques generation, but they are also involved in 
other γ–secretase-independent processes, such as Ca2+ homeostasis, protein trafficking, cell adhesion and 
autophagy. Beside the amyloid and tau hyperphosphorylated hypothesis, different studies reported a role for 
FAD-linked PS mutations in cellular Ca2+ alterations, often independently from γ–secretase activity. Ca2+ is a 
key second messenger in living cells that regulates a multitude of cell functions, and alterations in its 
signalling cascade can be detrimental for cell fate. Despite many efforts have been done in the last years, the 
role of PSs in Ca2+ homeostasis is still debated among the scientific community. To contribute on this topic, 
the second part of the thesis presents data on the characterization of the role played by PSs in AD Ca2+ 
dyshomeostasis. To address this issue we used a single cell analyses approach, employing different 
organelle-targeted Cameleon probes. In particular, a cytosolic FRET-based probe, Cameleon D3cpV, was 
used to perform a single cell analysis evaluating how CCE is influenced by wild type or mutated PSs 
overexpression in SH-SY5Y neuroblastoma cell line. Moreover, alterations in CCE in human fibroblasts 
derived from PS-FAD patients, compared to healthy controls, have been investigated.  
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Results 
6. Presenilins effect on CCE 
 
6.1 SH-SY5Y cells expressing different PSs show a decreased CCE 
Different FAD-linked PS1 and PS2 mutations has been reported to alter (generally decrease) CCE in 
different cell types; on the contrary, CCE is potentiated as a result of PSs KO or deficiency (Yoo et al., 
2000; Herms et al., 2003). These results were obtained by using chemical Ca2+ probes or they were carried 
out in cell population, employing Aequorin.  
The aim of the present investigation was to define whether CCE is altered in a neuroblastoma cell line 
expressing FAD-linked PSs, employed a single-cell analysis. To this end, we transfected SH-SY5Y cells 
with the FAD-linked PS1A246E, or PS1wt, and with the PS2T122R mutation, or PS2wt, or a void vector, as 
a control. Changes in [Ca2+]c were monitored using the FRET-based genetically encoded Cameleon probe 
D3cpV. To investigate the influence of the PSs, wt or FAD mutated, on CCE, ER Ca2+ depletion was 
induced by pre-incubating cells for 7 minutes in extracellular buffer, without Ca2+ and supplied with a Ca2+ 
chelator (EGTA, 600 μM), and an irreversible SERCA-pump inhibitor (thapsigargin, 100 nM). The induced 
ER Ca2+ depletion is able to trigger STIM1 redistribution into ER puncta close to the PM, where it activates 
Orai1. Upon 1.5 mM CaCl2 addition, CCE was detected as a large [Ca2+]i increase.  
Figure 45A shows [Ca2+]c changes as a ratio of the fluorescence intensity of the acceptor (cpV) and the donor 
(CFP), normalized to baseline (R/R0), in representative experiments carried out in SH-SY5Y cells 
overexpressing either PSs wt or FAD-linked PS1A246E/PS2T122R. The CCE average peak height was 0.91 
± 0.06 in controls (mean±SEM, N=16 number of cells analyzed), 0.59±0.04 in PS1 wt overexpressing cells 
(N=21), showing a reduction of 35% compared to controls (p<0.01); 0.60±0.08 in cells expressing 
PS1A246E (N=16, -33%, p<0.01); 0.65±0.045 in PS2wt (N=27,-28%, p<0.01) and 0.579±0.08 in PS2T122R 
(N=14, -36%, p<0.01) (Figure 46B). In addition to the CCE peak, also the rate influx has been evaluated and 
calculated, as maximal derivative of the peak. Similarly, a decrease in the CCE rate has been observed upon 
PSs expression: 0.086 ± 0.009 in controls  (N=16), 0.056 ± 0.005 in PS1wt overexpressing cells (N=21), 
corresponding to a reduction of 34% compared to controls (p<0.01); 0.06 ± 0.007 in cells expressing 
PS1A246E (N=16, -30%, p<0.05); 0.062 ± 0.007 in PS2wt (N=27, -28%, p<0.05), and 0.045 ± 0.009 in 
PS2T122R (N=14, -48%, p<0.01) (Figure 46C).  
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FIGURE 46. PSs overexpression in SH-SY5Y cells induces a reduction in CCE. (A) Representative traces of a typical experiment 
performed in SH-SY5Y cells transfected with void vector (blue), PS1wt (violet), PS1A246E (yellow), PS2wt (green) and PS2T122R 
(red). Cells expressing the D3cpV Ca2+ probe were first treated with thapsigargin (100 nM) in Ca2+-free, EGTA-containing medium, 
to deplete the stores, and then perfused with a medium containing 1.5 mM CaCl2, to visualize CCE, as indicated by top bars. Data are 
plotted as R/R0. (B) The histogram shows the average of CCE peak (measured as difference between peak and basal level) for 
each condition. (C) The histogram shows the average of CCE rate for each condition (* p<0.05; ** p<0.01; *** p<0.0001). Data are 
presented as mean±SEM of N≥14 cells. 
 
It is well known that differences in PM potential strongly affect the rate and extent of CCE by altering the 
driving force for Ca2+ entry (Penner et al., 1993). To nullify differences in membrane potential that could be 
present in cells differentially transfected, CCE experiments have been carried out using the same protocol 
described in Figure 45 but with cells perfused with a medium where NaCl was iso-osmotically substituted by 
KCl (K+-based medium). Under these conditions, the membrane potential collapsed and differences among 
cells mostly abridged. Since in this condition the driving force for Ca2+ is decreased, the [Ca2+] used to 
visualize CCE was doubled respect to the previous experiment (from 1.5 to 3 mM). The CCE average peak 
height and rate were then measured in SH-SY5Y cells transfected with the indicated constructs. Also in this 
condition, the two parameters are reduced upon PSs expression: CCE peaks height was 0.71±0.03 in controls 
(N=16), 0.48±0.06 in PS1wt overexpressing cells (N=16, -32%, p<0.01); 0.53±0.04 in cells expressing 
PS1A246E (N=17, -25%, p<0.01); 0.45±0.08 in PS2wt (N=9, -36%, p<0.01) and 0.42±0.04 in PS2T122R 
(N=11, -41%,p<0.0001) (Figure 47B). Similarly, a decrease in the CCE rate has been observed: a rate of 
0.06±0.01 in controls (N=16), 0.03±0.004 in PS1wt overexpressing cells (N=16, -52%, p<0.01); 0.04±0.003 
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in cells expressing PS1A246E (N=17, -40%, p<0.05); 0.03±0.005 in PS2wt (N=9, -50%, p<0.05) and 
0.03±0.007 in PS2T122R (N=11, -46% compared to controls, p<0.05) (Figure 47C). 
 
 
FIGURE 47. PSs overexpression in SH-SY5Y cells induces a reduction in CCE in a K+-based medium. (A) Representative traces of 
a typical experiment performed in SH-SY5Y cells transfected with void vector (blue) PS1wt (violet), PS1A246E (yellow), PS2wt 
(green) and PS2T122R (red). Cells expressing the D3cpV Ca2+ probe were first treated with thapsigargin (100 nM) in Ca2+-free, 
EGTA-containing K+-based medium, to deplete the stores, and then perfused with a medium containing 3 mM CaCl2, to visualize 
CCE, as indicated by top bars. Data are plotted as R/R0. (B) The histogram shows the average of CCE peak for each condition. 
(C) The histogram shows the average of CCE rate for each condition (* p<0.05; ** p<0.01; *** p<0.0001). Data are presented as 
mean±SEM of N≥9 cells. 
 
6.2 Human primary fibroblasts from patients carrying the FAD-associated PS1A246E or PS2N141I 
mutation show a decreased in CCE. 
 
To validate the results obtained in neuroblastoma cells overexpressing FAD-linked PSs, human skin 
fibroblasts from patients carrying the PS1A246E or the PS2N141I FAD-linked mutation in heterozygosis, 
and aged-matched controls form healthy individuals, have been analyzed. Fibroblasts have been 
electroporated with the cDNA for the cytosolic Cameleon D3cpV and CCE activation was induced using the 
same protocol employed for the SH-SY5Y cell line. 
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Figures 47A and 48A show [Ca2+]c changes, as ratio normalized to baseline (R/R0), in representative 
experiments carried out in human fibroblasts from controls and FAD patients. As far as FAD-PS1 mutation 
is concerned, the CCE average peak height measured was: 0.89±0.09 in controls (N=14) and 0.51±0.06 in 
PS1A246E fibroblasts (N=14), showing a reduction of 42% compared to controls (p<0.01) (Figure 48B). 
Similarly, a decrease in the CCE rate has been observed: 0.15±0.02 in controls (N=14) and 0.08±0.015 in 
PS1A146E fibroblasts (N=14), meaning a reduction in rate of 46% (p<0.05) (Figure 48C).  
 
 
FIGURE 48. Human fibroblasts from a FAD patient carrying the PS1A246E mutation show a reduction in CCE. (A) Representative 
traces of a typical experiment performed in control fibroblasts (blue) and fibroblasts carrying the PS1A246E mutation (red). Cells 
expressing the D3cpV Ca2+ probe were first treated with thapsigargin (100 nM) in Ca2+-free, EGTA-containing medium, to deplete 
the stores, and then perfused with a medium containing 1.5 mM CaCl2, to visualize CCE, as indicated by top bars. Data are plotted as 
R/R0. (B) The histogram shows the average of CCE peak for each condition. (C) The histogram shows the average of CCE rate for 
each condition (* p<0.05; ** p<0.01; *** p<0.0001). Data are presented as mean±SEM of N=14 cells. 
 
Then, the analysis was extended to fibroblasts from a FAD patient carrying the PS2N141I mutation, together 
with fibroblasts from three different age-matched healthy controls, allowing us to take into account also the 
inter-individual variability in CCE. The measured CCE average peak height was the following: the first 
control (named ctrl) has a peak of 0.47±0.04 (N=17); the second one (named ctrl bis), 0.44±0.03 (N=17); the 
third control (named ctrl ter), 0.49±0.05 (N=17); since no significant difference was observed between 
controls, CCE peaks heights were averaged, giving a mean value of 0.47±0.04 (N=51). CCE average peak 
height in PS2N141I was 0.33±0.04 (N=15), thus showing a reduction of around 30% compared to averaged 
controls (p<0.01) (Figure 49B). The CCE rate was also calculated: 0.05±0.006 for the first control (N=17); 
0.037±0.005 for control bis (N=17); 0.037±0.005 for control ter (N=17). A tendency to a reduction (-25%, 
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but not statistically significant) is thus observed in fibroblasts control bis and ter, compared to the first 
control. The mean CCE rate value for controls was 0.04±0.003 (N=51). In PS2N141I fibroblasts the 
calculated CCE rate was 0.023 ± 0.003 (N=15), showing a reduction of around 44% compared to the 
averaged value of controls (p<0.01) (Figure 49C).  
 
 
FIGURE 49. Human fibroblasts from a FAD patient carrying the PS2N141I mutation show a reduction in CCE. (A) Representative 
traces of a typical experiment, performed as described in figure 43, in control fibroblasts (dark blue for ctrl, blue for ctrl bis and cyan 
for ctrl ter) and fibroblasts carrying the PS2N141 mutation (red). (B) Left: The histogram shows the average of CCE peak for each 
condition. Right: The histogram shows the CCE peak mean value for the different controls (blue) and for PS2N141I fibroblasts 
(red). (C) Left:  The histogram shows the average of CCE rate for each condition. Right: The histogram shows the CCE rate mean 
value for the different controls (blue) and for PS2N141I fibroblasts (red); (* p<0.05; ** p<0.01; *** p<0.0001). Data are presented as 
mean±SEM of N≥15 cells. 
 
As for SH-SY5Y cells, a K+-based medium was employed to ensure that differences observed in CCE 
peaks/rate in human fibroblasts do not depend on different potential across the PM. However, the presence of 
L-type VOCCs and the activation of a not well-defined K+-exchanger in these latter cells (data not shown), 
prevented the possibility of collapsing membrane potential. 
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6.3 PSs overexpressing SH-SY5Y cells and PS1A246E/PS2N141I human FAD fibroblasts show a 
decreased STIM1 protein level 
 
Two proteins have been identified as major players in CCE: STIM1, the ER Ca2+ sensor, and Orai1, the pore 
forming subunit of the CRAC channel in PM. Increased expression levels of STIM1 has been reported in PS-
DKO MEFs and FAD-PSs patient-derived B-lymphocytes (Bojarski et al., 2009). To check whether 
alterations in the expression level of STIM could be involved in the CCE attenuation observed upon PSs 
expression, STIM1 protein level has been evaluated by Western blot in SH-SY5Y cells expressing the void 
vector, controls, or different PSs: a significant decrease in the protein level, compared to controls, was 
observed in all the different conditions: -21% in PS1wt (p<0.05), -45% in PS1A245E (p<0.05) and around 
-50% in PS2wt and PS2T122R (p<0.05) overexpressing cells (N=4). Similarly, a reduction of around 40% in 
STIM1 protein level has been measured in PS1A246E-FAD fibroblasts compared to controls (p<0.05, N=3) 
and a reduction of around 43% (p<0.0001) was found in PS2N141I fibroblasts compared with averaged 
controls (N≥5) (Figure 50). 
 
FIGURE 50. SH-SY5Y cells expressing different PSs and human FAD fibroblasts show a reduction in STIM1 protein level. (A) SH-
SY5Y cells were transfected with the void vector (ctrl), PS1wt, PS1A246E, PS2wt, PS2T122R cDNAs. 24 hrs after transfection, 
total proteins were extracted and subjected to Western blot with antibodies anti-STIM1, and anti-actin as loading control. Left: 
representative blot. Right: Quantification of STIM1 normalized to actin. (B) Total proteins from FAD-PS1A246E fibroblasts, and 
control fibroblasts from an age-matched heathy individual, were extracted and subjected to Western blot as in A. Left: representative 
blot. Right: Quantification of STIM1 normalized to actin. (C) Total proteins from FAD-PS2N141I fibroblasts, and control fibroblasts 
from three age-matched heathy individuals, were extracted and subjected to Western blot as in A. Left: representative blot. Middle: 
Quantification of STIM1 normalized to actin. Right: Quantification of STIM1 normalized to actin and averaging the three controls (* 
p<0.05; ** p<0.01; *** p<0.0001). Data are presented as mean±SEM of N≥4 independent experiments. 
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Discussion 
The aim of this project is to characterize the role of FAD-linked PSs mutations in the regulation of Ca2+ 
homeostasis. Indeed, beside the amyloid and tau hyperphosphorylated hypothesis, different studies reported 
that FAD-linked PSs are able to induce cellular Ca2+ alterations, independently from γ-secretase activity. 
Ca2+ is a key second messenger in living cells that regulates a multitude of cell functions, particularly 
essential in neuronal development, synaptic transmission and plasticity, as well as in the regulation of 
various metabolic pathways at the brain level. In the last decades, abnormalities in Ca2+ signaling are 
emerging as critical features in the pathogenesis of a wide range of neurodegenerative disorders, including 
AD (review in Mattson et al., 2000). Despite many efforts have been done in the last years, the role of PSs in 
Ca2+ homeostasis is still debated: increased, decreased and unchanged Ca2+ responses have been reported in 
peripheral cells from AD patients, compared to control cells (Honarnejad K. and Herms J., 2012). All the 
evidence proposes Ca2+ dysregulation as a player in the initial stage of the pathology, making Ca2+ 
hypothesis an interesting field to explore to better understand AD onset and progression. Despite opposite 
effects of PSs on CCE have been published, the majority of the studies reported a decrease in CCE in various 
cell models expressing FAD-linked PSs mutations. Moreover, CCE potentiation has been described as a 
consequence of PSs KO or deficiency (Yoo et al., 2000; Herms et al., 2003). These results were obtained by 
using chemical Ca2+ probes or they were carried out in cell population, employing Aequorin. In this study, 
the impact of FAD-PSs mutations on CCE was unravelled using the cytosolic Cameleon Ca2+ probe D3cpV. 
The use of a GECI presents numerous advantages, e.g.: the possibility of monitoring in single cell changes in 
[Ca2+]c in real time; the ability of performing ratiometric Ca2+ measurements, preventing artefacts due to 
focal plane shifts; the possibility of restricting analysis only to co-transfected cells. 
Firstly, the expression of FAD-linked PS1A246E, or PS1wt, and FAD-linked PS2T122R mutation, or 
PS2wt, in a neuroblastoma cell line (SH-SY5Y) causes a significant reduction of 30-40% in both CCE peak 
and rate, compared to controls. Since similar results could be caused by differences in PM potential (Penner 
et al., 1993), to exclude this possibility the collapse of membrane potential has been induced. Again, SH-
SY5Y cells expressing FAD-linked or wt PSs show a reduction of 25-40% in CCE peak and of 40-50% in 
CCE rate, compared to controls. Taken together, these results confirmed that the observed CCE reduction is 
not linked to differences in PM potential upon expression of the diverse PS forms. Of note, PS1wt and 
PS2wt overexpression mimic the effect on CCE of FAD-PS mutations. As previously reported by our 
laboratory, employing a tetracycline-inducible PS2 expression system in HeLa cells, Ca2+ dysregulation 
correlates with the PS2 protein expression level and higher level of PS2wt, compared to that of the FAD 
mutant, is required to obtain similar effects on Ca2+ handling (Giacomello et al., 2005). Thus, it can be 
speculated that the effect on CCE is due to an accumulation of PSs holoprotein, a phenotype potentially 
correlated to FAD-linked mutations (but that is also present upon the experimental overexpression of the wt 
form of the protein). Indeed, expression of PS2D366A (a mutant form of PS2 that precludes its 
endoproteolysis, preventing its incorporation in the γ-secretase complex) has been reported to cause a 
decrease in CCE (Zatti et al., 2004). To surely demonstrate that the effects on CCE are mediated by PS2 
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holoprotein further investigations are required. A pharmacological approach, inhibiting γ-secretase activity, 
and a genetic approach, using PS1 mutant “loss of function” for γ-secretase activity, could be employed to 
address this issue.  
In order to investigate CCE impairment in a more pathophysiological system compared to the exploited 
overexpressing models, CCE was investigated in FAD human fibroblasts carrying the PS1A246E or the 
PS2N141I mutation in heterozygosis. Fibroblasts carrying the PS2T122R mutation are not available 
anymore, however it has been previously demonstrated that in these cells the PS2T122R mutant induced a 
reduction in CCE rate and peak (Giacomello et al., 2005). Moreover, PS2N141I overexpression in MEFs 
(Yoo et al., 2000) and in HeLa cells (Zatti et al., 2006) has been shown to reduced CCE peak and rate. 
Human fibroblasts from a patient bearing the PS1A246E mutation show a reduction of 42% and 46% in CCE 
peak and rate, respectively, compared to healthy age-matched controls. Similarly, CCE in human fibroblasts 
from FAD patients carrying the PS2N141I mutation have been analyzed in comparison with fibroblasts from 
three healthy age-matched controls. In this case, the inter-individual variability is taken into account studying 
CCE in different healthy-individual fibroblasts. Unfortunately, fibroblasts from other FAD-PS2N141I 
patients are not available. Since no significant different was observed between controls, CCE peak values 
were averaged confirming that a reduction of around 30% and 44% in CCE peak and rate, respectively, is 
present in FAD fibroblasts. The involvement of PM potential in CCE reduction cannot be assessed in these 
cells, because of the presence of L-type VOCCs (Baumgarten et al., 1992) and the activation of a not well-
defined K+-exchanger.  
To provide some molecular hints about the mechanism by which PSs expression alters CCE, STIM1 protein 
level has been evaluated. Previously, an increased expression level of STIM1 in PS-DKO MEFs and patient-
derived B-lymphocytes expressing different FAD-PS mutations has been found (Bojarski et al., 2009). 
STIM1 protein levels in SH-SY5Y overexpressing PSs are significantly decreased (from -20% to -50%) 
compared to controls. Similarly, a reduction of around 40% was found in PS1A246E and in PS2N141I 
human fibroblasts, compared to controls. Thus, these data suggest that CCE reduction observed in fibroblasts 
is likely independent from changes in PM potential and, instead, correlates with the expression level of 
STIM1.  
Two are the proteins mainly involved in CCE: STIM1, the ER Ca2+ sensor and Orai1, the pore forming 
subunit of CRAC. Despite many attempts have been done, Orai1 protein levels failed to be evaluated by the 
available antibodies, because of the presence of non-specific bands that prevents the quantification of the 
expected specific one (at 35 or 50 kDa, depending on the glycosylation state of Orai1). An alternative 
approach, could be the evaluation of Orai1 and STIM1 mRNA level, in order to clarify if also Orai1 
expression is affected by PSs expression and whether the decreased STIM1 protein amount is due to 
transcriptional or post-transcriptional dysregulation. This is a critical point to address, since alterations in 
CCE peak and rate could be the result of the same phenomenon, but they could also be differentially 
mediated by either STIM1 protein level reduction or specific CRAC channel dysfunction, respectively. 
Moreover, different mechanisms, besides a decreased STIM1 level, could be involved in PS-mediated effects 
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on CCE. For example, PSs could somehow impairing STIM1 puncta formation, reducing STIM1 ability to 
activate Orai1. To investigate this point, puncta formation can be monitored employing FRET experiments 
expressing STIM1 and Orai1 constructs tagged with YFP and CFP, respectively.  
Finally, it should be considered that AD is a pathology linked to neuronal dysfunctions. It is still not clear 
which is the functional role of CCE in neurons, because in these latter cells Ca2+ influx from extracellular 
space is mainly due to VOCCs opening. However, recent studies reported an inhibitory effect of STIM1 on 
L-type Cav1.2 and T-type VOCCs (Park et al., 2010; Wang et al., 2010; Nguyen et al., 2013), opening the 
possibility of differential roles played by STIM and Orai in excitable cells. This latter point is surely worth to 
investigate, considering the observed reduction of STIM1 protein level associated to the expression of FAD-
PSs-linked mutations. 
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Materials and Methods 
 
Cell culture and transfection 
SH-SY5Y cells were grown in DMEM containing 10% FCS, supplemented with L-glutamine (2 mM), 
penicillin (100 U/ml), and streptomycin (100 µg/ml), in a humidified atmosphere containing 5% CO2. 
Human fibroblasts (from Coriell Institute for medical research: FAD-PS2-N141I (AG09908); control 
fibroblasts (AG08525)) were grown in DMEM containing 20% FCS, supplemented with L-glutamine 
(2 mM), penicillin (100 U/ml) and streptomycin (100 µg/ml), in a humidified atmosphere containing 5% 
CO2. Cells were seeded onto glass coverslips (18 mm diameter) and transfection was performed at 60-70% 
confluence using Lipofectamine™ 2000 Transfection Reagent (Life Technologies) for SH-SY5Y with 1 µg 
of DNA (0.25 µg of cameleon codifying cDNAs and 0.75 µg of pcDNA3 or PSs codifying cDNAs); 
fibroblasts were transfected by electroporation, using the Neon Transfection System (MPK500, Invitrogen). 
FRET measurements were usually performed 24 h after transfection.  
 
Ca2+ measurements 
FRET acquisition and analysis have been carried out as reported in PART-I of the Materials and Methods 
section. Cells, plated on cover slips (18 mm diameter), were mounted into an open-topped chamber 
thermostated at 37°C and maintained in an extracellular medium, composed by modified Krebs-Ringer 
Buffer (mKRB) containing in mM: 140 NaCl, 2.8 KCl, 2 MgCl2, 1 CaCl2, 10 HEPES, 11 glucose, pH 7.4, at 
37°C. For CCE activation, cells were pre-treated with the irreversible SERCA inhibitor thapsigargin (100 
nM) for 7 minutes in a Ca2+-free, EGTA (600 μM)-containing medium; cells were then perfused with the 
same medium without the inhibitor and challenged with CaCl2 (1.5 mM). Where indicated, extracellular-like 
medium was substituted with K+-based medium ( in mM: 5 NaCl, 130 KCl, 2 MgCl2, 3 CaCl2, 10 HEPES, 
11 glucose, pH 7.4, at 37°C).  
 
Preparation of Protein Extracts and Western Blot Analysis 
Human fibroblasts or SH-SY5Y cells overexpressing PSs were solubilised in RIPA buffer (50 mM Tris, 150 
mM NaCl, 1% Triton X-100, 0.5% deoxycholic acid, 0,1% SDS, protease inhibitor cocktail, pH 7.5) and 
incubated on ice for 30 min. Insolubilized material was spun down at 4000 x g for 5 min at 4°C. 35 μg of 
protein were loaded onto polyacrylamide gels (10-12%) and immunoblotted. Proteins were resolved by 
TruPAGE™ Precast Gels 4-12% (Sigma Aldrich) in TruPAGE™ TEA-Tricine SDS Running Buffer (Sigma 
Aldrich) and blotted onto a nitrocellulose membrane and probed with -STIM1 antibody (BD Transduction 
Laboratories Purified Mouse 1:250). The proteins are visualized in chemiluminescence using as secondary 
antibody -Mouse (Biorad, 1:5000). The intensity of the bands was analysed using ImageJ software. 
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Materials 
Thapsigargin was purchased from Sigma-Aldrich, all other materials were analytical or of the highest 
available grade.  
 
Statistical analysis 
All data are representative of at least three different experiments. Data were analyzed using Origin 7.5 SR5 
(OriginLab Corporation) to calculate CCE rates, and ImageJ (National Institutes of Health,) for the off-line 
analysis of FRET experiments (as reported in PART-I of the Materials and Methods section). Data are 
presented as a R/R0 values (where R is the change of the cpV/CFP emission intensity ratio at any time, R0 
is the fluorescence emission ratio at the time 0). 
CCE peak values were calculated as difference between peak and baseline values using Microsoft Excel. 
Numerical values presented throughout the text are mean±SEM (N=number of independent experiments or 
cells;  = p < 0.05, =p<0.01,  = p < 0.001, unpaired Student’s t test). 
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